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CHAPTER 1. 
Introduction 
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Parti. 
Clinical background of malignant hyperthermia. 
In 1960, Denborough and Lovell descnbed the case of a 21 year old man who was admitted 
to a Melbourne hospital for the surgical resetting of compound fractures of the tibia and 
fibula He appeared anxious about the prospect of surgery since he knew of several close 
relatives who had died during or shortly after general anaesthesia It was believed in the 
family that ether was responsible for the deaths, and the patient only consented to general 
anaesthesia provided that ether was not given The patient was administered pethadine and 
atropine as premedication, and general anaesthesia was continued with thiopentone, nitrous 
oxide, oxygen and halothane Within 10 minutes of the start of the operation, the patient 
developed hypotension and cyanosis, and halothane was reduced Tachycardia and a further 
drop in blood pressure signalled continued detenoration in the condition of the patient, and 
the operation was rapidly terminated A high fever then developed which required the patient 
to be cooled in ice Fortunately, the condition of the patient slowly improved dunng the 
following 1/4 hours, and further recovery proceded without incident Subsequent enquiñes 
revealed that ten out of 24 members of the patient's family who had been anaesthetised in 
the period from 1922 up to that time, had died dunng or shortly after surgery Inspection of 
the family tree led the authors to surmise that the factor responsible for the adverse reactions 
to anaesthesia was mhented as a dominant gene 
This was the first unambiguous report of the condition now known as malignant 
hyperpyrexia (or malignant hyperthermia, MH) Further reports of fulminant MH, including 
cases involving skeletal muscle ngidity (Saidman et a l , 1964), followed in the following 
decade It became apparent that some mechanism, once tnggered, initiated a catastrophic 
series of events leading to the loss of thermoregulatory control and death in at least 75% of 
all cases (Harnman, 1ΘΘ8, Strazia and Fox, 1ΘΘ3) Conditions closely resembling MH have 
also been observed in other species, including pigs (Hall et a l , 1966), dogs (Nelson, 1991) 
and horses (Klein and Rosenberg, 1987) 
Clinical manifestation of MH. 
Patients exhibiting some combination of the following symptoms can be descnbed as 
"classic" examples of the disorder 
1 A rapid rise m body temperature, sometimes at a rate of 2°C per hour, to more than 42°C 
2 Skeletal muscle ngidity 
3 Metabolic and respiratory acidosis 
4 Tachycardia or arrythmia 
5 Hyperkalemia 
6 Muscle tissue breakdown, as reflected in high concentrations of serum creatine kinase 
(frequently to >20,000 U/l) and myoglobinuna 
If not treated immediately, the MH patient may die within minutes from acute 
ventricular fibnllations, within hours from disseminated intravascular coagulopathy (DIC) or 
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pulmonary oedema (Gronert, 1980), or within a few days from neurological damage or 
obstructive renal failure (MacLennan and Philips, 1992) These last two conditions frequently 
contnbute to morbidity among MH survivors 
As can be surmised from the variety of presenting symptoms, MH has been 
considered to comprise a spectrum of disorders varying in seventy from the "classic" 
fulminant MH, to cases with mild symptoms and unusual presentations. Mortality may depend 
on how quickly the syndrome is recognized, on how quickly treatment is begun, and also on 
the vanability of the syndrome itself (Rosenberg, 19Θ8) Increased alertness among 
anaesthetists to the danger signals of developing MH, such as muscle ngidity after the 
administration of suxamethonium, dramatically increased end-tidal CO, concentrations and 
unexplained hypotension and tachycardia, led to a fall in the fatality rate from an initial 75-
80% in the early 1960s to approximately 45% in the 1970s (Stazis and Cox, 1993) The 
demonstration of the efficacy of the non-depolarizing muscle relaxant dantrolene sodium (1-
{[5-(p-paraphenyl) furfuryhdene] ammo} hydantoin) in treating porcine (Hamson, 1975, 
Gronert et a l , 1976) and human MH (Kolb et a l , 1982) has now led to a further reduction in 
MH fatality to less than 10% (Strazis and Cox, 1993) 
Triggering of MH. 
It is recognized that any volatile anaesthetic, but halothane in particular, and depolanzing 
muscle relaxants such as succinylcholine, can trigger fulminant MH in susceptible individuals 
However, cases of fulminant MH have been reported in patients who have previously 
undergone uneventful anaesthesia (Halsall et a i , 1979, Ellis et a l , 1986) and patients may 
also develop MH despite a normal response to succinylcholine (Rosenberg, 1988) Therefore, 
exposure of MH-susceptible (MHS) patients to these agents does not always result in the 
development of MH In addition, several cases have been described (reviewed by Strazis and 
Cox, 1993) where MH occurred subsequent to the administration of opioids (or drugs from 
other classes) in the complete absence of volatile anaesthetics 
Cases of MH outside the operating theatre are rare Among 15 reports reviewed by 
Strazis and Cox (1993), six were clearly associated with drug abuse (cocaine or 
phencyclidme) and another six were associated with drug therapy for psychiatric disorders 
However, four of the reported cases were apparently indistinguishable from neuroleptic 
malignant syndrome (NMS, see later) and in the other 11 cases the true causes of illness or 
death were difficult to establish However, a recent report descnbing severe rhabdomyolysis 
after a viral infection may represent a case of "ambulant MH" (Denborough et a l , 1994) The 
father of the proband had become ill from a flu-like virus and had complained of high fever, 
headache and muscle pains Symptomatic treatment did not result in any improvement in the 
patient's condition and he was admitted to hospital. Dunng the following three days the 
condition of the patient deteriorated with the development of acutely painful and severe 
swelling of calf, thigh and arm muscles, acute renal failure, respiratory distress, metabolic 
acidosis and gross rhabdomyolysis Despite intense efforts at resuscitation, the patient died, 
with his serum creatine kinase activity having risen to 243,000 U/L (normal 0-195 U/L) The 
only finding from septic screens was that his antibody titre to influenza В virus was raised 
fourfold The proband himself developed symptoms similar to his father two days after his 
father became ill with headache, fever and aching calf muscles The seventy of the reaction 
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in his father resulted in his immediate admisssion to hospital, where he recovered The 
patient was biopsied four years later and was diagnosed as MHS in the IVCT Significantly, 
the patient's paternal grandfather had died from renal failure following a flu-like ilness, and it 
was suggested that these cases of viral-induced rhabdomyolysis were a consequence of MH-
susceptibihty 
Masseter muscle ngidity 
The occurrence of masseter muscle ngidity (MMR) after induction with succinylcholme is one 
of the most common symptoms signalling the onset of MH (Rosenberg, 1988) MMR has 
been termed a "myotonic" reaction to succinylcholme since similar responses are sometimes 
observed in patients with myotonic disorders (Ellis, 1984) Rigidity usually resolves within 1-3 
minutes, and MH can follow within minutes or hours if the anaesthetic is continued 
(Rosenberg, 1988) The incidence of MMR has been estimated at 1 in 12000 patients who 
receive suxamethonium during general anaesthesia (0rding, 1985), but a retrospective study 
of its occurrence at the Boston Children's Hospital revealed MMR to have occurred in 
approximately 1% of all children who had received suxamethonium and halothane (Schwartz 
et a l , 1984) Several studies have indicated that approximately 50% of all patients presenting 
with MMR also prove to be MHS upon muscle biopsy (Ellis, 1984, Flewellen and Nelson, 
1984, Rosenberg and Fletcher, 1986) This implies that if the results of the Boston survey 
represent a true frequency of the propensity to develop MMR, then 1 in 200 people in the 
general population are also at nsk from MH However, MH crises do not develop this 
frequently, estimates as to the frequency of MH vary from 1 in 15,000 pediatric to 1 in 40,000 
adult anaesthetic procedures (Kaus and Rockoff, 1994) It would therefore appear that other 
factors modulate the development or seventy of MH Age may be one such factor, since 
52 1% of all reported cases up to 1992 were aged 15 years or less It would appear that as 
people age, the ease with which MH can be tnggered decreases Sex may be another factor, 
since there was no sex-bias in the occurence of MMR found in either the Boston or other 
surveys (Rosenberg, 1988) but in the USA males accounted for 68 8% of all reported cases 
of MH while representing only 40 1% of the general surgical population (Strazis and Cox, 
1993) Clearly, further studies will be required to resolve the discrepancy between the 
frequency of MMR and the occurrence of MH 
Diagnosis of MH. 
Although MH is not a common disorder, there has long been a need for a presymptomatic 
diagnostic test for MH pnmanly because of the autosomal dominant mode of inheritance of 
the disorder and the potentially disastrous consequences of an MH cnsis Although MH in the 
pig can be determined by the simple exposure of animals to 3% halothane and observing 
whether they develop muscle ngidity and high body temperature (the so-called barnyard 
challenge), such procedures are obviously impractical in man Several diagnostic tests for MH 
have been described over the years, but few have proven to be suffiently reliable or specific 
to be generally accepted 
Tests on blood 
The initial recognition of MH as being a disorder of skeletal muscle resulted in the 
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development of a test to measure the levels of creatine kinase (CK) activity in the serum 
(Denborough et al , 1970, Isaacs and Barlow, 1970) However it soon became apparent that 
while some MH patients exhibited elevated serum CK activities consistent with a subclinical 
myopathy, other MH patients had either normal or variably raised levels of serum CK (Ellis et 
al 1975) Moreover, elevated serum CK activity is a non-specific sign of muscle injury and 
may result from factors other than MH (Ellis et a l , 1972) Consequently, the value of serum 
CK estimation as an indicator of susceptibility to MH was considered to be limited (Ellis et a l , 
1975) 
A report that MH was possibly associated with the fluonde-resistant gene for plasma 
Cholinesterase (Whittaker et a l , 1977) prompted investigators to explore the possibility of 
screening for MH with a Cholinesterase test However, analysis of the Cholinesterase 
genotypes in larger MHS populations from Great Bntam (Evans et a l , 1981) and Denmark 
(0rding et a l , 1981) failed to demostrate any association between the fluonde-resistant gene 
and MH Indeed, it became clear that the frequency of the fluonde-resistant gene was similar 
in both affected and normal populations, thereby invalidating the test 
Proposals that MH was due to a generalized membrane defect (Gordon et a l , 1973) 
leading to increased membrane fluidity in many tissues prompted several studies to assess 
the potential of ascertaining MH nsk in blood cells Erythrocyte osmotic fragility (Zsigmond et 
al , 1978) and chemiluminescence after exposure to halothane (Jones and Bready, 1986) 
were both found to be useless for the diagnosis of MHS Ohnishi and co-workers (1988) 
studied the behaviour of the spin-label 16-doxylsteanc acid in erythrocyte membranes using 
electron paramagnetic resonance spectroscopy They reported an increase in the fluidity of 
MHS erythrocytes after exposure to halothane sufficient to distinguish MHS camers reliably 
However, the proposal of this technique as a non-invasive method for the diagnosis of MHS 
was not accepted since attempts to reproduce the results in other laboratones were 
unsuccessful (Halsall et a l , 1990) 
Platelet aggregation, platelet nucleotide depletion and Η LA typing (reviewed by 
0rding, 1988) have also been investigated as potential indicators of MH status, but none 
were found to be reliable Another test based on the measurement of calcium fluxes in quin2-
loaded lymphocytes upon exposure to halothane (Klip et a l , 1987) appeared adequately to 
separate MHS patients from normal controls, with the release of Ca2* being significantly 
greater in MHS cells However, the test required participants to fast overnight prior to 
venepuncture It was subsequently shown that penods of fasting affected the kinetics of 
calcium release in lymphocytes, and that the test distinguished more reliably between 
persons who had eaten within the previous 12 hours and those who had not, rather than 
between MHS and normal individuals (Fletcher et a l , 1990b) 
Tests on muscle 
A vanety of electrophysiological and biochemical tests (reviwed by 0rding, 1988) on skeletal 
muscle have been undertaken in the search for a test capable of reliably identifying MHS 
individuals Electrophysiological tests have included the counting of motor units (Britt et a l , 
1977), tourniquet tests (Roberts et a l , 1979), recruitment patterns after local administration of 
suxamethonium (Eng et a l , 1984), and the assessment of relaxation rates of elicited twitch 
responses (Lennmarken, 1987) While these tests have been claimed to detect abnormalities 
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in ΜΗ muscle, other myopathic conditions can mimic test results, and the degree of overlap 
between MHS and normal individuals observed in the tests abrogated their usefulness as 
reliable indicators of MH risk (0rdmg, 1988) 
The observation in swine that ATP levels were more reduced in MH muscle than in 
normal muscle after exposure to halothane resulted in an ATP depletion test which measured 
the ratio of sarcoplasmic ATP concentrations before and after equilibration in halothane 
(Harrison et a l , 1969) While this test apparently allowed the prediction of MH risk in pigs, in 
man it was found that the ATP ratio decreased with increasing age (Bntt et a l , 1976) and that 
the ATP ratios in normal and MHS muscle showed significant overlap (Sporn, 1981) 
Similarly, other tests based on the determination of glycolytic metabolites, myophosphorylase 
ratios, adenylate kinase and adenylate deaminase deficiencies, calcium uptake by the 
sarcoplasmic reticulum and heat production (reviewed by 0rding, 1988) all proved to be of 
little use for the diagnosis of MH-susceptibility 
Non-invasive assessment of MH risk has also been attempted using in vivo 3'P 
nuclear magnetic resonance spectroscopy (NMR) Measurements of the levels of 
phosphocreatine (PCr), inorganic phosphate (Pi) and ATP in the forearm flexor muscles 
during rest, graded exercise and post-exercise recovery in a group of MHS individuals and 
normal controls apparently revealed a clear elevation of the resting Pi/PCr ratios in MHS 
muscle compared to controls (Olgin et al., 1988) In contrast, a study on porcine MH muscle 
revealed no difference in Pi/PCr ratios at rest, but differences did appear after periods of 
anoxia (Foster et al., 1989) Another report described combined IVCT and 3 ,P NMR 
investigations in four MHS families (Kozak-Reiss et a l , 1990) In this study a perturbed 
energy metabolism was found in all patients diagnosed as MHS or МНЕ However, at least 1 
ΜΗΝ individual in each family also exhibited similar disturbances in muscle energy 
metabolism In the absence of a resolution to these problems, the value of this technique for 
the diagnosis of MH risk remained doubtful Moreover, increases in Pi/PCr ratios are 
observed in a variety of other conditions, with the consequence that in vivo 31P NMR has not 
been accepted as a useful and specific test for MH 
The in vitro contracture test 
The development of the only test considered to be sufficiently reliable and specific for the 
diagnosis of MH, the in vitro contracture test (IVCT), was initiated by Kalow and co-workers in 
1970 They showed that when muscle strips biopsied from patients who had survived MH 
were immersed in Krebs Ringers solution and exposed to caffeine, contractures developed in 
MH muscle at caffeine concentrations that were ineffective at eliciting contractures in normal 
muscle. They also noted that exposure to caffeine in the presence of 1% halothane enhanced 
the contractures in all muscle strips studied, but to a much greater degree in the MH muscle 
The use of halothane as a test agent in the IVCT, either alone or in combination with 
suxamethonium, was described shortly thereafter (Ellis et a l , 1971) The IVCT was further 
refined by the development of the dynamic halothane test (Ellis et a l , 1973) in which the 
length of the muscle stnp being tested was cyclically stretched and relaxed prior to halothane 
exposure Another contracture test involved the immersion of muscle strips in 80 mM KCl to 
induce complete depolanzation MH muscle was found to develop a marked contracture 
whereas normal muscle did not (Moulds and Oenborough, 1974a,b) Suxamethonium was 
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later excluded from contracture testing because it was shown that enhanced contractures 
observed in some muscle biopsies were elicited by the preservative in the preparation, and 
not by the drug itself (Galloway and Denborough, 1986) 
The European Malignant Hyperthermia Group (EMHG) was established in 1983 to co­
ordinate contracture testing for MHS, and a standardized IVCT protocol was published the 
following year (EMHG, 1984) The protocol required biopsy to be performed on the 
quadnceps muscle and that the muscle removed should be large enough for in vitro testing A 
size of 15-25 mm in length with a thickness of 2-3 mm was recommended The protocol 
required dynamic halothane, static halothane and static caffeine contracture tests to be 
earned out, and defined the threshold for contracture as the concentration of caffeine or 
halothane that produced a sustained increase in baseline tension of 0 2g A modified 
laboratory protocol (EMHG, 1985) allowed the diagnosis of MH status in the following 
categories 
MHS (susceptible) A caffeine threshold at a caffeine concentration of 2 mM or less 
together with a halothane threshold at 2% v/v or less 
ΜΗΝ (normal) A caffeine threshold at a caffeine concentration of 2 mM or more 
without a halothane contracture at 2% v/v or less 
МНЕ (equivocal) All other results 
The МНЕ category was created to minimize the nsk of false positive or false negative 
diagnosis, since it was envisaged that some МНЕ individuals would in fact be clinically MHS 
Unfortunately, the proportion of МНЕ results can be as high as 10-15% (Viering, 1987, 
Heiman-Patterson, 1993) Nevertheless, patients who test as МНЕ are usually advised that 
they are at nsk from anaesthesia It has long been recognized that patients suffering from 
neuromuscular disease can sometimes exhibit reactions that mimic MH dunng anaesthesia 
(see below), and a recent study showed that 16% of patients biopsied for the diagnosis of a 
variety of suspected neuromuscular diseases other than MH also proved to be МНЕ upon 
contracture testing Two patients actually tested as MHS (Heytens et al , 1992) While the 
IVCT may be the only reliable test presently available for the assessment of MH nsk, its 
failure to discnminate consistently between MHS and other neuromuscular disorders 
indicates that the test is not sufficiently specific Modifications to the IVCT employing the 
plant alkaloid ryanodine (see later) have been claimed to increase the specificity of MHS 
detection (Hopkins et a l , 1991a, Lenzen et a l , 1993), but these results await venfication 
MH and association with other disorders. 
Episodes resembling MH have been reported in a number of different neuromuscular 
disorders (reviewed by Brownell, 1988) and cases of congenital contractures (Froster-
Iskenius et al , 1988) However, the significance of this association has been the cause of 
much debate As mentioned above, the tendency of (neuro)myopathic muscle to react 
abnormally in the IVCT has also added to the difficulties encountered when attempting to 
distinguish MH from other diseases A few of the more significant associations that have 
been described in the literature are discussed below 
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Muscular dystrophies 
A recent report (Tang et a l , 1992) described the cases of two infants from families with no 
history of muscle disease or adverse reactions to anaesthesia Both infants developed 
"anaesthetic-induced mabdomyolysis" and fever strongly reminiscent of MH during halothane 
general anaesthesia, which only receded after treatment with dantrolene sodium 
Surpnsingly, examination of muscle biopsied from each child revealed pathology suggestive 
of Duchenne muscular dystrophy (DMD) This diagnosis was further supported when both 
tissue samples were shown to be dystophin-deficient, although neither child showed 
symptoms of DMD at the time of operation Clearly, administration of succinylchohne and 
halothane to dystrophic patients can precipitate life-threatening reactions In contrast, 5 DMD 
patients examined by Heytens and co-workers (1992) were diagnosed as ΜΗΝ in the IVCT, 
although one of two patients with Becker muscular dystrophy examined was diagnosed as 
MHS The lack of a clear correlation between MH and these muscular dystrophies would 
suggest that these clinical entities are not related 
Several cases of death due to anaesthesia have been reported in patients with 
myotonic dystrophy (DM, Harper, 1989) A single case has been reported where MH occurred 
dunng surgery on a patient with subclinical DM (Schellnack et al , 1976), but in contrast to the 
course of events in MH, a frequent cause of anaesthetic death in DM appears to be acute 
respiratory failure Thiopentone was first related to the development of respiratory difficulties 
in such patients (Bourke and Zuck, 1957), but a subsequent case review (Kaufmann, 1960) 
suggested that these deaths were due to a general depressive effect of the drugs rather than 
to any specific effect Moreover, muscle biopsies from DM patients do not exhibit the 
characteristic contractures of MH muscle upon exposure to halothane and caffeine (Harper, 
1989), and would therefore be classified as ΜΗΝ Nevertheless, the propensity of some 
dystrophic patients to react adversely to anaesthetic agents, either by developing MH-like 
episodes or respiratory failure, necessitates that an anaesthetic be chosen with care in 
patients with muscular dystrophies 
Exertional heat stroke 
This condition is a life-threatening syndrome characterized by high fever with rhabdomyolysis, 
hyperkalemia and acidosis, leading to acute renal, cardiac and haemostatic failure (Knöchel, 
1989) An association between heat stroke and MH was first made by Wingard and Gatz 
(1978) when they suggested that MH may be a stress syndrome More recently, a report 
described two soldiers who had collapsed from exertional heat stroke dunng intense physical 
training (Hopkins et a l , 1991) Muscle biopsies taken from the two soldiers were investigated 
in the IVCT Both samples reacted normally to caffeine, but both exhibited abnormal 
réponses to halothane, and one also reacted abnormally to ryanodine The soldiers were 
therefore diagnosed as МНЕ Contracture testing of family members showed the father of 
one soldier to respond abnormally to halothane while the father of the other responded 
abnormally to ryanodine The authors of this report concluded that the soldiers suffered from 
an underlying skeletal muscle abnormality, that while probably being distinct from MH, was 
possibly related to MH and could lead to abnormal responses in the IVCT 
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Myoadenylate deaminase deficiency (MDD) 
The absence of myoadenylate deaminase (MD) may result in exertional myalgia (Keleman et 
al 1982) An association between MDD and MHS was proposed when it was observed that 
MHS and MDD appeared to co-segregate in a family (Fishbein et a l , 1985) One of the 
patients investigated by Heytens and collegues (1992) for exertional myalgia was diagnosed 
as MHS and also found to be deficient in MD However, closer inspection of the family 
described by Fishbein and co-workers (1985) revealed that the MDD and MHS genes had 
entered the family via different routes and could therefore not be linked Furthermore, the 
MDD patient descnbed by Heytens had undergone uneventful general anaesthesia three 
times previously and an association between the two disorders was dismissed as 
coincidental Since MDD occurs in approximately 2% of the population (Fishbein et a l , 1978) 
it is perhaps to be expected that MHS and MDD occasionally occur together 
Neuroleptic malignant syndrome (NMS) 
The primary symptoms of NMS manifest as the development of muscle rigidity and 
hyperthermia dunng administration of neuroleptics or the withdrawal of dopaminergic agents 
(Heiman-Patterson, 1993) The muscle rigidity can lead to rhabdomyolysis which can in turn 
lead to acute renal failure Mortality in untreated NMS can be higher than 20%, but as in MH, 
this disorder can be treated successfully with dantrolene sodium It is the similarity of the 
clinical manifestations of NMS and MH that may lead to confusion when interpreting cases 
histories Both syndromes exhibit muscle rigidity, hyperthermia and a favourable response to 
dantrolene, and both can be triggered by pharmacological agents (Heiman-Patterson, 1993) 
However, tnggenng agents in NMS include neuroleptics drugs, or the withdrawal of 
dopaminergic agents (Hams et a l , 1987), while anaesthetic agents are not recognized as 
triggers of NMS In addition, drugs which can abolish ngidity in NMS, such as curare and 
diazepam, are ineffective in reducing muscle ngidity in MH (Heiman-Patterson, 1993), and the 
behaviour of NMS muscle in the IVCT is normal (Adnet et al , 1989, Reyford et al , 1990) 
Clearly, while the clinical manifestations of the two syndromes are similar, their underlying 
aetiologies differ 
Central core disease (CCD) 
A definite association does appear to exist between MH and central core disease (Shy and 
Magee, 1956) This rare myopathy is inherited as an autosomal dominant trait and is 
characterized by proximal muscle weakness and hypotonia CCD usually presents in infancy 
and the clinical course of the disease is either slow or non-progressive Diagnosis of CCD is 
based on the presence of amorphous myofibrillar 'cores' lacking oxidative enzyme activity 
The severity of the symptoms can vary from patients being asymptomatic, to patients being 
severely disabled by muscle weakness (Shuaib et a l , 1987) The association between CCD 
and MH was first recognised by Denborough and co-workers (1973), and a later study of 13 
CCD patients showed all to react abnormally in the IVCT Significantly, among these patients 
two had experienced MH reactions dunng general anaesthesia and a third had developed 
masseter ngidity following injection of suxamethonium (Brownell, 1988) Several families have 
now been identified where CCD and MH co-segregate (Haan et a l , 1990, Kausch et a l , 
1991, Quaneeta , 1993, Zhang et a l , 1993) 
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The aetiology of MH. 
Attempts to gain a better understanding of the aetiology of MH received an unexpected 
impetus from studies on the porcine stress syndrome (PSS) and the rapid postmortem 
degeneration of PSS pork to form a pale, soft exudate (Bnskey et a l , 1964) The syndrome is 
charactenzed by muscle ngidity, hypermetabolism and high body temperature leading to 
death as an acute reaction to stress Dunng an experiment wherein succmyl choline-
halothane anaesthesia was administered to a group of swine from a single litter, ngidity and 
hyperthermia strongly reminiscent of human MH was found to develop in three of the pigs 
(Hall et a l , 1966) A descnption of the clinical, biochemical and metabolic events dunng 
porcine MH (Berman et a l , 1970) served to emphasize the importance of the pig as an 
animal model for MH, and the majonty of biochemical, pharmacological and physiological 
studies on MH have been earned out since then using the porcine model 
Central and sympathetic nervous systems, and myocardium 
The thermal control of body temperature is regulated by the hypothalamus through the 
autonomous nervous system (Kandel and Schwartz, 1985), and disturbances in these 
systems can lead to alterations in the control of body temperature Dopaminergic blockade of 
the hypothalamus, for example, can tngger NMS (Heiman-Patterson, 1993) However, 
thermoregulation is apparently not disturbed in MH (Gronert, 1988) and so the nse in body 
temperature frequently observed dunng fulminant MH is not likely to involve the central and 
sympathetic nervous systems The factors responsible for the altered function of heart 
muscle during MH en se s remain, in contrast, the subject of debate Changes in the 
myocardium of MHS pigs have been reported (Hartigan and McGloughlm, 1980), and 
abnormal excitation-contraction coupling has been observed in heart muscle following 
exposure to halothane (Rower et a l , 1986) Suggestions that the cardiac disturbances which 
can occur in MH are due to ß-agonist effects (Gronert et a l , 1978) have not been confirmed 
(Böhm et a l , 1988) The observation that the use of drugs such as adrenaline, calcium and 
digoxin was associated with increased MH mortality led to the inference that cardiac muscle 
is abnormal in MH, and that the use of these drugs can produce MH responses in cardiac and 
skeletal muscle (Bntt, 1983) However, direct stimulation of cardiac muscle with calcium, 
digoxin and potassium in MHS pigs produced similar responses in both MHS and normal pigs 
(Gronert, 1986) 
Skeletal muscle 
When it was shown that PSS pigs exhibited the paradoxical reaction to anaesthetics and that 
PSS was a disorder of skeletal muscle (Topal et a l , 1968), it became apparent that skeletal 
muscle was the principal tissue involved in the aetiology of MH The experiments of Kalow 
and co-workers (1970) which demonstrated the abnormal response of MH muscle to caffeine 
served to support this view Caffeine was known to elicit contractures in skeletal muscle 
(Sandow, 1965) by enhancing the release of calcium from the sarcoplasmic reticulum (Weber 
and Herz, 1968) It was therefore proposed that the increased sensitivity of MHS muscle to 
caffeine was due to a defect in the regulation of calcium in skeletal muscle, and that the 
rigidity observed dunng MH occured as a consequence of an excessive accumulation of 
sarcoplasmic calcium with a resultant activation of the sarcomenc contractile apparatus 
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(Kalowet al , 1970) 
Since the intracellular site of calcium storage is in the sarcoplasmic reticulum 
(Peachy, 1965), studies have focussed on the SR as being the principal site for the 
localization of the MH defect The SR responds to sarcolemmal depolanzation via the 
transverse tubule system to release calcium into the sarcoplasm, which in tum activates 
muscle contraction ATP-dependent Ca2* pumps in the SR then return sarcoplasmic calcium 
concentrations to submicromolar resting levels It had been observed that increases in 
sarcoplasmic Ca2* concentrations to micromolar levels caused the release of calcium from 
the SR, a phenomenon termed calcium-induced calcium release (Endo et a l , 1970, Endo, 
1977) An indication that the mechanism of Ca2*-mduced calcium release might be altered in 
MHS muscle was provided when it was shown that skinned fibres from MHS muscle were 
more sensitive to calcium, and that the amount of calcium released was much higher than in 
normal muscle (Endo et a l , 1983) The development of techniques to ennch calcium release 
activity from crude prepearations of SR vesicles (Campbell et a l , 1980, Mitchell et a l , 1983, 
Meissner, 1984) allowed the direct investigation of calcium uptake and Ca2*-mduced calcium 
release in porcine MHS muscle A study by Mickelson et al (1986) showed that Ca2* uptake 
by MHS and normal SR was identical, and halothane was found to enhance Ca2* release to a 
similar extent from MHS and normal SR vesicles, although a more recent study indicated that 
halothane increased the rate constant of calcium release from MHS SR vesicles to a greater 
degree than vesicles from normal muscle (Louis et a l , 1992) Importantly, Ca2'-induced 
calcium release was found to be significantly enhanced m MHS muscle, while stimulation of 
calcium release by ATP or caffeine was greater than normal in MHS SR vesicles, and Mg2* 
was less effective at inhibiting this release These results suggested that a defect in the 
control of calcium efflux from the SR might underly the pathophysiology of MH (Mickelson et 
al , 1986, Louis et al , 1992) 
The source of the excessive sarcoplasmic calcium in MH crises has remained a 
subject for debate While the entry of extracellular calcium upon depolarization is essential for 
cardiac muscle contraction (Wier, 1991), it is not necessary for the initiation of skeletal 
muscle contraction, and MHS muscle still exhibits abnormal contractures in response to 
halothane and caffeine in calcium-free medium (Moulds and Denborough, 1974a) However, 
halothane- and caffeine-induced contracture cannot be maintained in the absence of 
extracellular Ca2*, and it has been proposed that a tight coupling must exist between the 
release of calcium ions from intracellular stores and their replacement from outside the cell, 
presumably via the sarcolemma (Moulds and Denborough, 1974a) Indeed, depolanzation of 
the sarcolemma per se has been implicated in the aetiology of MH (Gronert, 1988), since in 
addition to the known tnggenng effects of depolanzmg muscle relaxants (see earlier), 
halothane has also been shown to depolarize the sarcolemma by between 7-15 mV (Gallant 
et al , 1979) Furthermore, electncal stimulation produces exaggerated responses in MH 
muscle and can tngger fulminant MH in pigs (Ahem et a l , 1985) Previously, a defect in the 
sarcolemma of MH muscle resulting in an increased efficiency of intracellular Ca2' 
replacement had been proposed to explain the pathophysiology of MH (Moulds and 
Denborough, 1974a) Interestingly, halothane enhances the permeability of the sarcolemma 
for Ca2* significantly more in MH muscle than in normal muscle (Rock and Kozak-Reiss, 
1987) Nevertheless, a recent study has demonstrated that extracellular Ca2' is required for 
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maintenance of voltage sensor activity, which is rapidly lost in Ca2* free medium (Schmer et 
al , 1993) Therefore, the failure of muscle to contract in the absence of extracellular calcium 
may in fact reflect a reduction in voltage sensor activity rather than a failure to replace 
intracellular calcium 
Whether the influx of calcium into the sarcoplasm dunng an MH cnsis is from outside 
the cell or from intracellular stores, or both, it results in a severe metabolic disturbance within 
the cell The uncontrolled activation of the contractile apparatus together with the continuous 
removal of excess calcium by SR Ca2*-ATPases result in a rapid depletion of ATP Glycolysis 
is activated in the presence of elevated Ca2*, and both anaerobic and aerobic respiration 
increase sharply to replenish the phosphocreatine and ATP reserves (Heffron, 1988) The 
early signs of impending MH, namely elevated venous PC02 and lactate levels, and lowered 
pH and P02 (Gatz et a l , 1978), are therefore the direct result of the dramatic increase in 
metabolic activity triggered by the persistant increase in calcium levels Another early 
consequence of the nse in sarcoplasmic Ca2' is the activation of phosphohpase A2 (Berman 
et a l , 1970, Heffron, 1988) This leads to the liberation of free fatty acids from the membrane 
and increased sarcolemmal permeability The resulting leakage of inorganic phosphate, K* 
and Mg2* into the extracellular space, and the further reduction in the ability to regulate Ca2* 
fluxes exacerbate the metabolic imbalance The free fatty acids released by membrane-
bound phosphohpase activity can also influence SR function by enhancing Ca2* release 
(Fletcher et a l , 1990a, El-Hayek et a l , 1993, Dettbam and Palade, 1993) Calcium is 
sequestered not only by the SR, but also by mitochondna during an MH crisis (Stadhouders et 
al , 1984), and this may lead to depression of normal mitochondnal function and impairment 
of ATP production (Denton and McCormack, 1986, Gronert et a l , 1988) Indeed, the 02 
consumption at the climax of an MH cnsis may be elevated only three-fold above resting 
levels (Gronert, 1986) at a time when ngor may become acute and ATP may be depleted to 
levels approaching zero (Heffron, 1988) The VICIOUS cycle of events tnggered by the 
breakdown in calcium regulation during fulminant MH rapidly leads to membrane damage and 
the loss of larger molecules, such as myoglobin and creatine kinase, to the extracellular 
space Since the skeletal muscolature compnses nearly half the body mass, the heat 
generated during fulminant MH can lead to a rapid rise in body temperature Moreover, the 
loss of muscle tissue integrity with consequent hyperkalemia and disturbances of blood 
viscosity can exert severe, and often fatal, stresses on other organs 
Treatment. 
When the warning signals of acute phase MH present, treatment must be initiated 
immediately A recent guide on emergency therapy for MH published by the Malignant 
Hyperthermia Association of the United States (MHAUS) recommended that besides the 
immediate discontinuance of volatile inhalation anaesthetics and succmyl choline dantrolene 
sodium should be administered at doses of up to 10 mg/kg bodyweight until such time as the 
symptoms recede In addition, steps should be taken to combat hyperkalemia, metabolic 
and respiratory metabolic acidosis, high body temperature, and (if necessary) cardiac 
arrythmias Observation of the patient in an intensive care unit for up to 24 hours after the 
symptoms have passed was also recommended since recrudescence of MH may occur, 
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particularly after a fulminant episode resistant to treatment (Rosenberg, 1988) 
A number of drugs have been investigated for their ability to combat MH Calcium 
channel blockers such as verapamil have been found to be ineffective for the treatment of 
porcine MH (Gallant et a l , 1985), while procaine, which inhibits calcium efflux from the SR 
(Meissner, 1984) and can prevent caffeine contractures (Gronert et a l , 1988), has also been 
shown to exert no therapeutic effect in MH (Nelson and Flewellen, 1979) The one drug that 
has proven to be effective in reversing MH is dantrolene sodium (see earlier), and since its 
introduction in 1979 has been responsible for the reduction in MH mortality to less than 10% 
(Strazisand Fox, 1993) 
Dantrolene sodium is a muscle relaxant whose effects are particularly pronounced in 
skeletal muscle (Ellis and Bryant, 1972, Ellis and Carpenter, 1972, 1974) Its inability to 
induce relaxation in cardiac and smooth muscle, where muscle contraction is due to the influx 
of extracellular calcium rather than to the release of intracellular calcium, suggested that 
dantrolene blocked the efflux of calcium from the SR (Ellis and Carpenter, 1974) However, 
early in vitro studies of calcium release from isolated SR vesicles found no effect for the drug 
(Mickelson et a l , 1986) However, it was later shown that Ca2*-induced calcium release in 
skinned fibres was indeed blocked by dantrolene, but only at 37°C (Ohla et a l , 1989) and not 
at 22°C, the temperature at which the previous experiments were earned out (Mickelson et 
al , 1986) However, it is still not clear whether dantrolene inhibits the efflux of calcium from 
the SR directly or indirectly An initial report on the action of dantrolene suggested that the 
drug acted at two sites in excitation-contraction coupling (ECC) firstly by blocking the efflux 
of calcium from the SR and secondly by interfenng with the transfer of depolanzation signals 
from the sarcolemmal T-tubule to calcium efflux channels in the SR (Morgan and Bryant, 
1977) However, two recent reports indicated that dantrolene does not block calcium efflux 
from the SR, either in the presence or absence of volatile anaesthetics (Louis et a l , 1992), 
while it does inhibit binding of dihydropyndmes to the calcium channels of the T-tubules (El-
Hayek, 1992) It would therefore appear that dantrolene interferes with ECC by supressing 
the transfer of depolarization signals from the T-tubule to the SR, thereby inhibiting calcium 
release (El-Hayek, et al 1992) 
Part 2. 
The molecular genetics of malignant hyperthermia. 
The SR calcium release channel in porcine MH. 
The skeletal muscle sarcoplasmic reticulum had been known to be a site of calcium storage 
and release since the 1960's (Sandow, 1965), but significant progress towards the 
identification of the calcium efflux channel was made only when it was demonstrated that the 
neutral plant alkaloid ryanodine was able to enhance calcium release from the SR (Fairhurst 
and Hasselbach, 1970) Later studies showed ryanodine to bind with high affinity to a large 
protein present in the SR terminal cisternae, and that the protein was associated with the 
calcium release activity of the SR (Inui et a l , 1987) The development of monoclonal 
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antibodies to the ryanodine receptor (RYR) (Campbell et a l , 1987) allowed the subsequent 
immunoaffmity punfication of an approximately 450 kDa protein from rabbit skeletal muscle 
which, when incorporated into planar lipid bilayers, was shown to exhibit large conductance 
cation channel activity It was also shown that the binding of [3H]ryanodme to the channel was 
enhanced by micromolar Ca2* and milhmolar ATP, and was inhibited by tetracaine, millimolar 
Ca2', Mg2* and ruthenium red (Imagawa et a l , 1987), agents known to modulate calcium 
release from the SR in vivo Using [3H]ryanodine as a probe for the release channel, Lai and 
co-workers (1988) were able to isolate the protein from isolated heavy SR vesicles by sucrose 
gradient centnfugation Functional reconstitution of the isolated RYR protein in planar lipid 
bilayers revealed the presence of high conductance calcium currents sensitive to modulation 
by ATP, Ca2*, Mg2* and ruthenium red Taken together, the data indicated that the SR 
calcium efflux channel and RYR were one and the same (Lai et a l , 1988) Electron 
microscopy of the isolated receptor indicated that the native protein existed as a 'jack-like' 
(Inui et a l , 1987) or quatrefoil structure consisting of four subunits, with an estimated total 
molecular mass of approximately 1,600 kDa (Lai et a l , 1988) 
Molecular cloning of the RYR cDNA from rabbit (Takeshima et a l , 1989) and human 
skeletal muscle (Zorzato et a l , 1990) allowed the detailed structural analysis of this unusual 
protein The 15 kb human RYR mRNA was predicted to encode a protein compnsing 5032 
amino acids with a relative molecular mass (M,) of 563,584 Da, substantially higher than that 
estimated by SDS Polyacrylamide gel electrophoresis The protein was predicted to contain 
two potential transmembrane domains in the middle of the molecule and 10 in the carboxy 
terminal fifth of the molecule The remainder of the structure was found to compnse 
hydrophilic, presumably cytoplasmic domains (Zorzato et a l , 1990) Although the function of 
the ryanodine receptor was known to be modulated by adenine nucleotides, Ca2* and calmo-
dulin, no clear EF-hand structures or high affinity ATP-binding domains were detected, but 
three potential calmodulm-binding sites were found between residues 2807 and 3049 A 
glutamate-nch region between residues 1872 and 1923 was assigned as a putative low-
affinity Ca2*-binding domain Two highly charged sequences in the carboxy terminal fifth of 
the molecule were predicted to lie in the lumen of the terminal cistemae and were suggested 
to influence the gating activity of the channel, or to influence the interaction of luminal 
proteins such as calsequestnn (MacLennan and Wong, 1971) or calsequestnn-binding 
proteins (Mitchell et a l , 1988) 
A distinct isoform of the ryanodine receptor was subsequently cloned from cardiac 
muscle The 16 5 kb cardiac ryanodine receptor mRNA was found to encode a 4969 residue 
protein with a M, of 564,711 Da (Otsu et al , 1990) While exhibiting similar topologies, the 
skeletal and cardiac muscle proteins were found to be only 66% identical and were clearly 
encoded by separate genes A third and distinct 16 kb ryanodine receptor mRNA whose 
expression is induced by TGF-ß has also recently been cloned (Gianni et a l , 1992) This 
novel ryanodine receptor is expressed in a variety of tissues, including skeletal muscle, 
smooth muscle, liver, spleen, lung and kidney, but not in heart (Gianni et a l , 1992) 
The fact that alterations in the kinetics of calcium release appeared to play a crucial 
role in MH led investigators to study RYR activity in MHS muscle The maximum binding of 
ryanodine to the SR terminal cistemae from normal and MHS muscle was shown to be 
similar, thereby indicating that differences in the density of the channels in the SR could not 
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account for the altered calcium regulation (Mickelson et a l , 1988) In addition, ATP was 
found to increase the opening probability (P0) of both MHS and normal channels threefold 
above control, and ryanodine altered the gating behaviour of both MHS and normal channels 
in the same way (Fill et al ,1990) by locking the channel in a permanently open state of 
subconductance which was then insensitive to Mg2* and ruthenium red inactivation (Imagawa 
et a l , 1987, Rousseau et a l , 1987) It therefore appeared that the calcium release channel 
from porcine MHS muscle was completely functional (Fill et a l , 1990). However, binding of 
ryanodine to its receptor occurs when the calcium channel is open (Fleischer et a l , 1985, 
Meissner, 1986), and a significant increase in the amount of ryanodine bound by the receptor 
from porcine MHS muscle suggested that the P0 of the channel was increased in the 
presence of micromolar calcium concentrations (Mickelson et a l , 1990) The calcium 
conductance of single MHS channels was also found to be higher than normal (Fill et al , 
1990) In addition, measurements of single channels in planar lipid bilayers not only detected 
calcium currents from MHS channels at Ca2* concentrations (10^-103 M) that inhibited the 
opening of the normal channel, but also showed that the opening time of the channels from 
MHS muscle was much longer than normal (Fill et a l , 1990) The altered kinetics of calcium 
release from MHS SR vesicles described previously (Mickelson et a l , 1986) were therefore 
due to not only to an increased stimulation of calcium release via RYR by micromolar 
calcium, but also to a reduced sensitivity to the inhibitory effects of calcium at higher 
concentrations It appeared that a low affinity Ca2*-binding site in the ryanodine receptor was 
responsible for the inhibition of channel opening, and an alteration of the protein structure 
leading to a reduced affinity for calcium at the inhibitory site was proposed to explain the 
altered gating characteristics of the MHS channel protein (Fill et al , 1Θ90) Significantly, 
immunopeptide maps of the calcium release channel from MHS and normal pigs showed 
distinct and reproducible patterns from MHS muscle, suggesting that structural alterations in 
the release channel protein were indeed involved in porcine MH (Knudson et a l , 1990) 
Identification and expression of a point mutation in the RYR gene associated with porcine 
MH 
Detailed DNA sequence analysis of the RYR cDNA from normal and MHS pig muscle 
revealed а С - Τ point mutation at position 1843 which resulted in the substitution of a Cys 
residue at Arg615 (Fujii et al , 1991) This mutation was found to co-segregate with muscle 
hypertrophy and MHS in all strains of pig investigated In total, 338 méioses were found to be 
informative, yielding a logarithm of the odds (lod) score of 101 75 at a recombination distance 
of zero in favour of linkage between the C-1843-T mutation and MHS, and thus providing 
definite evidence of a causal association between the mutation and MHS (Otsu et al , 1991) 
Physiological evidence for an altered function of the mutant RYR protein was recently 
provided when full length rabbit RYR cDNAs modified to encode the Arg615Cys mutation were 
expressed in COS-7 cells (Treves et a l , 1994) The results showed the threshold for 
induction of intracellular Ca2+ transients by chlorcresol (a preservative used in 
succinylchohne preparations which has been shown to elicit contractures in skeletal muscle, 
Tegazzm and Gonano, 1994), to be three times lower in cells expressing the mutant protein 
than in cells expressing the wild-type RYR Since the threshold for chlorcresol-induced 
contractures in MHS muscle is 2 5 times lower than in normal muscle (Tegazzm and Gonano, 
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1994), it would appear that the single Arg6,5Cys amino acid substitution is itself capable of 
conferring the functional properties of the RYR protein from porcine MHS muscle (Treves et 
al, 1994) 
Since porcine ΜΗ is a recessive disorder (Mabry et a l , 1981), only those pigs carrying 
two copies of the mutant RYR gene would be expected to express the MHS phenotype A 
previous study by Gallant and co-workers (1989) on Yorkshire and Pietrain pigs had shown 
that exposure of isolated muscle bundles from halothane-sensitive homozygotes to 2 5% 
halothane resulted in a reduction in the tetanus tension developed and an increase in the 
relaxation times compared to normal Halothane-sensitive bundles also developed 
contractures characteristic for MHS muscle (Gallant et a l , 1989) Interestingly, while the 
contractile properties of muscle bundles from heterozygotes were similar to normal muscle, 
small halothane-induced contractures did occur in some cases In addition, signs of altered 
metabolism (elevated venous PC02 and [K*]) developed in the heterozygotes on prolonged 
exposure to halothane and succinylcholine, but these alterations were below the levels 
indicative of developing MH (Gronert, 1986) The calcium release and ryanodine-bindmg 
activities from SR isolated from the heterozygote animals were also found to be altered, but 
to a lesser degree than in halothane-sensitive animals (Mickelson et a l , 1989) Together, 
these results suggested that a single copy of the halothane sensitivity gene conveyed an 
intermedíate phenotype to earners 
The studies described above had used animals whose sensitivity to halothane had 
been determined in the so-called barnyard challenge (see diagnosis of MH), but the 
identification of the porcine RYR C-1843-T mutation allowed the direct analysis of the 
animals' halothane genotype A recent report (Fletcher et a l , 1993) extended the work of 
Gallant et al (1989) to Yorkshire/Duroc pigs genotyped for the RYR mutation In contrast to 
the earlier findings, in vitro contracture testing (according to the MHAUS protocol, Rosenberg 
et al , 1992) showed the responses of heterozygous and normal muscle to 3% halothane to 
be similar, while all animals homozygous for the C-1843-T mutation developed strong 
contractures However, four out of 15 C-1843-T homozygotes failed to develop muscle ngidity 
and other symptoms of MH upon prolonged, combined halothane and succinylcholine 
challenge Significantly, all 15 animals had previously developed ngidity in the barnyard 
challenge Consequently, it was concluded that while the C-1843-T mutation might be 
necessary, it was not sufficient for consistently eliciting the MH syndrome (Fletcher et a l , 
1993) Although interbreed differences may have accounted for the variable responses to 
halothane in the heterozygous animals, the failure of the four pigs to develop MH upon 
challenge suggested that other factors may modulate the development of MH in susceptible 
Yorkshire/Duroc pigs Age and gender were found not to be factors in this instance nor was 
initial body temperature, which has also been implicated as a modifying factor for the MH 
syndrome (Gronert et al , 1988) Other potential modulators of MH such as alterations in the 
levels of free fatty acids, inositol 1,4,5-tnphosphate and defects in the antioxidant defense 
system have been proposed to influence the onset of MH (Fletcher et a l , 1993, and 
references therein) Whatever the reasons for the failure to develop MH in the four animals, 
these results desenbed for the first time a vanable expression of the porcine MHS phenotype 
in a manner analogous to that found in humans (see masseter muscle ngidity) 
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The genetics of MH in man. 
Whereas the clinical manifestation of the porcine and human syndromes may resemble each 
other closely, genetically they differ significantly The principal difference between the two 
syndromes lies in the fact that the porcine syndrome is autosomal recessive (see above), but 
MHS in man is inherited as an autosomal dominant trait Nevertheless, genetic mapping of 
the porcine halothane sensitivity locus {Hal) provided an important starting point for the 
search for the MHS locus in man Double backcross experiments had indicated that Hal was 
linked to the glucose 6-phosphate isomerase (Gpi), the porcine H blood group antigen (H) 
and phosphogluconate dehydrogenase (Pgd) loci, with the order of loci being Gpi - Hal - H -
Pgd (Archibald and Imlah, 1985, Davies et a l , 1987, Davies et a l , 1988) The linkage group 
was assigned to porcine chromosome 6 (Harbitz et a l , 1990) In man, GPI was known to map 
to the q12-q13 2 region of chromosome 19 (Schonk et a l , 1988), and the fucosyltransferase 
1 and 2 (FUT1 and FUT2) loci associated with the expression of the human Η blood group 
antigen, had also been localized to chromosome 19 (McAlpme et a l , 1990) Since the GPI -
FUT1/FUT2 linkage group has been well conserved during evolution (Cavanna et a l , 1990), it 
appeared likely that the human homologue of the Hal locus would map to chromosome 
19q12-q13 2 
The molecular cloning of the skeletal muscle ryanodine receptor cDNA allowed the 
chromosomal assignment of the RYR1 locus Using a high-resolution mapping panel of 
human/hamster and human/mouse somatic cell hybrids containing defined chromosomal 
fragments of chromosome 19 (Schonk et a l , 1989), we were able to locate the RYR1 gene 
specifically to the proximal region of band 19q13 1 (MacKenzie et a l , 1990) Interestingly, this 
assignment placed RYR1 extremely close to GPI in the conserved chromosomal region, 
which strongly suggested that RYR1 might be involved in human MH also Indeed, two 
reports appeared that localized MHS to the region 19q12-q13 2 in a group of Irish and 
Canadian families (McCarthy et a l , 1990, MacLennan et al., 1990), with the consequence 
that RYR1 was proposed as a candidate gene for MHS (MacLennan et a l , 1990) 
The chromosome 19-specific somatic cell hybrid mapping panel used for the 
assignment of RYR1 also proved useful for the localization of other genetic markers 
potentially of use in the study of MHS inheritance A restriction fragment length polymorphism 
(RFLP) marker at D19S28 (Smeets et a l , 1989) and highly polymorphic dinucleottde repeat 
markers at D19S75 and D19S47 (Weber and May, 1989) were found to bracket the RYR1 
locus These markers, together with the RFLPs detected by several different fragments of the 
RYR1 cDNA (MacLennan et a l , 1990), finally opened the way to the detailed genetic analysis 
of MHS families worldwide Linkage between the D19S75 - D19S28 - RYR1 - D19S47 marker 
group and MHS was apparent in some families, with a lod score sufficiently high (>3, 
representing odds of > 1000:1 in favour of linkage) to allow presymptomatic genetic diagnosis 
of MHS (see later) However, other families were detected where clear recombination events 
had occurred between the linkage group and MHS, thus demonstrating genetic heterogeneity 
in MH (see later). Nevertheless, where linkage between the marker group and MHS could be 
demonstrated, genetic diagnosis of MHS became a reality The haplotypes of one such 
'chromosome 19' family based on the results of genetic analyses carried out in Nijmegen, is 
shown in figure 1 
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A mutation homologous to the porcine RYR1 mutation was detected in the human 
RYR1 gene and shown to result in a Cys614Arg substitution in the human RYR1 protein 
(Gillard et a l , 1991) However, this mutation was found to co-segregate with MHS in only one 
of 35 MHS families initially tested (Gillard et a l , 1991), and the limited occurrence of this 
mutation suggested that it might play only a minor role m MHS Indeed, subsequent studies 
have found an association between this mutation and MHS in less than 5% of all families 
investigated (EMHG, 1993) Attempts to identify other mutations in the human RYR1 gene 
potentially causitive for MHS have therefore been undertaken A detailed analysis of RYR1 
cDNAs from three MHS individuals identified 21 polymorphic sequence vanations in the gene 
(Gillard et a l , 1992) Four of the mutations resulted in amino acid substitutions, namely Arg 
for GlyJ4e, Cys for Arg470, Leu for Pro1785 and Cys for Gly2059 However, out of the 45 MHS 
families tested only the Arg248Gly mutation was found to co-segregate with MHS in a single, 
small family (Gillard et a l , 1992) The other three substitutions appeared to be unusual 
polymorphisms that did not affect RYRIprotein function (Gillard et a l , 1992) More detailed 
analyses of the RYR1 gene in other MHS families have recently led to the identification of 
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Figure 1. A large pedigree investigated for susceptibility to malignant hyperthermia by the in 
vitro contracture test (IVCT) Linkage between the MHS trait and the genetic markers for 
chromosome 19q was determined at our laboratory Depicted below each individual are the 
alleles detected by pnmers for the loci D19S75, D19S191 and D19S47 using the polymerase 
chain reaction (PCR) Shaded bars show the haplotype co-segregating with MHS 
Recombination events between D19S75 and MHS are indicated by shortened bars and 
exclude the MHS locus from the immediate vicinity of D19S75 No recombinations have 
occurred between MHS and allele 5 of D19S191, and allele 6 of D19S47 Pairwise lod scores 
in favour of linkage with MHS at a recombination fraction of zero are 4 61 for D19S191 and 
7 67 for D19S47 Lod scores were calculated using the MLINK program of the LINKAGE 5 03 
software package (Lathrop et a l , 1984) On the basis of the genetic data it can be predicted 
that the three family members diagnosed as МНЕ in the IVCT (shaded circles or squares) are 
in fact ΜΗΝ, since they have not inhented the MHS haplotype segregating in this family 
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mutations at positions 163 (Arg · Cys) (Quane et al , 1993) and 341 (Gly · Arg) (Quane et al , 
1994) Of particular interest is the discovery of point mutations in RYR1 associated with 
central core disease (CCO) at positions 403 (He · Met) (Quane et al , 1993) and at 2434 (Arg 
His) (Zhang et al , 1993) It would therefore appear that mutations in RYR1 can lead to two 
distinct clinical disorders, in a manner analogous to paramyotonia congentia and 
hyperkalaemic periodic paralysis, both of which are caused by mutations in the SCN4A gene 
on chromosome 17q (Caldwell and Schaller, 1992) Unfortunately, none of the six RYR1 
mutations identified to date are associated with more than 5% of MHS cases 
Despite the evidence in favour of an association between mutations in RYR1 and 
MHS in some families, it became evident early in the genetic analysis that the situation in 
man was clearly more complex than in porcine MH A first indication of genetic heterogeneity 
in human MH (McPherson and Taylor, 1982) was subsequently confirmed when multiple 
recombinations between the chromosome 19q linkage group and MHS were detected in both 
European (Deufel et a l , 1992) and North American families (Levitt et a l , 1991), thereby 
excluding RYR1 as a candidate gene for MHS in these families More recently, data 
accumulated from the genetic analysis of more than 100 families throughout Europe suggest 
that linkage between RYR1 and MHS occurs in less than half of all European MHS families 
(EMHG, 1993) and that proteins other than RYR1 must be involved in the aetiology of MHS 
Outline and aims of this study. 
At present, the only accepted test for the diagnosis of MHS is the IVCT The procedure is, 
however, expensive and invasive Moreover, the test is unsuitable for the assessment of MH 
risk in young children, and since more than 50% of all MH cases occur in children below the 
age of 15, an important and vulnerable group is unavailable for contracture testing The high 
incidence of equivocal results in the IVCT (10-15%, see earlier) also serves to emphasise the 
shortcomings of the IVCT Consequently, there exists an urgent need to develop more 
specific, and less cumbersome methodologies to replace the IVCT for the determination of 
MH status 
Since MHS in man is inhented as an autosomal dominant disorder, presymptomatic 
identification of earners of the MHS trait is theoretically possible by means of genetic testing 
Such a procedure, which utilizes genomic DNA extracted from white blood cells, is potentially 
not only much more accurate than the IVCT, but by being non-invasive, is also more patient-
friendly and less expensive Most importantly, DNA testing would be open to all age 
categones, thus allowing the reliable determination of MH nsk in the group of children 
particularly at risk from MH 
The principle aim of this study was, therefore, to develop new and highly polymorphic 
genetic markers for the MHS locus on chromosome 19q, and to apply them in the 
development of a simple diagnostic DNA test for MHS Initially, our search for new and 
potentially useful microsatellite repeat markers (Weber and May, 1969) focussed on the 
RYR1 region of 19q13 1, and yielded two novel markers at D19S190 and D19S191 (see 
appendices 1 and 2) However, as desenbed in chapter 3, use of these markers revealed 
further genetic heterogeneity in MHS As a result, the aims of the study were subsequently 
extended to search for microsatellite markers in or near other candidate MHS genes, and to 
27 
test them for linkage with those forms of MHS not linked to RYR1 As descnbed in detail in 
chapter 2, a close structural and functional relationship exists at tnadic junctions between 
RYR and the L-type voltage-dependent calcium channels, also known as dihydropyridme 
receptors (DHPR), of the transverse tubule system Since the two channels function together 
in excitation-contraction coupling to regulate the release of Ca2* from the SR in response to 
membrane depolarization, the genes encoding the five subunits of the human skeletal muscle 
DHPR were also considered to be potential candidates for a second MHS locus The genes 
were therefore isolated, assigned to chromosomal regions, and assessed for their potential 
involvement in those forms of MHS not linked to chromosome 19 The results of these 
investigations are presented in chapters 4 - 7 The insights into the aetiology of human MH 
gained from these studies, the conclusions which can be drawn, and the future directions of 
MH research are discussed in the final chapter 
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CHAPTER 2. 
The structural basis of excitation-contraction coupling in 
muscular contraction. 
A M. Stadhouders and D E Iles 
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In the early fifties biochemists succeeded in isolating a 'factor* from skeletal muscle capable of 
relaxing contracted muscle fibres The factor was subsequently shown to be comprised of 
complex vesicular elements which were in reality denved from two different, internal reticular 
membrane systems One system was composed of cisternae that were wrapped around 
myofibrils and were connected by a reticulum of longitudinally onented tubules, while the other 
membrane system formed tubules that transversed the muscle fibre at the level of the boundary 
between the anisotropic (A) and isotropic (I) bands of the repetitive contractile subunits, or 
sarcomeres The two systems were termed the longitudinal system or sarcoplasmic reticulum 
(SR) and the transverse or T-tubular system respectively (figure 1) Subsequently, it was 
demonstrated that the slender tubules of the T-system were in fact invaginations of the muscle 
fibre surface membrane or sarcolemma Zones of apparent contact between the two membrane 
systems are frequently observed, but a gap of approximately 12-15 nm always exists between 
them The aim of this bnef review is to present existing evidence concerning the structural 
organization of these areas of contact and descnbe the roles they play in the process of 
excitation-contraction (Ε-C) coupling 
Tnadic junctions and junctional feet. 
T-tubules and SR are structures unique to the muscle cell Contact between the T-tubular system 
and SR elements occurs at structures known as tnadic junctions or tnads and in electron 
micrographs of skeletal muscle, the tnadic junctions can be seen at the boundaries of the 
sarcomenc Α-bands and l-bands (figures 1 and 2) Each tnadic junction usually consists of two 
terminal cisternae of the SR flanking a single interposed T-tubule (figures 1, 2 and 7) Vanant 
forms consisting of one T-tubule and one terminal cisterna, or two T-tubules and three terminal 
cisternae may also be observed occasionally As mentioned above, T-tubules are invaginations 
from the sarcolemma and may be observed to continue directly into this membrane at the 
penphery of the muscle fibre 
In favourably onented and contrasted sections for electron microscopy regularly arranged 
specializations which maintain a 12-15 nm gap between the T-tubule and SR membranes can 
be observed (figure 3) Since these structures have been assumed to play a crucial role in E C 
coupling, they have been extensively studied to provide evidence for a direct physical link 
between the two membrane systems The specialized structures have been variously termed'feet' 
(Franzini-Armstrong, 1970), 'bndges' (Somlyo, 1979) or'pillars' (Eisenberg and Eisenberg, 1982) 
Three basic types of foot structure were defined by Franzini-Armstrong and Nunzi (19Θ3), 
namely feet that partially cross the junctional gap and are associated with the surface of the 
terminal cisternae but do not contact the T-tubule (type I), feet that form a single, amorphous, 
electron dense column that contact both the SR and the T-tubule membranes (type II), and feet 
which consist of two electron dense columns separated by a less dense core and which contact 
both the SR membranes and T-tubules (type III) In tangential views of the junctional gap it can 
be observed that these structures are comprised of four apparently spherical subunits arranged 
with tetragonal symmetry to form a quatrefoil structure They are regularly ordered with a centre 
to centre distance of approximately 30 nm (Ferguson et a l , 1984) 
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Figure 1. 
Diagram of the internal structure of a muscle 
fibre. Each myofibril (1) is surrounded by a 
segment of sarcoplasmic reticulum (SR) (2) at 
the level of the A- and l-bands. The longitudinal 
reticulum of the SR is termed the L-system. At 
the boundary of the A- and l-bands, the tubules 
of the L-system converge to form the terminal 
cisterna (3). Neighbouring terminal cistemae 
are separated by invaginations of the sarco-
lemma, termed T-tubules (T) which run 
perpendicularly to the direction of the myofibrils. 
The T-tubules anastomose transversely to form 
the T-system. The two terminal cisternae and 
the interposing T-tubules form a tripartite 
structure termed a triad (4), as depicted in the 
middle myofibril. In the lower part of the figure 
the transversely anastomismg T-tubular system 
an be seen to be in direct contact with the 
intercellular space. The openings (arrowheads) 
of the T-tubules appear on the surface of the 
muscle fibre at regular intervals. Outside the 
sarcolemma (6) lie the basal lamina (7) and a 
network of reticular and collagen microfibrils (8). 
(Reproduced from R.V. Krstic: Ultrastructure of 
the mammalian cell. Springer-Verlag. 1979.) 
Figure 2. 
Electron micrograph of 
segment of human skeletal 
muscle fibre (m quad­
riceps) Several myofibrils 
(My) are present in this 
longitudinal section and at 
least two sarcomeres are 
included in each myofibril. 
The anisotropic (A) and 
isotropic (I) zones of the 
transverse banding pattern 
are indicated. Profiles of 
mitochondria (M) are 
present on both sides of 
the electron-opaque Z-
lines in the middle of the I-
bands Note that the triads, 
some of which are 
encircled, are regularly 
arranged at the junction 
between the Α-bands and 
l-bands. 
Bar : 1 pm. 
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The various bridging structures were studied in detail by Dulhunty (1989). Using a variety of 
fixation and staining techniques, this author was able to show that the 'feet', 'bridges' and 'pillars' 
all showed the same regular periodicity and were frequently encountered side by side in the 
same junction. The results of this study indicated that the various junctional gap specializations 
described previously were in fact a single spanning structure and that the different appearances 
were the result of variations in the orientation of the triadic junction with regard to the plane of 
sectioning and/or the thickness of the section. 
The particular fixation and sectioning procedures used by Dulhunty to preserve 
cytoskeletal integrity demonstrated the presence of disc-like structures in the T-tubule lumen 
which appeared to tether the T-tubule walls into the characteristic elliptical shape. The tethers 
were seen to be arrayed in register with the foot structures spanning the junctional gap and 
aligned with calsequestrin strands in the terminal cistemae. Calsequestrin in turn appeared to 
be anchored to the inner SR membrane via thinner filaments in register with the outer edges of 
the junctional feet, with the result that calsequestrin molecules in opposite terminal cistemae 
appeared to be connected via the junctional feet and T-tubule tethers. 
Figure 3. 
Electron micrograph of human 
skeletal muscle (m. quad­
riceps). Arrowheads indicate 
triadic junctions favourably 
sectioned to show junctional 
feet between the transverse 
tubules and the sarcoplasmic 
reticulum. Observe a mitochon­
drion (M) running longitudinally 
between two myofibrils (My). 
Inset: enlarged triad to show 
the regular arrangement of the 
gap-spanning foot structures 
between the T-tubule (T) and 
the SR terminal cistemae 
(asterisk). 
Bar : 0.5 pm, insert 0.25 pm. 
Щ 
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Figure 4. 
"Ч Electron micrograph of V "w 4 
human skeletal muscle ^ Е ^ШІ) 
stained with lanthanum to 
demonstrate the strong 
cation binding capacity of the 
T-tubule luminal content. X \ \ 
Bar : 0.5 pm 
r> ^ 
4 
The T-tubule luminal tethers apparently contain abundant cationic binding sites as can be 
demonstrated by lanthanum staining (figure 4). The presence of buffers for cations may be of 
paramount importance since Ε-C coupling is sensitive to external calcium ion concentrations 
(Dulhunty and Gage, 1988; Brum et al., 1988), and a buffer near the voltage sensor could reduce 
Ca2* fluctuations arising from the activities of T-tubule calcium pumps (Malouf and Meissner, 
1979) and voltage-gated calcium channels (Aimers et al., 1981). In addition, buffers may be 
important for the orderly propagation of depolarization signals throughout the T-tubule system 
without the risk of electrochemical gradient generation between the extracellular environment and 
the T-tubule interior. 
Architecture of the triadic junctional membranes. 
Particularly relevant information on the architecture of cellular membranes can be obtained by 
using freeze-fracture techniques for electron microscopy. In this procedure cells and tissues, 
either prefixed or unfixed, are quickly frozen and then mechanically fractured, after which a 
shadowed replica of the surface is made. Since the fracture will often pass through the plane of 
the cellular membranes while splitting lipid bilayers midway through their thickness, details of the 
internal membrane structure can be viewed face on. This technique is particularly useful for the 
study of integral membrane proteins. 
When the triadic junctional membranes of a muscle fibre are freeze-fractured, four 
internal membrane surfaces are exposed (see figure 7). These are: (a) the cytoplasmic leaflet 
of the junctional SR membrane (jSRc), (b) the cytoplasmic leaflet of the junctional T-tubule 
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membrane (jTc), (c) t n e luminal leaflet of the junctional T-tubule membrane ΟΤΙ) and (d) the 
luminal leaflet of the junctional SR membrane (jSRI) Each leaflet exhibits distinct characteristics 
The jSRI carnes two rows of evenly spaced protrusions consisting of four rounded bumps 
enclosing a central pit The localization and penodicity of these protrusions are identical to those 
of the junctional feet, indicating that each foot structure lies above one such protrusion The jSRc 
carries numerous small particles which are distnbuted irregularly over the membrane surface, 
although small clusters of such particles are occasionally visible Both the jTI and jTc leaflets 
contain a population of tall, intramembranous particles which are clustered in orderly groups of 
four (jT tubule tetrads) and aligned in two parellel rows The spacing and disposition of the 
tetrads are such that they match the position of alternate feet and jSRI protrusions Each jT 
tubule tetrad is located directly above the centre of a gap-spanning foot structure, but since the 
longitudinal centre to centre distance between the jT tubule tetrads is twice that of the SR feet, 
there can be only one jT tubule tetrad for every two SR foot structures (Block et a l , 1988) 
Identification of molecular components of the triadic junction. 
Clues to the identity of the protein components of tnadic junctions have mainly come from studies 
into the binding of 1,4-dihydropyridme (DHP) calcium channel blockers and ryanodine The 
skeletal muscle DHP receptor is a slow (L-type) voltage-dependent calcium channel compnsed 
of five subunits, a, a2, β, γ and δ (Catterall, 1991), and is depicted schematically in figure 5 T-
tubules are highly ennched in DHP receptors, which exist as integral membrane proteins (Flucher 
et a l , 1990) The importance of these structures in Ε-C coupling has been demonstrated in 
cultured myotubes from dysgenic mouse (mdglmdg) skeletal muscle, which show a dramatic 
reduction in DHP binding, a lack of the L-type calcium current, and a total lack of Ε-C coupling 
(Tanabe et a l , 1988) A mutation in the gene encoding the DHP receptor a, subunit, which leads 
to a loss of functional protein from mdg/mdg muscle, has been shown to cause this lethal 
recessive condition (Chaudhan, 1992) The other subunits of the DHP receptor complex are 
expressed in dysgenic muscle, but in the absence of the a, subunit cannot assemble correctly 
Since jT tetrads are also absent from dysgenic skeletal muscle (Franzini-Armstrong et a l , 1991), 
it appears likely that the jT tetrads are in fact groups of four DHP receptors which function as the 
T-tubule voltage sensors 
The neutral plant alkaloid ryanodine has been shown to bind avidly to the Ca2* release 
channels in the junctional SR (Fleischer et a l , 1985), and the high affinity of this binding has 
allowed the isolation of the so-called ryanodine receptor The ryanodine receptor has been 
identified with the foot proteins by Block et al (1988) and been shown to exist as tetramer of 
apparently identical 565 kD subunits (Lai et al , 1988, Takeshima et a l , 1989) The crucial role 
played by this protein in Ε-C coupling has recently been demonstrated in mice wherein the 
ryanodine receptor gene had been functionally inactivated by targeted mutagenesis (Takeshima 
et al , 1994) Mice homozygous for the mutant gene (sW^/sW 1 ) exhibited a pennatally 
fatalphenotype, morphologically and physiologically closely similar to the mdg/mdg mice 
described above The normal function of the ryanodine receptor has also been shown to be 
mediated by a 12 kDa proline isomerase in recent studies earned out by Brillantes and co­
workers (1994) These investigators demonstrated a close association between this proline 
isomerase, known as the FK506-bindmg protein (FKBP12), and the ryanodine receptor, with 
FKBP12 associating with the ryanodine receptor at a ratio of 1 1 Therefore, four FKBP12 
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Figure 5. 
Schematic representation of the skeletal muscle L-type voltage-dependent calcium channel or 
dihydropyridine receptor. The proposed transmembrane conformation of individual subunrts is based on 
hydropathicity analyses of the cDNA sequences. Regions I, II, III and IV are the transmembrane domains 
of the α,-subunit, and + depicts the voltage-sensing amphiphatic α helix. Ρ depicts sites phosphorylated 
by cAMP-dependent protein kinases, S shows the disulphide bridge between the a2- and δ-subunits. 
Shaded boxes around the S5-S6 linker and the S6 transmembrane sequences of regions III and IV of the 
α,-subunit are thought to be involved in dihydropyridine (DHP) and phenylalkamine (PAA) binding. The 
arrowhead indicates the site where the C-terminal region of the α,-subunit is subject to post-translational 
processing. Hollow boxes indicate the S5 and S6 helices of each transmembrane domain thought to form 
the internal pore of the ion channel, and the intervening S5-S6 loop thought to be involved in ion selectivity 
(adapted from Hullin et al., 1993). 
molecules are associated with each foot, implying that the functional calcium efflux channel/foot 
structure is a complex with a molecular mass of approximately 2300 kDa. Block and co-workers 
have shown the foot structures to consist of two domains One is a large, hydrophihc domain that 
spans the junctional gap, while the other is a smaller hydrophobic domain that spans the jSR 
membrane. Computer generated reconstructions of the internal structure of the SR foot have 
shown it to contain a central pore which likely functions as the calcium channel (Wagenknecht 
et al., 1989) The central pore does not, however, continue through the foot structure to the 
surface facing the T-tubule directly, but procedes via four radial connecting channels into four 
peripheral vestibules, which in turn open to the sarcoplasm (figure 6). Therefore, calcium is 
probably released into the sarcoplasm at right angles to the central axis of the foot structure, and 
thus along the plane of the junctional gap. 
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Figure 6. 
Cross section of a computer-
generated three dimensional 
reconstruction of the foot 
structure/calcium efflux channel of 
skeletal muscle (ryanodine 
receptor). The reconstruction of the 
molecular interior shows that a 
single central channel (CC) leads 
outward through four radial chañéis 
(RC) to four peripheral vestibules 
(PV) which in turn open to the 
sarcoplasm. This structural orga-
nization may allow the release of 
calcium ions into the sarcoplasm at 
right angles to the central channel 
along the plane of the junctional 
gap. 
Knudson and co-workers (1993a,b) have recently isolated and characterized a 94 kDa 
glycoprotein predominantly expressed in skeletal muscle. This protein, termed triadin, was 
predicted to consist of a short (47 amino acids) cytoplasmic domain, a single transmembrane 
domain, and a large, glycosylated, basic and highly charged domain projecting into the SR lumen 
(Knudson et al., 1993b). Triadin was proposed to exist as a population of multimeric structures 
comprising variable numbers of the 94 kDa subunits. Immunofluorescent and immunocolloidal 
gold labeling showed the protein specifically to co-localize with the ryanodine receptor at the 
junctional SR (Knudson et al., 1993a). Furthermore, triadin and the ryanodine receptor were also 
found to co-localize in dysgenic mouse muscle SR, suggesting that the DHP receptor a, subunit 
is not required for triad formation and the normal assembly of proteins in SR terminal cistemae 
(Flucheretal., 1993). As mentioned previously, networks of calsequestrin present in the lumen 
of the terminal cistemae are anchored in close proximity to the calcium efflux channels by thinner 
filaments (Dulhunty, 1989; Franzini-Armstrong et al., 1987). Since calsequestrin is an acidic 
protein not directly associated with the SR membrane (Franzini-Armstrong et al., 1987), and in 
view of the proposed toplogy and charge of triadin, it has been suggested that the filaments 
responsible for anchoring calsequestrin to the inner SR membrane are strands of triadin 
multimers (Knudson et al., 1993b). 
The organization in the triadic junction of the structures described above is depicted 
schematically in figure 7. Also depicted in the figure are Ca2*-ATPases and phospholambans of 
the non-junctional SR, and the SR luminal glycoproteins gp 53 and gp 160, which are the 
alternatively spliced transcripts of the sarcalumenin gene (Leberer et al., 1989). The identity of 
the T-tubular tethers described by Dulhunty remains unclear, although a 28 kDa protein of 
unknown function has been described that localizes to T-tubules but not to the sarcolemma or 
SR (Jorgenson et al., 1990). In addition, proteins of 106 kDa (Zaidi et al., 1989) and 71 kDa 
(Chadwick et al., 1988) have been reported to localize to triadic junctions, but again, their precise 
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localizations and possible roles in Ε-C coupling, if any, have not been elucidated Other proteins 
involved in Ε-C coupling remain to be identified 
Excitation-contraction coupling. 
The process by which depolanzation of the sarcolemma results in the activation of the contractile 
apparatus represents an essential but still incompletely understood aspect of skeletal muscle 
function It is known that excitation of the sarcolemma results in the release of calcium ions from 
the SR, and the structural organization of the T-tubular system is such that the action potential 
is rapidly propagated to the intenor of the muscle fibre, thereby allowing the near simultaneous 
release of calcium throughout the muscle fibre almost immediately after depolanzation of the 
sarcolemma 
The central question in Ε-C coupling is how the electncal signal that is generated on the 
muscle fibre surface at the motor end plate and subsequently propagated down the T-tubule 
system, bridges the 15 nm gap to effect the release of calcium from the SR terminal cistemae 
In the past there has been much debate as to whether 'transmitter molecules', such as calcium 
ions or inositol 1,4,5-tnphosphate, are released into the junctional space and bind to SR 
membrane receptors to cause the opening of Ca2* release channels, or whether there is a direct 
structural link between the T-tubules and the SR membranes In this second model, voltage 
sensitive 'sensor1 molecules perceive changes in the potential difference across the T-tubule 
membrane and through conformational changes of gap-spanning components, induce the 
opening of the SR calcium channels In view of the structural data now available the latter 
mechanism of Ε-C coupling appears more likely However, molecules such as adenine 
nucleotides, Ca2* and Mg2* ions, fatty acids and phopsphohpids, and inorganic phosphate may 
modulate Ε-C coupling and calcium release from the SR 
Current evidence indicates that depolanzation of the T-tubule membranes is 'sensed' by 
the DHP receptor, which responds by voltage-dnven conformational changes accompanied by 
an outward movement of gating charge across the T-tubule membrane (Schneider and Chandler, 
1973, Catterall, 1991) A single cytoplasmic domain (DCL) between transmembrane domains II 
and III (figure 5) of the DHP receptor α,-subunit has been shown to determine the properties of 
skeletal muscle Ε-C coupling (Tanabe et a l , 1990), which strongly suggests that T-tubule 
depolanzation induces conformational changes of the DHP receptor within the tnadic junctional 
gap How these conformational changes result in the release of calcium remains unclear, since 
direct physical associations between the DHP receptor and the calcium efflux channel in situ 
have not been demonstrated (Knudson et al, 1993a, Flucher et a l , 1993) However, DCL's from 
skeletal muscle and cardiac muscle DHP receptors have been shown to activate isolated skeletal 
muscle calcium efflux channels in vitro (Lu et a l , 1994), strongly suggesting that depolanzation-
mduced conformational changes in the voltage sensor lead directly to conformational changes 
in the calcium efflux channel, which in tum open the central pore The open state of the pore is 
then stabilized by the FKBP12 protein (Bnllante et al, 1994) The close proximity of the DHP and 
ryanodine receptors in the triad certainly argues in favour of a physical association between the 
two structures directly related to their function in Ε-C coupling Dulhunty (19Θ9) speculated that 
conformational changes in the DHP receptor might also be transmitted via a connecting protein 
to calsequestnn, which in tum could lead to a reduction in the affinity of calsequestnn for 
calcium It is tempting to speculate that the connecting protein responsible for relaying 
sarcoplasmic reticulum 
terminal cisterna 
Figure 7. 
Schematic three-dimensional representation of a triad showing the relative positions of T-tubule tetrads 
(dihydropyndine receptors), SR foot proteins (calcium efflux channels or ryanodine receptors) and triadin. Also 
shown are the proteins of the SR lumen calsequestrin and calreticulin, and the glycoproteins gp53 and gp 160 
(sarcalumenin). The calcium ATPases and phospholamban pentamers are depicted on the outer surface of the 
SR. The ryanodine receptors occupy the T-tubule - SR junctional gap. Triadin molecules co-localize with the 
ryanodine receptors in the junctional SR and serve to anchor calsequestrin ajacent to the sites of calcium efflux 
from the SR. Dihydropyndine receptors are located in the T-tubule junctional membrane opposite alternate 
ryanodine receptors. The T-tubule tethers are not depicted in the figure (adapted from Franzini-Armstrong et al., 
1987, and MacLennan and Philips, 1992) 
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conformational changes in the T-tubule tetrads or ryanodine receptor to calsequestnn is triadm 
The opening of the calcium efflux channel and the simultaneous reduction in calsequestnn 
affinity for calcium would then allow the rapid release of calcium into the sarcoplasm The precise 
mechanism of Ε-C coupling still awaits expenmental venfication, but it has nevertherless become 
clear that the DHP receptor and the calcium efflux channel together fulfil an essential role in E-C 
coupling, and that their co-ordinated function results in the release of calcium into the 
sarcoplasm at an important site of myofilament interaction 
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Abstract. 
Malignant Hyperthermia (MH) is a potentially lethal, hereditary disorder of skeletal muscle 
which may be tnggered by inhalation anaesthetics and depolanzing muscle relaxants Defects 
in the gene encoding the ryanodine receptor (RYR1) localized on human chromosome 
19q13 1 have been proposed to be responsible for Malignant Hyperthermia susceptibility 
(MHS) Using a chromosome 19-specifìc human/hamster somatic cell hybnd mapping panel, 
we were able to determine that four closely linked microsatellite repeat markers bracket 
RYR1 with the order 19cen-D19S75-D19S191-RYR1-(D19S47, D19S190)-19ter Application 
of the four markers in genetic studies of MHS showed recombination between the markers 
and MHS in two families, with linkage analysis apparently excluding the MHS locus from the 
RYR1 region of 19q13 1 These results therefore support the recent observations of genetic 
heterogeneity in MH 
Introduction. 
Malignant Hyperthermia (MH) is an autosomal dominant disorder of skeletal muscle which 
manifests as a life-threatening hypermetabolic crisis triggered by commonly used inhalation 
anaesthetics and depolanzing muscle relaxants (Gronert, 1980, Bntt, 1987) The primary 
defect in MH appears to involve mechanisms which regulate myoplasmic calcium ion fluxes 
(Nelson, 1988) The gene on chromosome 19q131 encoding the skeletal muscle 
sarcoplasmic reticulum calcium efflux channel (ryanodine receptor RYR1) was proposed as a 
candidate gene for Malignant Hyperthermia susceptibility (MHS) when tight linkage between 
RYR1 and MHS was observed in Canadian families (MacLennan et a l , 1990, MacKenzie et 
a l , 1990) The coincident assignment of a MHS locus to 19q12-13 2 in Irish families 
(McCarthy et a l , 1990) further supported the hypothesis that defects in RYR1 were 
responsible for MH Mutations in RYR1 were also proposed to be reponsible for Central Core 
Disease (CCD) when the CCD locus was found to map to, or near the MHS locus on 19q13 1 
(Haan et a l , 1990, Kausch et a l , 1990) Recently, however, evidence has been presented for 
genetic heterogeneity in MH (Levitt et a l , 1991, Deufel et a l , 1992), and in only one family 
has a mutation in the RYR1 gene been shown to co-segregate with MHS (Gillard et a l , 
1991) Furthermore, detailed genetic examination of families in which CCD segregates has 
proved difficult due to a lack of informative markers for chromosome 19q13 1 New, highly 
polymorphic markers for this chromosomal region are therefore required to maximize the 
informitivity of those families in which MHS and 19q12-q13 2 markers do co-segregate, to 
allow the CCD locus to be mapped more accurately, and to allow the rapid identification of 
those families in which the MHS trait does not lie on chromosome 19 
We report here the physical and genetic mapping of a novel trinucleotide repeat, 
D19S190 (lies et a l , 1992a), and three dinucleotide repeat markers D19S47, D19S75 (Weber 
& May, 1989, Weber et a l , 1990) and the new locus D19S191 (lies et a l , 1992b) Using an 
existing panel of human/hamster somatic cell hybnds containing chromosome 19 
translocation products and der(19) fragments, we were able to determine the order of these 
markers relative to RYR1 in a region of approximately 15 cM surrounding the RYR1 locus 
Haplotypes of MHS families constructed from genetic data obtained using the four 
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markers revealed several instances in two families where the entire marker set segregated 
independently from the MHS locus These data apparently exclude the MHS locus in these 
two families from the region flanking RYR1 and thus support the recent suggestion that 
genetic heterogeneity may underlie the clinical heterogeneity in MH 
Materials and Methods. 
Somahc Cell Hybrids 
The constructor!, maintenance and cytogenetic analysis of the human/hamster somabc cell hybrids has 
been described in detail previously (Schonk et al, 19Θ9) Bnefly, the somabc cell hybrid 908K1 contains 
as sole human DNA a der(19,X) chromosome with a rearranged ρ arm (Hulsebos et al, 19Θ6) Irradiati­
on of 90ΘΚ1 yielded the somabc cell lines 908K1A1 and 908K1B which retained the der(19p) and 
der(19qcen-q13 2) segments respectively A further round of irradiabon of 908K1B yielded the somabc 
hybrids 908K1B1-908K1B30 which retained as sole human DNA chromosome 19q fragments 
beginning at the centromere and terminabng at various intervals in the 19q12-q13 2 region ORIM 7-1 
(Boyd et al, 1988) contained a t(X,19)(Xqter-Xp21,19q13 1-qter) chromosome in a hamster Wg3-h 
background, and 1219G2 (Schonk et al, 1989) contained a der(19) 19q13 1-19qter 12pter-12q15 
product, a small 19q13 1 fragment and chromosomes 5, 6,17,18, 20, 21 and 22 
DNA Analysis and Polymerase Chain Reactions 
Chromosomal DNA was isolated from somabc cell hybrids essenbally as described in Sambrook et al 
(1989), and from EDTA whole blood according to the method described by Miller et al (1988) 
DNA sequences for the synthesis of oligonucleotide primers (Pharmacia) for the markers 
D19S47 and D19S75 (PIC values 0 69 and 0 61 respectively) have been published (Weber and May, 1-
989, Weber et al, 1990) The sequences for D19S190 and D19S191 (PIC values 0 55 and 0 79 
respectively) were determined at our laboratory (lies et al, 1992a, 1992b) and are as follows D19S190, 
CCCATTGGTTGATTTTGCTGC (CAC strand) and TTCTACTTGGAGGAAGAGGAGG (GTG strand), 
D19S191, AGTAAAGAGGTTGAATTAA-TGACC (AC strand) and TGCCAGCGAAGCTATCTGG (TG 
•trand) Prior to all polymer··« chain reaction (PCR) «rmly··«, 100 ng AC strand primar (or CAC strand 
in the case of D19S190) per template was end-labeled with 32P as described (Weber and May, 1989) 
PCR conditions for D19S75 varied from the published protocols In that 100 ng genomic DNA templates 
were amplified in a volume of 50 μΙ containing 16 5 mM (NH4)2S04, 65 mM Tns-HCI pH 8 8, 4 mM 
MgCI2, 10 mM 2-mercaptoethanol, 0 15 mg/ml BSA, 0 2 mM each of dGTP, dATP, dTTP, dCTP, 100 
ng end-labeled AC primer, 100 ng TG pnmer, 0 5 unit AmpliTaq polymerase and 10% DMSO Samples 
were processed through 30 temperature cycles consisbng of 94°C for 45 seconds, 55°C for 60 seconds 
and 72°С for 45 seconds Condibons for D19S190 were as for D19S75, except that the magnesium 
concentrabon was reduced to 1 5 mM Amphficabon reacbons using the D19S191 and D19S47 markers 
were carried out in 1x GeneAMP buffer (Perkin Elmer Cetus) containing 0 2 mM dNTP, 100 ng TG 
strand primer and 100 ng 32P-labeled AC strand pnmer in a 50 pi final volume Samples were 
processed through 30 cycles consisbng of 94°C for 45 seconds, 45°C for 90 seconds and 72°C for 45 
seconds Allele sizes were determined on 8% denatunng Polyacrylamide gels as descnbed (Sambrook 
et al, 1989) 
MHS Families and In Vitro Contracture Test 
Family MH04 was referred to the University Hospital of Antwerp for neurological examinabon and 
assessment of MHS status after the proband suffered a suspected fulminant MH crisis The proband 
was admitted to hospital for a tonsillectomy, and anaesthesia was induced with fluothane After admi-
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nistrabon of succinyl choline, the patent developed severe m asse te г spasms, making tracheal 
intubation almost impossible, generalized rigidity and cardiac arrythmia Administration of fluothane was 
immediately stopped No increase in body temperature was noted, but the pabent developed 
myoglobinuria and the postoperative serum creatine kinase activity had increased to 26940 U/1 The 
patient suffered from painful muscle stiffness for 4 days after the operabon The pabent was confirmed 
as MHS in the Г СТ Family MH05 was referred to the University Hospital of Nijmegen after a family 
member had died as a result of anaesthesia (Houthooft and Schilderspel, 1974) MH status was 
determined using the standardized European in vitro contracture test (Г СТ) protocol (the European 
Malignant Hyperpyrexia Group, 19Θ4) The contracture tesbng procedure has been described in detail 
elsewhere (Klein et al, 1987) ΜΗ diagnoses fall under one of three categories namely MH-
suscepbble (MHS), MH-normal (ΜΗΝ) and MH-equrvocal (МНЕ) 
Linkage Analysis 
Two-point and multipoint linkage analysis was performed using version 5 03 of the LINKAGE program 
of Lathrop et al (1984) ΜΗ penetrance was assumed to be 1 0 for the probands, and 0 98 for MHS 
individuals whose MH status was assessed using the IVCT An unknown disease status was assigned to 
all untested and МНЕ individuals The frequency of the MHS allele was assumed to be 0 0001 For 
multipoint linkage analyses, we assumed a recombinabon fracbon of 0 1 between D19S75 and 
D19S191, and a recombinabon fracbon of 0 05 between D19S191 and D19S47 
Results. 
Cellular DNAs isolated from human/hamster somatic cell hybrids were taken as templates for 
PCR amplifications using primer pairs for the microsatellite repeat markers D19S47, D19S75, 
D19S190 and D19S191 The approximate human chromosome 19 content of each somatic 
hybrid cell line is shown in figure 1a 
Agarose gel analysis of the amplification products of the D19S190 primer pair 
revealed a band of approximately 110bp in all samples tested, including the negative hamster 
control (data not shown) However, analysis on denatunng Polyacrylamide sequencing gels 
showed that the product amplified from hamster DNA migrated as a distinct band between 
the human bands representing alleles two and three of the D19S190 marker system (figure 
1b) Human bands were detected in cell lines 908K1A, 90ΘΚ1Β18, ORIM 7-1 and 908K1B2 
Primers for D19S47 also amplified DNA from cell lines 908K1A, 908K1B18, ORIM 7-1, and 
908K1B2 (figure 1b), and the similar reaction patterns for D19S47 and D19S190 therefore 
place both markers in the same short interval of chromosome 19q13 1 delineated proximally 
by the breakpoint in cell line 908K1B26 and distally by the breakpoint in cell line 908K1B2 
Primers for D19S191 amplified DNA from 908K1A, 908K1B18, ORIM 7-1, 908K1B2, 
908K1B26 and 1219G2 Since the only human DNA from the proximal region of chromosome 
19q13 1 contained in cell line 1219G2 is a small fragment that cames the genes for GPI and 
MAG, this result places D19S191 in the immediate vicinity of these genes, and confirms the 
physical map location of the 5B18 (D19S28) probe used to seed the cosmid contig from 
which D19S191 was denved (lies et a l , 1992b) D19S75 pnmers amplified DNA from cell 
lines 908K1A, 908K1B18, ORIM 7-1, 908K1B2, -B26 and -B19, thus placing D19S75 proximal 
toD19S191 
We have previously shown that RYR1 cDNA hybndized with human DNA in the 
somatic hybnd 908K1B26, but not with 908K1B15 or in those cell lines whose chromosome 
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Figure 1. (A) Schematic representation of the chromosome 19 content of the human/hamster somatic 
cell hybrid mapping panel used in these studies. The detailed cytogenetic characterization of these cell 
lines has been described elsewhere (21). A physical map of genetic and anonymous DNA markers for 
the 19q12-q13 2 region is depicted to the right of the figure The order of D19S75, D19S191, D19S47 
and D19S190 have been determined in the present study, while the order of the other markers has 
been determined previously (16, 22, 23). (B) Polyacrylamide gel analysis (20) of the PCR products 
amplified from the somatic cell hybrids using primers for D19S75, D19S191, D19S47 and D19S190 
From each 50 μΙ PCR reaction volume, 1.5 - 2 μΙ was analysed on 8% polyacrylamide/6M ureum gels 
as described (20). Electrophoresis was carried out at 60W for 2 hours, and reaction products were 
visualized by autoradiography with or without intensifying screens at -80°C. The human/hamster somatic 
cell hybrid templates are indicated above each lane. (C) Detail of D19S190 reaction products after 
overexposure of the gel to show the human band (indicated by the arrow) in cell line 908K1B2 
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19q fragments terminate at intervals more centramene to 908K1B26. This effectively located 
the RYR1 gene very close, but proximal to the 908K1B26 breakpoint (MacKenzie et al., 
1990). From the previous RYR1 mapping data and the mapping data presented above, we 
conclude that the physical order of the microsatellite repeat markers relative to RYR1 is cen-
D19S75-D19S191-RYR1-(D19S47,D19S190)-19qter. The localization of the microsatellite 
repeat markers in relation to the physical order of other markers previously mapped to the 
q12-q13.2 region of chromosome 19 is presented in figure 1a. 
The set of four markers was used to test for linkage with an autosomal dominant MHS 
locus segregating in families from the Benelux. Neurological examination of the patients 
found no evidence of neuromuscular disorders, while histological examination of muscle 
tissue showed some minor alterations in a only a few patients. Importantly, no pathological 
changes characteristic for other neuromuscular diseases were detected. 
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Figure 2. MHS segregation data and haplotypes for D19S75, D19S191, D19S47 and D19S190 in 
families MH04 and MHOS. The order of D19S47 and D19S190 relative to D19S191 depicted in the 
figure is only for illustrative purposes. 
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Segregation data and haplotypes constructed from the genetic data obtained for families 
MH04 and MH05, neither of which was informative for RYR1 markers (data not shown), are 
shown in figure 2 Although we were unable to determine the MHS status of the grandparents 
in family MH04, we were able to determine the grandmatemal haplotypes and deduce the 
grandpatemal haplotypes Individual 301, the MH proband of this family, has inhented the 
MHS gene from his father (201), but the same chromosome 19 haplotype as carried by 201 
and passed on to his son, is also earned by four other family members, individuals 203, 207, 
216 and 220, who were diagnosed as being ΜΗΝ The other, presumably grandpatemal, 
haplotype earned by the MHS individuals 205, 209 and 218 has been passed on by individual 
205 to his daughter, 304, who was clearly ΜΗΝ, and is also earned by the unaffected 
individual 211 Therefore, neither of these haplotypes co-segregates with the MHS locus On 
the grandmatemal side, two crossovers between D19S75 and D19S191 appear to have 
occurred in individuals 201 and 220, with allele 1 instead of allele 2 of the D19S75 system co-
segregating with allele 4 of D19S191 Nevertheless, the crossover does not account for the 
difference in MH status between individuals 201 and 220, both of whom carry recombined 
chromosomes 19, since they further share identical haplotypes for all four markers tested 
The MH proband in family MH05 died as a result of anaesthesia and was unavailable 
for study, as were also his parents The proband's two sisters share one combination of 
alleles for D19S191 and D19S190 that has been passed on by individual 202 to her daughter, 
301, who was diagnosed MHS However, the proband's brother cames this same allele pair 
and was found to be ΜΗΝ Furthermore, the sister of 301 was also found to be MHS, but she 
has inherited the other D19S191/D19S190 allele combination from her mother, who is 
presumably an obligate carrier of the MHS gene A crossover between D19S75 and D19S191 
appears to have occurred in individual 202, but this does not influence the exclusion data 
since D19S191 and D19S190 bracket RYR1 and neither marker co-segregates with the MHS 
trait 
The results of twopomt linkage analyses are summarized in table 1 Combined two-
point lod scores of -1 83 at θ = 0 and -0 55 at θ = 0 1 for D19S75 would appear to exclude 
the MHS locus in these families from the region immediately proximal to D19S75 Moreover, 
two-point lod scores of -2 35 at θ = 0 (-0 92 at θ = 0 1) for D19S191, and -1 89 at θ = 0 (-0 59 
at θ = 0 1) for D19S47, further suggest exclusion of the MHS locus from the short interval of 
19q13 1 defined by these markers The results of combined multipoint linkage analysis (table 
1) showed lod scores lower than -2 across the whole 19q12-q13 1 interval between D19S75 
and D19S47, strongly suggesting that the MHS-1 locus in this region of chromosome 19q13 1 
cannot be responsible for the MHS trait segregating in these two families 
Discussion. 
The assignment of loci for the hereditary disorders of skeletal muscle Malignant Hyperthermia 
and Central Core Disease (CCD) to the proximal long arm of chromosome 19 (McCarthy et 
al , 1990, Haan et a l , 1990, Kausch et a l , 1990) and the coincident physical mapping 
(MacKenzie et a l , 1990) of a candidate gene for MH, RYR1 (MacLennan et a l , 1990), to 
19q13 1, aroused much interest in this chromosomal region and opened the way to the 
genetic study of greater numbers of pedigrees carrying the MHS and CCD traits 
Unfortunately, genetic studies have until recently been significantly hampered by the lack of 
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D19S75 
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MH04 
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MH04 
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Table 1. 
between MHS and D19S7S, D19S191, 
0 
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-1.84 
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-0 007 
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-0,007 
-0012 
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0 
0 
0 
0 
0.02 
0 02 
0 05 
0 
0 05 
0 009 
0 
0 009 
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Multipoint lod scores (bold type, 0 = 0) were calculated using LINKMAP and two-poml lod scores 
(plain type. 6 = 001 - 0 4 ) were calculated using ML1NK (13) assuming an autosomal dominant trait, 
untested and МНЕ individuals were assigned an unknown disease status N D DI9SI90 was not 
included in multipoint analysis 
sufficiently informative markers for chromosome 19q12-q13 2, a problem that has become 
more acute since the observations of genetic heterogeneity in MH (Levitt et a l , 1991, Deufel 
étal , 1992) 
We therefore undertook a search for highly informative microsatellite repeat markers 
in the chromosome 19q13 1 area surrounding the RYR1 locus, and sought to establish the 
accurate physical location of two other microsatellite repeat markers, D19S75 (Weber et a l , 
1990) and D19S47 (Weber & May, 1989) Our search for new markers yielded a tnnucleotide 
repeat polymorphism at D19S190 (lies et a l , 1992a) and a dmucleotide repeat poymorphism 
at D19S191 (lies et a l , 1992b) While D19S190 detects only 3 alleles, its PIC value of 0 55 
makes it significantly more useful in genetic studies than the conventional RFLP markers now 
available for chromosome 19q12-13 2, while the PIC value of 0 79 for D19S191 makes it one 
of the most informative markers in the vicinity of the RYR1 gene 
The results of physical mapping showed that D19S190 and D19S47 both lie in the 
same short interval of chromosome 19q13 1 immediately distal to RYR1 While both pnmer 
pairs apparently amplified the human target sequences in 908K1B2 less efficiently than 
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D19S191 and D19S75 (figure 1b), the observation that the primer pair for D19S190 also 
amplified rodent DNA implied that the D19S190 target sequence lies in an evolutionary 
highly conserved chromosomal region A computer search for open reading frames (ORF) in 
the sequence of the pOL5 12a2 clone which contained the (CAC)14 motif of D19S190 yielded 
three short putative ORF which continued through the repeat sequence and both pnmer pairs 
The deduced amino acid sequences contained stretches of 14 histidine residues, 14 tyrosine 
residues, or 14 tryptophan residues Detailed restriction analysis (data not shown) indicated 
that DNF11, the cDNA marker used to seed the cosmid contig from which D19S190 was 
derived, is situated at least 10 kb away from D19S190, and that D19S190 does not lie within 
any genomic domain recognized by the DNF11 probe We are currently investigating whether 
D19S190 is contained within transenbed sequences of another gene in close proximity to 
DNF11 
The panel of human/hamster somatic cell hybrids used in our studies (Schonk et a l , 
19Θ9) was originally developed for the definition of subchromosomal intervals of 19q around 
the Myotonic Dystrophy locus, but has become extremely useful for high resolution physical 
mapping of markers in the more proximal areas of chromosome 19 In particular, the 6 
breakpoints (figure 1a) clustered in 19q13 1 around RYR1 allow for accurate physical 
assignations of genetic and anonymous markers in the vicinity of this locus Consequently, 
we were able to determine unambiguously that D19S75 and D19S191 are proximal, and that 
D19S190 and D19S47 are distal to RYR1, with the physical order cen-D19S75-D19S191-
RYR1-(D19S190, D19S47)-ter However, limitations to the resolution of the mapping panel 
have not allowed us to determine the physical order of the last two markers relative to each 
other Moreover, it is difficult to relate directly physical orders to genetic distances without 
some points of reference A recent estimate of the sex-average distances between D19S9 
(pU2, Shaw et a l , 1986, known to map proximally to the 19q13 1 fragment of 1219G2, 
Schonk et a l , 1989), RYR1 and D19S47 of 4 9 cM and 2 8 cM respectively (J M Mulley, 
personal communication), would imply that D19S191 is located at a distance of 4 9 cM or less 
from RYR1, and at a distance of 7 7 cM or less from D19S47 This is in good agreement with 
a recent estimate of the genetic distance between GPI, which is very close to D19S191, and 
D19S47 of approximately 6 cM (Dr J Weber, personal communication) The eventual 
integration of D19S190 and D19S191 into the genetic map of chromosome 19q should 
hopefully resolve the precise order of the markers which map to the same intervals defined by 
the breakpoints in our somatic hybrid mapping panel 
To date, we have earned out genetic analysis of 5 MHS families, which together 
comprise a total of 58 méioses, using D19S75, D19S191, D19S47 and D19S191 Evidence 
for a MHS locus at chromosome 19q13 1 was found in three familes, with one large family 
showing no recombination between the D19S191/D19S47 marker pair and MHS in 26 fully 
informative méioses In contrast, segregation data for MH04 and MH05, families which have 
been clearly shown to carry the MHS trait and have had their MH nsk determined using a 
reliable IVCT protocol, apparently exclude RYR1 as the candidate gene for MHS in these 
families Combined multipoint linkage analysis with MHS as the test locus yielded lod scores 
below -2 for the whole region defined by D19S75, D19S191 and D19S47 In the light of 
recent observations of genetic heterogeniety in MH, we consider these results to provide 
further evidence for the existence of another MHS locus (or loci) distinct from the MHS locus 
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at chromosome 19q13 1 Further studies are currently in progress to identify a second MHS 
locus in the human genome 
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CHAPTER 4. 
Chromosomal localization of the genes encoding the α,-subunits of 
the heart and skeletal muscle L-type voltage-dependent calcium 
channels, CACNL1A1 and CACNL1A3: segregation analysis in 
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Abstract. 
We isolated and partially sequenced cosmid clones containing the human heart and skeletal 
muscle L-type voltage-dependent calcium channel genes, CACNL1A1 and CACNL1A3 Novel 
dinucleotide repeat markers for each locus were identified in these cosmids which allowed 
the assignation of CACNL1A1 to the distal short arm of chromosome 12 and CACNL1A3 to 
the distal long arm of chromosome 1 using panels of somatic hybnd cell lines These results 
were refined by fluorescence in situ hybndization expenments which localized CACNL1A1 to 
12p13 3 and CACNL1A3 to 1q32 1-q32 2 The markers were tested for linkage with malignant 
hyperthermia susceptibility (MHS) segregating in a group of families whose trait was 
previously shown not to be linked to the ryanodine receptor (RYR1) gene on chromosome 
19q13 1 Several instances of recombination between the markers and MHS were detected 
which exclude CACNL1A1 and CACNL1A3 as candidate genes for MHS in those families 
where recombination had occurred 
Introduction 
In cardiac and smooth muscle, the entry of extracellular calcium in response to membrane 
depolarization is an essential step in excitation-contraction coupling mediated by L-type 
voltage-dependent calcium channels (reviewed in 1), also known as dihydropyndine receptors 
(DHPR) In skeletal muscle, the DHPR apparently functions primarily as a voltage sensor in 
excitation-contraction coupling, and although it exhibits voltage-gated calcium channel 
activity, the entry of extracellular calcium is not required for skeletal muscle contraction 
(reviewed in 2) The DHPR α,-subunits, which form the ion pore structure of the channel 
complex and bind calcium channel blockers (reviewed in 3), exhibit a strong topological 
similanty to members of the superfamily of voltage-gated, ion gated, and second messenger-
gated ion channels (4) However, despite their structural similarities, the L-type a,-subunits 
exhibit a notable degree of molecular diversity, with distinct a, protein isoforms having been 
identified in skeletal muscle, cardiac muscle, brain, and pancreatic ß-cells (reviewed in 5) 
The genes encoding the brain (CACNL1A2) and cardiac isoforms (CACNL1A1) have 
previously been localized to human chromosomes 3 and 12 respectively (6, 7), while the 
skeletal muscle α,-subunit (CACNL1A3) has recently been mapped to chromosome 1q31-q32 
(8) In this report, we descnbe the identification and charactenzation of new, highly 
poymorphic dinucleotide repeat markers for CACNL1A1 and CACNL1A3, and the refined 
localization of the genes by fluorescence in situ hybridization (FISH) and physical mapping 
Hereditary disorders associated with defects in the regulation of intracellular Ca2' 
concentrations are conceivably due to mutations in calcium channels The potentially fatal 
pharmacogenetic disorder of skeletal muscle malignant hyperthermia (MH) is caused by a 
breakdown in the regulation of Ca2* influx into the sarcoplasm (9) tnggered by commonly 
used volatile anaesthetic agents such as halothane, and depolarizing muscle relaxants such 
as succmycholme (10) An MH cnsis is characterized by some combination of the following 
symptoms elevated body temperature, skeletal muscle rigidity, tachycardia and arrythmia 
respiratory and metabolic acidosis, myoglobinuna and elevated serum creatine kinase 
activities (11) The gene encoding the skeletal muscle sarcoplasmic reticulum calcium efflux 
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channel (RYR1, 12) was proposed as a candidate gene for MHS on the basis of tight linkage 
between MHS and markers for the RYR1 region of chromosome 19q13 1 (13, 14), and 
mutations in the RYR1 gene have recently been identified in some MHS families (15-17) 
However, several MHS families have also been identified where no linkage between RYR1 
and MHS exists (18-21), thereby providing evidence that mutations in genes other than RYR1 
can underly this disorder 
In order to investigate the potential roles played by the CACNL1A1 and CACNL1A3 
genes in MHS, we tested the new microsatelhte repeat markers at these loci for linkage with 
MHS in a group of families whose trait had been excluded from the RYR1 region of 
chromosome 19q31 1 (18-21) Several instances were detected where marker alleles and 
MHS did not co-segregate, with the results of linkage analyses not supporting CACNL1A1 
and CACNL1A3 as candidate genes for MHS in these families 
Materials and methods. 
Cosmid isolation and characterization 
Clones were isolated from a human genomic DNA cosmid library (kindly provided by Dr Marten Hofker, 
University of Leiden) on the basis of hybridization to the complete rabbit cardiac α,-subunrt cDNA (22), 
and to a 1 5 kb BamHI fragment from the rabbit skeletal muscle α,-subunrt cDNA (23), using standard 
procedures (24) Random Sau3AI fragments from positive cosmid clones were subcloned into pGEM4 
and rescreened with the same cDNA probes used to screen the cosmid library Positive subclones were 
sequenced using dideoxy chain termination (25) and T7 DNA polymerase (Pharmacia) on double 
stranded plasmid templates All DNA sequences were analysed using Intelhgenetics 5 4 software and 
the University of Nijmegen CAMMSA package Cosmids CCCha19 1 and SMDHPa12 4 were found to 
contain sequences homologous to the cardiac and skeletal muscle DHPR α,-subunrt genes 
respectively, and were taken for further studies The sequences of two subclones from CACNL1A3 
have been submitted to the EMBL database (accession numbers Z22672 and X75503) 
Identification and charactenzahon of microsatelhte repeats at CACNL1A1 and CACNL1 A3 
SauSAI subclones from both cosmids were also screened for the presence of potentially polymorphic 
microsatellrte repeats as described previouly (20) The Repeat motifs found in cosmids CCCha19 1 
and SMDHPa12 4 have been deposited in the EMBL database (accession numbers Z18274 and 
Z18273) 
Somatic hybnd cell lines 
The generation and maintenance of human/hamster and human/mouse somatic hybrid cell lines 
containing fragments of human chromosomes 1 and 12 have been descnbed in detail elsewhere (26, 
27) For these studies the following cell lines and their human chromosome contents from each panel 
were selected chromosome 12, A3TE7b, intact human chromosome 12, A3JA5b, 12qter-12p13 1, 
M28, i(12p), WgM1 1, 12cen-12p12 2 12p12 2-12pter Chromosome 1 12CB17B, intact chromosome 
1. HRA11, 1pter-1q21, PaC2,1pter-1q31. PaD1, 1q31-1qter, AN27, 1q42-qter 
Polymerase chain reaction (PCR) analysis of genomic DNA 
Chromosomal DNA was isolated from human/hamster and human/mouse somatic hybrid cell lines and 
from peripheral blood lymphocytes using a high salt method (28) Amplification reactions were carried 
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out in 50 μΙ volumes containing 50 mM KCl, 10 mM Tns-HCI pH 8 4, 1 5 mM MgCI2, 100 ng each 
primer, and 0 5 U Taq DNA polymerase using a 'hot start' procedure (29) Reactions were processed 
through 30 cycles involving denaturabon at 94°C for 40 seconds, annealing at 55°C for 30 seconds and 
extension at 72°C for 30 seconds Amplification products from somatic hybrid cell lines were resolved 
either on 2% agarose gels or 6% denaturing Polyacrylamide gels Denaturing Polyacrylamide gel 
electrophoresis was also used for the resolution of alleles at the CACNL1A1 and CACNL1A3 loci in 
MHS families, when one primer from each pair was labeled with 32P as described (30) 
Fluorescence in situ hybridization 
Cosmid DNA (1 pg) was labelled with ЫоЬп-14-dATP (Sigma) using a two-nick system (Life 
Technologies), and hybridized to high resolution chromosomal preparations as described (27) Details 
of the procedures for hybridization, immunocytochemical detecbon of hybridized probe, reverse banding 
and staining have been reported previously (28) Chromosomes were viewed under a Zeiss Axiophot 
epifluorescence microscope equipped with filters appropriate for the visualization of FITC and 
propidium iodide fluorescence Recording and processing of digital images were carried out as 
described (28) 
MHS families and linkage analysis 
The clinical backgrounds and case reports of the MH probands in families MH04, MH06, MH09, LMH03 
and LMH08 have been described in detail elsewhere (18-21) The assessment of MHS status of 
probands and their relatives was earned out using the standardized European halothane/caffeme in 
vitro contracture test (IVCT) (32), which recognizes the following categories MH-susceptìble (MHS), 
ΜΗ normal (ΜΗΝ), MH-equivocal caffeine (MHEc) and MH-equivocal halothane (MHEh) Pairwise 
linkage analyses for CACNL1A1 and CACNL1A3 against MHS were carried out using MLINK program 
of the LINKAGE version 5 03 software package (33) The frequency of the MHS allele was assumed to 
be 0 0001 without mutation, MHS penetrance was assumed to be 1 for probands, 0 98 for those 
diagnosed as MHS in the IVCT, and 0 02 for those diagnosed as ΜΗΝ An unknown disease status was 
assigned to all untested and МНЕ individuals 
Results. 
Isolation and partial DNA sequence analysis of genomic clones for CACNL1A1 and 
CACNL1A3 
Genomic clones were isolated from a human genomic DNA cosmid library on the basis of 
hybridization with the rabbit heart and skeletal muscle DHPRa,-subunit cDNAs The identity 
of the cosmtds was confirmed by sequencing subclones which also hybndized with the cDNA 
probes One subclone from cCCChalP» 1 (figure 1a) was found to contain a sequence 
exhibiting 100% homology with nucleotides (nt) 6657-6768 of the human heart DHPRa,-
subunit cDNA (34) and 9 1 % homology with rabbit heart sequence (35) The predicted amino 
acid sequence shows significant homology with the rabbit heart a , protein in a region of the 
C-terminal cytoplasmic domain showing no significant homology with the skeletal muscle 
isoform Shown in figure 1b are the partial sequences determined for two independent 
subclones from cosmid SMDHPRa12 4 which were found to exhibit homology with the rabbit 
skeletal muscle α,-subunit cDNA (36) Alignment of the human and rabbit sequences showed 
the subclones to contain two putative exons exhibiting 92% homology to nucleotides 3981-
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hi l t TqqCOTOQAAOCTCAQCTCCftftrMlgtaagtgggaggotggccaccccaffgoggcacacag 
r h t CK λ α 
V A W K L S S H 
В. 
Exon Α. 
ham QATCCTACTGGCCTGCAÍK^ATGGGAAGCTOTGTa^CCJlGAGTCGGACTATtKCCCAcra^^ 100 
i m O С Τ С А С Θ С О C C 
3 9 9 1 
ham TTCATCAGCTlH.TACATOCfClt jUHJCcrrcCTgjt^aqacqcfc^aqy^oqtqtJg^mgcaqyaf f i iqqgctttqataaqctqagycatgygyagcctgootg 2 0 0 
ram С 
4 1 1 3 
ham c c a a t t c c t g g c c a g t t t o o a a c t c t c a t g g g a t t a a t a t e g g g g a c g c a g g a g g a t c t a g t t a g g t t g t c c a a a t t e t g g t a a t a t g a g t g t g g o t t t g 3 0 0 
Eton В. 
ham a a g c g t g y c a a g t g a a a c o t o c c a g o t c c c o c a a c a t a a c c a t g t a c c a c c t g c o t t t c t g t g t t g g g a o c o c t t g g t t a t t o t a t t g c a g a T C A T C A A C 1 0 0 
ram А 
4114 
ham CTCTTTOTGeCTGTCATCATeOACAATnTGACrACCTCACCCGGGACTGG^ 2 0 0 
r a m С С О А С C C T 
ham A G T A T G A C C C A a A a g a t a a g t g a g t c a a a t o t g t a g g c t c t g t g c t g g g c c c t o c a t a c t a g a c o c t t c o t a o o g t c t c a o a g g g a g t c a c t a t c c a g t f c 3 0 0 
4 2 3 6 
hflm t a t t c a g t a t g a g t g g g e t t a t e c t t c c c c c t t c a t t t a t a t g a g g t e t c a g a t a 
3 5 4 
IVS6 I I -hand 
ham ILUtCSYaKLCDPESDYAP- - ЕЕгТОТТНГА УУГІЗГУНЬСАІЪ ІНЬГ А ІИЭНПЗ ЪТгаЖЗІЬОРКНІІЗЕГкЛІ ІАВ ОРС 
ram 1Э2 I 
h h i 1 3 9 2 И HF К A EPSHSTBO TP SS VT I А 
Figure 1. A) Alignment of a partial nucleotide sequence from cosmid CCCha19 1 (hht) with the rabbit 
cardiac muscle DHPRa,-subunrt cDNA (rht) sequence (22) The region of exact identity with the human 
cardiac α,-subunrt is depicted in upper case letters and the putative intron sequence is shown in lower­
case letters Numbers to the right of the figure indicate the positions in the human and rabbit heart cDNA 
sequences (22 34) The predicted partial amino acid sequence encoded by the region of homology is 
shown below the DNA sequence Differences in the rabbit cDNA and amino acid sequences are 
indicated below the human sequences, while stops ( ) indicate homology B) Alignment of two partial 
nucleotide sequences from cosmid SMDHPa12 4 (hsm) with the rabbit skeletal muscle DHP receptor 
α,-subunrt cDNA (rsm) sequence (23) Regions of homology and putative intron sequences are depicted 
in upper case and lower case letters respectively and differences between the human and rabbit 
sequences are indicated as in A. Numbers below the rabbit sequence indicate the position in the rabbit 
cDNA C) Alignment of the human skeletal muscle DHP receptor α,-subunrt protein (hsm) encoded by 
the exons depicted in ( ) The single amino acid substitution in the rabbit skeletal muscle (rsm) 
sequence (lie for Val) is shown below the human sequence Aligned below the human and rabbit 
skeletal muscle α,-subunrt sequences is the relevant region from the human cardiac muscle α,-subunrt 
protein sequence (hht) Numbers to the left indicate the ammo acid positions in the rabbit and human 
heart proteins The IVS6 segment of the DHP receptor α,-subunrt protein and part of the EF-hand 
domain are indicated above the ammo acid sequence 
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4236 of the rabbit sequence The deduced amino acid sequence of the human skeletal 
muscle DHPRa, protein encoded by the two exons (figure 1c) is predicted to contain the 
membrane-spanning IVS6 segment and part of the cytoplasmic EF-hand domain (1) Although 
there are 21 nucleotide differences between the human and rabbit DNA sequences, only one 
results in an amino acid substitution (Val for He) in the human protein On the basis of the 
DNA sequence data and the deduced amino acid sequences, we conclude that cosmids 
CCCha19.1 and SMDHPa12.4 contained portions of the CACNL1A1 and CACNL1A3 genes 
Identification and charactenzation of dinucleotide repeat markers at the CACNL1A1 and 
CACNL1A3loci 
The subclones from cosmids CCCha19.1 and SMDHPct12 4 were screened for the presence 
of microsatellite repeats which could be potentially useful as genetic markers An ACAT(AC)21 
CACNL1A3. Pnmers (CACNL1A1 AC strand 5'-TGACATCCCATCTCTCTAAAC-3', TG strand 
5'-TATTATTTGTCTGCTACTCTT-3', CACNL1A3 AC strand 5'-CAAGAGCC-
TTAGGCCTGGCA-3', TG strand 5'-CACACCTGTCTCATTCCTGG-3') were synthesized for the 
amplification of the repeats. The expected product sizes were 95 bp for CACNL1A1 and 131 bp 
for CACNL1A3 The results of analyses of 50 unrelated individuals for the presence and extent 
of polymorphisms detected by primer pairs developed for each marker are shown in table 1 
The marker at CACNL1A1 detected 9 alleles with a size range from 89-115 bp and an 
observed heterozygosity of 73%. The marker at the CACNL1A3 locus detected 8 alleles 
ranging in size from 131-147 bp with an observed heterozygosity of 72 3% 
Table 1. 
Dinucleotide repeat polymorphisms at CACNL1A1 and CACNLI A3. 
CACNLIAI CACNLI A3 
allele 
1 
2 
3 
4 
5 
6 
7 
8 
size (bp) 
147 
145 
143 
141 
135 
134 
133 
131 
frequency 
0 04 
0 06 
0 02 
0 14 
0 02 
0 02 
0 36 
0 34 
allele 
1 
2 
3 
4 
5 
6 
7 
8 
9 
size (bp) 
115 
109 
107 
105 
97 
95 
93 
91 
89 
frequency 
0 01 
0 02 
0 04 
0 02 
0 18 
0 43 
0 22 
0 06 
0 02 
observed hclcro/ygosity = 73% observed heterozygosity - 72 3% 
Note 
Allele frequencies were estimated from 50 unrelated individuals (Caucasians) 
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Physical mapping of CACNL1A1 and CACNL1A3. 
The new dinucleotide repeat markers for the CACNL1A1 and CACNL1A3 loci were used in 
PCR analyses of human/hamster and human/mouse somatic hybrid mapping panels (26, 27) 
containing fragments of chromosomes 1 and 12 (figure 2). The presence of a human band in 
cell lines A3TE7b, M28 and WgM1.1 localized CACNL1A1 to chromosome 12p. No human 
signal was observed for cell line A3JA5b, and since this cell line contains a chromosome 12 
lacking a 12p13.2-pter fragment, the cardiac gene must be located distal to the 12p13.2 
breakpoint in this cell line. The primer pair for CACNL1A3 amplified DNA from cell lines 
12CB17B and PaD1. Since PaD1 contains a 1q31-qter fragment as sole human chromosome 1 
DNA, this result places CACNL1A3 in the same region. However, no PCR product was 
obtained from cell line AN27, which contains a 1q42-qter fragment. Therefore, CACNL1A3 is 
A. Chromosome 12 B. Chromosome 1 
Figure 2. Localization of CACNL1A1 and CACNL1A3 by somatic cell hybrid analysis The upper panels 
in each figure show the identity and the (partial) human chromosomal contents of the cell lines used in 
the study, and the lower panels show the results of analyses of the PCR products generated with 
dinucleotide repeat markers. Samples were loaded in the order indicated in the upper panels in both 
figures. A) Agarose gel analysis of PCR products from CACNL1A1. B) Polyacrylamide gel analysis of 
CACNL1A3. Cell lines A3 (hamster) and DBA2 (mouse) were taken as negative controls, and human 
leukocyte DNA (blood) as a positive control. Cosmid SMDHPul 2 4 was taken as an additional control for 
CACNL1A3. 
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located in the region 1q31-q42. As a positive means of confirming these results, we used 
cosmids CCCha19.1 and SMDHPa12.4 in FISH experiments. In all metaphase spreads hybri-
dized with the CANCL1A1 probe, distinct signals were located sub-telomerically on the short 
arm of chromosome 12, apparently in the region 12p13.3-pter (figure 3a,b). With the cosmid 
SMDHPa12.4 probe, signals were observed on the distal long arm of chromosome 1. 
Superimposition of fluorescent signals on positively imaged chromosomes (figure 3c) 
apparently located CACNL1A3 in the region 1q32.1 (figure 3d). 
Figure 3. Fluorescence in situ hybridization of cosmids CCCha19.1 and SMDHPa,2.4 to human 
chromosomes. A) hybridization of CCCha19.1 to the region p13.3-pter of chromosome 12. Two different 
chromosomes 12 are visible, both clearly showing the probe hybridizing to the same region. B) Detail of 
the short arm of chromosome 12 showing hybridization of the probe to a region close to the telomere. C) 
positively imaged chromosomes counterstained with DAPI for chromosome identification, and (D) 
hybridization of SMDHPa12.4 to band q32 of human chromosome 1. The image of (D) is superimposed 
on (C). 
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Linkage analyses 
The dinucleotide repeat markers for CACNL1A1 and CACNL1A3 were tested for linkage with 
MHS, and the results of pairwise linkage analyses are shown in table 2 Negative or strongly 
negative lod scores were found with the CACNL1A1 marker in the families MH06, MH09, 
LMH03 and LMH08, indicating that an association between CACNL1A1 and MHS in these 
families is highly unlikely In MH04, only two of eleven méioses were informative and the 
weakly positive lod score that was generated as a result cannot definitely exclude linkage in 
this case With regard to CACNL1A3, a previous report had excluded this gene as a candidate 
for MHS in families MH06 and MH09 (-5 29 at θ = 0 for MH06, and -1 11 at θ = 0 for MH09, 
37) Consequently, CACNL1A3 was only tested for linkage in families MH04, LM03 and 
LMH08, and pairwise lod scores were negative in all three families These results do not 
support linkage between the MHS locus and CACNL1A3 in these families either 
Table 2. 
Lod scores CANCL1AI and CACNL1A3 vs. MHS 
CACNL1AI 
Ζαι θ 
LMH03 
MH04 
MH06 
LMH08 
MH09 
0 
-4 77 
0 20 
-2 87 
-2 31 
-0 23 
0 05 
-3 28 
0 16 
-2 06 
-0 86 
-0 06 
0 I 
-2 7 
0 12 
-162 
-0 47 
0 01 
0 2 
-148 
0 04 
-0 92 
-0 16 
0 06 
CACNLIA3 
Ζ at θ 0 0 05 0 1 0 2 
LMH03 -140 -0 74 -0 39 -0 02 
ΜΗ04 -2 77 -111 -0 55 -0 11 
LMH08 -133 -0 71 -0 44 -0 16 
DISCUSSION. 
Recently, much interest has arisen in the potential role played by defects in calcium channels in 
hereditary diseases of skeletal muscle A single nucleotide deletion at nucleotide 4010 in the 
munne skeletal muscle DHPR α,-subunit mRNA has been shown to underly the fatal recessive 
disorder of mice, muscular dysgenesis (mdg, 38), and mutations in the gene encoding the 
calcium efflux channel of skeletal muscle sarcoplasmic reticulum (RYR1) have been 
associated with central core disease and some forms of the genetically and clinically 
heterogeneous disorder MHS (15-17) The RYR1 and DHPR channel complexes are localized 
in close apposition at tnadic junctions (39, 40), and the two channel complexes are believed to 
Note. 
" 3 Lod scores were calculated 
using the MLINK program of 
LINKAGE version 5 03 
assuming an autosomal 
dominant trait Untested and 
МНЕ individuals were 
assigned an unknown disease 
status Families MH06 and 
MH09 were not tested with the 
0 04 CACNL1 A3 marker 
-0 67 
0 00 
-0 47 
-0 04 
03 
0 06 
0 00 
-0 06 
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function together in the regulation of calcium ion release from the sarcoplasmic reticulum 
during excitation-contraction coupling (2) Since an MH cnsis is believed to be associated with 
a breakdown in the regulation of Ca2* influx into the sarcoplasm, components of the DHPR 
complex, in particular the σ,-subunits, are conceivably involved in those forms of MHS not 
associated with RYR1 The isolation and refined chromosomal localization of the CACNL1A1 
and CACNL1A3 loci, and the charactenzation of new genetic markers for the two genes, have 
now allowed the direct analysis of the roles played by these genes in MHS 
The previous assignments of CACNL1A1 and CACNL1A3 to the regions 12p13-pter 
and 1q31-q32 (7, 8) were confirmed by somatic cell hybnd analysis using the new dinucleotide 
repeat markers for both loci (figure 3) The somatic hybrid mapping data were further refined by 
the results of FISH expenments (figure 4) which placed CACNL1A1 in the region 12p13 3-pter 
and CACNL1A3 in the region 1q32 1 The gene encoding the neuronal isoform of the a, protein 
has been assigned to the short arm of human chromosome 3 (6), but a second a, isoform 
recently cloned from a human brain cDNA library has also been localized to the same 12p13-
pter chromosomal region as CACNL1A1 (41) Interestingly, we isolated two distinct cosmid 
contigs using the cardiac muscle cDNA probe and both localized to 12p13 3-pter in FISH 
experiments (data not shown) While it may be premature to assume that two closely related 
genes are syntenic in the chromsome 12p13 3-pter region, the diversity of DHPRa,-subunits is 
most easily explained by the duplication of several genes during evolution Functional domains 
may have been conserved among the vanous proteins, but the sequence differences possibly 
provide a basis for tissue-specific functions 
The fact that the disturbance of calcium ion homeostasis which occurs in skeletal 
muscle during an MH cnsis can also be triggered by depolarizing muscle relaxants such as 
succinylchohne (11), renders CACNL1A3 an interesting candidate gene for MHS Although 
CACNL1A1 is not expressed in skeletal muscle (5, 34), cardiac disturbances such as 
tachycardia and arrythmia occur in many cases of MH (11, 42), and data excluding any 
involvement of this gene in MH are therefore relevant The results of linkage analyses carried 
out using the two new microsatellite repeat markers (table 2) excluded CACNL1A3 as a 
candidate gene for MHS in all families tested CANCL1A1 was also excluded as a candidate in 
all families except MH04 where the marker was insufficiently informative to allow exclusion 
Although other markers from the p13 2-pter region of chromosome 12 should be tested to 
exclude definitively the candidacy of CACNL1A1 as an MHS-associated gene, the genetic data 
for CACNL1A1 and CACNL1A3 together indicate that neither gene is involved in the aetiology 
of MH The potential roles m MHS of the other subunits of the DHPR calcium channel complex 
are presently being evaluated, and a search of the entire human genome for regions linked to a 
second MHS locus is currently underway 
Interestingly, a recent genome search has revealed linkage between another hereditary 
disorder of skeletal muscle, hypokalemic periodic paralysis (HypoPP, 43), and markers for 
chromosome 1q (44) Detailed linkage analysis co-localized HypoPP and CACNL1A3 to the 
same 5cM region of 1q31-q32, and CACNL1A3 was proposed as a candidate gene for HypoPP 
as a consequence (44) One might expect the decrease in serum potassium levels which 
occurs during a HypoPP crisis to be due to a defect in a potassium channel and a Shaw-
related potassium channel (KCNC4) has indeed been assigned to chromosome 1, although its 
regional localization remains to be determined (45) It is not clear how defects in a calcium 
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Channel can affect potassium ion exchange, but the eventual identification of mutations in the 
CACNL1A3 gene associated with HypoPP might allow electrophysiological studies to elucidate 
further the role played by the DHPR complex in membrane depolanzation and the regulation of 
ion fluxes across the sarcolemma 
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Abstract. 
A genomic clone for the y subunit of the human dihydropyrídme receptor was used to map 
the gene to chromosome 17q24 by in situ hybridization Contained within the gene is a 416 
bp polymorphic repetitive DNA element which is potentially useful as a genetic marker 
Introduction. 
L-type voltage-dependent calcium channels (VDCCs) are abundant in heart, smooth and 
skeletal muscle, where they play an essential role in voltage-gated calcium entry and excitati-
on-contraction coupling (reviewed by Spedding and Paoletti, 1992) L-type VDCCs, also 
known as dihydropyridine receptors (DHPRs), are composed of five subunits, a,, a?, β, γ and 
б The α, subunit contains the binding-site for Ca2* channel blockers, forms the ion pore 
structure and functions both as a voltage sensor and as a calcium channel (Spedding and 
Paoletti, 1992). Expression of the skeletal muscle α,-subunit cDNA in murine fibroblasts 
results in the appearance of DHP-sensitive Ca2* currents, but with abnormal activation 
kinetics Co-expression of the β subunit with a, leads to the restoration of normal current 
kinetics and increased current density (Singer et a l , 1991) Co-expression of the α2/δ 
subunits with the cardiac a, subunit in Xenopus oocytes also enhances the amplitude of the 
current and shortens activation time, while the γ subunit appears to shift the voltage depen­
dence of the channel to more negative values (Singer et a l , 1991) 
The primary structures of the skeletal muscle DHPR subunits have been determined 
from their cDNAs. The α,-subunit is a 165 kDa protein encoded by a 6 5 kb mRNA (Spedding 
and Paoletti, 1992) derived from a gene distinct from those which encode the brain and heart 
isoforms of this protein In contrast, the 135-150 kDa a 2 glycoprotein and the 28 kDa δ 
subunit, which together form a disulphide-linked dimer, are the proteolytic products of a single 
precursor polypeptide encoded by a single 8 kb mRNA (reviewed by Spedding and Paoletti, 
1992) Two brain isoforms of 478 and 596 amino acids, and the 523 ammo acid skeletal 
muscle ¡soform of the β subunit are encoded by alternatively spliced mRNA variants 
transcribed from the same gene (Powers et al., 1992) The γ subunit is a 32 kDa protein 
encoded by a 1171 nucleotide (nt) mRNA (Bosse et a l , 1990) apparently expressed 
exclusively in skeletal muscle 
The genes encoding the brain and heart isoforms of the DHPR a, subunit have been 
localized to human chromosomes 3 and 12p13 3 respectively (Chin et al , 1991, Schultz et 
a l , 1993), and the β subunit gene has been mapped to chromosome 17 (Pragnell et 
al ,1991) In this paper, we report the chromosomal localization of the γ subunit gene by in 
situ hybridization, and show that a repetitive DNA sequence within the gene is polymorphic 
and potentially useful as a genetic marker 
Materials and Methods. 
Oligonucleotide primers (forward - 5TGCATCCTGGTGGGCATCG3', and reverse - 5'GATGGGAA-
CAGGGCAGGTT3', corresponding to nucleotides 43-61 and nucleoides 732-750 of the published 
rabbit DHPR γ subunit cDNA sequence (Bosse et al, 1990)) were used to amplify a 708 bp Fragment of 
the rabbit DHPR γ subunit cDNA from first strand rabbit skeletal muscle cDNA generated from total 
rabbit skeletal muscle RNA with MMLV RNase H" reverse transcnptase (Superscript, Life Technologies) 
according to the manufacturer's instructions Amplification reactions were carried as described (Weber 
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and May, 1969) except that approximately 2 pg single stranded cDNA was used as template and 
tetramethylammonium chloride (TMAC) was added to a final concentration of 50 μΜ Amplification 
products were digested with proteinase K, purified by agarose gel electrophoresis, treated with Klenow 
E coli DNA polymerase I and T4 polynucleotide kinase (Life Technologies), prior to ligation into the 
Smel site of pGEM4 (Promega) Clones containing inserts of the expected size were sequenced by 
double-stranded dideoxy chain termination using af^PJdCTP (Amersham International) and T7 DNA 
polymerase (Promega) using the manufacturer's protocol The sequence of one 0 7 kb insert was 
found to match exactly the rabbit DHPR γ subunit cDNA sequence (data not shown), and the excised 
insert was used to screen a human genomic cosmid library. Two overlapping cosmid clones, cCChG29 
and cCChGKI, were isolated which contained sequences hybridizing with the cDNA probe The identity 
of the cosmids was confirmed by random subcloning of Seu3AI fragments from the cosmids in pGEM4, 
and partial sequencing of those subclones which hybridized with the rabbit cDNA probe 
One subclone from cosmid CChG29, designated pDHPG29.1, was found to contain a 416 bp 
repetitive DNA element upstream from a putative exon in the human DHPR γ subunit gene (see figure 
1) In order to determine whether the repeat structure was polymorphic, forward (5'CCATTGTCGGGA-
GTACAGA3') and reverse (5'CTTGTCATGGCTCGTTAGGG3') primers for the amplification of the 
repeat element were synthesized For detection of alleles, reverse pnmer (100 ng per reaction) was 
labeled with ур2Р]АТР (Amersham International) using T4 polynucleotide kinase (Life Technologies) 
Amplification conditions were as described above, except that 100 ng genomic DNA per reaction was 
used as template and TMAC was omitted from the reaction mixes Alleles were separated by electrop­
horesis (60 W for 5 hours) on 4% denaturing Polyacrylamide gels, and bands were visualized by 
autoradiography at -80°C with a single enhancer screen (DuPont Cronex) 
To determine the chromosomal localization of the DHPR γ subunit gene, we used cosmid 
cCChG29 for in situ hybridization experiments Cosmid DNA (1 pg) was labeled with biotin-14-dATP 
using a bio-nick system (Life Technologies), separated from unincorporated nucleotides and ethanol 
precipitated in the presence of a 200-fold excess of sonicated human genomic DNA Probe diluted to a 
concentration of 5 ng/μΙ was denatured, preannealed and hybridized to high resolution chromosomal 
preparations, according to methods described by Sinke et al (1992; and references therein) 
Immunocytochemical detection and visualization of hybridized probe DNA was carried out as described 
by Sinke et al (1992) Digital images were recorded using a Photometries high performance CH 250/a 
cooled CCD camera controlled by TCL-image analysis and processing software (TNO, Delft, The 
Netherlands, modified by Biological Detection Systems, Pittsburgh, USA) 
Results. 
DNA Sequence Analysis 
A 744 bp Sau3AI subclone from cosmid cCChG29, designated pDHPG29 1 (figure 1a), was 
found to contain a 138 bp sequence showing 83% homology with nucleotides (nt) 305-442 of 
the published rabbit DHPR γ subunit cDNA sequence (Bosse et al , 1991) Immediately 
preceding and following the homology are sequences closely resembling the intron 3'- and 5'-
splice site consensus sequences. It is therefore likely that the 138 bp region of homology 
represents an exon in the human DHPR γ subunit gene Of the 23 nucleotide differences in 
the putative exon, only 12 are predicted to result in amino acid changes in the human DHPR γ 
subunit protein sequence, with only 5 of these being non-conservative substitutions (figure 
1a) In addition, a 235 bp partial sequence of a second Sat/3AI subclone from cosmid 
CChG29, designated pDHPG29 2, showed 90% homology with a 151 nt sequence encoding 
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Λ. 
hum gatecgcagagctcagacgcacacceattgtcgggagtacagacccgtgcctgcctgogcccagacagctgcacacagggtgagtgggcagacaeacaga ЮО 
hum cacacactgacacacaeagaeacacacaacacagatacaeacacactgacacaoacaagaoaeagaogcacagagacactgacacaoaeacactgacaca 200 
hum caaatgacacacagtgacagacaeaeactgataaaoatgcatgatgacacacaaaatgacaeaeagtgacacacaeagacacacactgacacacaegtae 300 
hum aatgacacagacacagagacacacaotgaoacacacgtaeaatgacagacacagagacaeacactgacaeatatgcatgacacacaatgacacaoacaga 400 
hum cactgacacaeacacagatacaeacatacaatgacacacacaagaeagaeacagagacacacacttgaeacacacacatgacacacacagacaetgacac 500 
hum aoacactgtggtgcatggtgtggtcccfcaaagagc<iatgacaagagaotaocgtgctgaggeagcatgctgggtgtaccttgtgtttgaagA<3TACAOCA βΟΟ 
rab -- -- - ^ — — ^ — ^ ^ — ~ 
Y S hum y 
xab у 104 
hum TCTCGOCAOCCœCATCGCCATCTTCWKXTrTGOCTTCATaiTCCTG«^^ 700 
r a b g a g g g с a a a o c g a g t a c t o 
I S A A A I A i r S L O r i I L a s L C V L L F L G K R R D Y L L R hum γ 
- - - - - - S V - - - - - L - H - T I - A - M A r R - - - - - - - - r a b γ 1ЭВ 
hum ACCCGCOTCCATITTTCTATOCCTTTtKAegtagactgggygatc 7 4 4 
r a b g g e t 
Р А 9 Н Г Т А Г А hum γ 
- - - - - - y - - r a b γ 147 
hum ATaCCCCeaAACCCATGGOA<TrCCTOCATG(»TQCTQAOCCCaAGCACrAAcaoteotgoggc-ootagogaccctcaggctttcttaccaaggaagcgg 1 9 9 
r a b a a α α a t g g g o g g g c 
H P R N P W 1 S C M D A 1 P I H * hum γ 
_ _ g _ _ _ _ _ _ _ _ _ _ _ _ _ # r a b γ 2 2 2 
hum g g t e t t g g c c t g g a a c c t t c e a g a g a g g a g g o g g g a 2 3 5 
Figure 1. 
DNA sequences from human genomic clone cCChG29 showing homology to the rabbit DHPRy subunrt 
cDNA sequence (A) The 744-bp sequence of the Sau3AI subclone pDHPG29 1 The repetitive DNA 
element and the primer sequences used for its amplification are underlined once and twice respectively 
Consensus 3'- and 5'-splice sites flank the putative exon (B) Partial sequence from pDHPG29 2 
Predicted protein-encoding regions of the human sequences are depicted in uppercase letters, while 
lowercase letters Indicate intron and non-coding sequences Differences in the nucleoide sequence of 
the rabbit DHPR γ subunrt cDNA are shownbelow the human sequence, while stops or periods ( ) 
indicate homology The predicted partial amino acid sequences of the human DHPR γ subunrt protein 
are shown below the DNA sequences Amino acids in the rabbit protein identical to the predicted human 
sequence are shown (-), while amino acid substitutions are indicated below the human sequence, 
underlined residues indicate Dayhoff non-conservative substituions 
the 49 C-terminal residues of the rabbit DHPR γ-subunit protein, starting at the Sau3AI site at 
nt 519 (figure 1b) Since the DHPR γ-subunit exhibits no significant homology with other 
proteins (Bosse et a l , 1990), we conclude that cCChG29 contains, at least in part, the human 
DHPR γ-subunit gene The sequences of pDHPG29 1 and pDHPG29 2 have been submitted 
to the EMBL data bank, accession numbers Z19587 and Z19603 
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Table 1. 
Repetitive DINA sequence polymorphism within the DHPR γ-subunit gene (CACNLG). 
size (bp) 
526 
524 
522 
520 
516 
frequency 
0.473 
0.027 
0.013 
0.46 
0.027 
* Alleles were estimated from 37 unrelated Caucasians; observed heterozygosity = 56.5%. PIC = 0.47. 
Polymorphism of the Repetitive Sequence. 
The 416 bp Α-rich, repetitive sequence in pDHPG29.1 terminates 86 bp upstream from the 
putative exon. Agarose gel analysis of the amplification products of the DHPR γ-subunit 
repeat did not resolve differences in allele size (data not shown), but differences were detec­
ted after electrophoresis on 4% Polyacrylamide sequencing gels. Analysis of genomic DNA 
from 37 unrelated individuals showed the marker to detect 5 alleles (table 1) varying in size 
from 516 to 526 bp, with an observed heterozygosity of 56.5%. 
In Situ Hybridization. 
Twenty five normal male metaphase spreads were examined for the presence of hybridizing 
cCChG29 probe, and in 20 of these, distinct, fluorescent signals were observed on one or 
both chromatids in the lower region of chromosome 17q (figure 2). Specific hybridization of 
the probe to other chromosomes was not observed. Images of fluorescent signals 
superimposed over positively imaged chromosomes localized the L-type DHPR γ-subunit 
gene, CACNLG, to band q24 of chromosome 17. 
Figure 2. 
Partial metaphase spread showing 
in situ hybridization with the 
cosmid probe cCChG29 to 
chromosome 17q24. 
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Discussion. 
There has been much recent interest in the long arm of chromosome 17 since the localization 
of the breast and ovarian cancer gene, BRCA 1, to 17q21 (Hall et a l , 1992), the identification 
of allelic heterogeneity for hyperkalemic periodic paralysis and paramyotonia congentia at the 
SCN4A locus at 17q23 1-25 3 (McClatchey et a l , 1992), and the reported localization of a 
second locus for malignant hyperthermia susceptibility (MHS2) to 17q11 2-q24 (Levitt et a l , 
1992) Importantly, since malignant hyperthermia (MH) results from a potentially fatal break­
down of mechanisms regulating Ca2* influx into the skeletal muscle myoplasm which can be 
triggered by volatile anaesthetics and depolarizing muscle relaxants (reviewed by Nelson, 
1988) it is of particular significance that two components of the skeletal muscle DHPR that 
are involved in the modulation of channel activity, localize to this region We have recently 
developed a microsatellite repeat marker for the DHPR β subunit and genetically mapped the 
gene to chromosome 17q11 2-q21 (lies et a l , manuscnpt in preparation) With the physical 
mapping of the DHPR γ subunit to chromosome 17q24 and the identification of a polymorphic 
repetitive DNA sequence within the gene, it should now be possible to investigate directly 
whether these genes play a role in MH, and to investigate further the linkage relationships of 
other disorders on chromosome 17q 
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ABSTRACT. 
Malignant hyperthermia susceptibility (MHS) is an autosomal dominant disorder of skeletal 
muscle which manifests as a life-threatening hypermetabolic cnsis tnggered by commonly-
used inhalation anaesthetics and depolanzmg muscle relaxants Defects in the ryanodine 
receptor (RYR1) protein have been proposed to underty MHS, but significant genetic 
heterogeneity in MHS has recently been demonstrated In order to investigate the potential 
roles played by other skeletal muscle calcium channels in MHS, we isolated cosmids 
containing the gene encoding the ßrsubunit of skeletal muscle L-type voltage-dependent 
calcium channel (CACNLB1) We identified a new, highly polymorphic dmucleotide repeat 
motif close to this gene, and linkage analysis placed the marker proximal to the HOX2B 
locus, previously localized to chromosome segment 17q21-q22 We recently identified a 
novel marker within the y-subunit locus (CACNLG) at band 17q24, and since both markers 
are within the 17q11 2-q24 region reported to contain the MHS2 locus, we tested them for 
linkage m MHS families whose disease trait has been shown not to co-segregate with 
markers for the RYR1 region on chromosome 19q13 1 Our results apparently exclude 
CACNLB1 and CACNLG as candidate genes for MHS2, and do not support the reported 
chromosome 17q localization for the MHS2 locus in our families 
INTRODUCTION. 
Malignant hyperthermia (MH) is a potentially catastrophic manifestation of an autosomal 
dominant, pharmacogenetic disorder of skeletal muscle (1), caused by a defect in 
mechanisms regulating calcium ion influx into the myoplasm (2) In susceptible individuals, a 
MH crisis can be tnggered by a number of anaesthetic agents, but in particular by 
depolanzmg muscle relaxants such as succinyl choline, and volatile anaesthetics such as 
halothane (3) A clinically similar syndrome has also been described in other animal species 
including pigs and dogs (2) The coincident localization of the gene encoding the 
sarcoplasmic reticulum calcium efflux channel (RYR1) to chromosome 19q13 1 (4), the 
assignment of the first descnbed locus for MH-susceptibihty (MHS1) to chromosome 19q12-
q13 2 (5), and the demonstration of tight linkage between MHS and markers for RYR1 in 
Canadian families (6), lead to the proposal of RYR1 as a candidate gene for MHS A Cys to 
Arg substitution at postion 614 in the RYR1 protein was shown to be associated with the 
porcine syndrome (7, 8), but this mutation has been found in only a small minority of MHS 
tamiles (9) The subsequent demonstration of genetic heterogeneity in MHS (10-12) has 
recently provided strong evidence that other proteins beside RYR1 are potentially involved in 
MHS 
Morphological and physiological evidence indicates that an association exists at tnadic 
junctions between the transverse tubule L-type voltage-dependent calcium channels (the 
dihydropyndine receptors, DHPRs) and the RYR1 channel complex (13, 14) Although the 
essential function of the skeletal muscle DHPR is as a voltage sensor in excitation-
contraction coupling (15, 16), it can also function as a calcium channel (17, 18) Skeletal 
muscle DHPRs are composed of five subunits α,, α^δ, β and γ (14) The α,-subunit itself 
forms the ion pore structure and voltage sensor (15, 16) and binds calcium channel blockers 
such as 1,4 dihydopyndmes, phenylalkylamines and benzodiazepines (19) The α,/δ, β and γ 
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subunits while themselves not exhibiting any channel activities, together exert pronounced 
effects on channel kinetics, voltage-dependence of activation and inactivation and agonist 
enhancement (20-22) 
Progress towards the chromosomal localization of the DHPR subunits and their 
several isoforms has opened the way to direct investigation of the possible involvement of 
these proteins in MHS The genes encoding the brain and cardiac isoforms of the α,-subunit 
have been localized to chromosomes 3 and 12p13 respectively (23, 24), and are distinct from 
the gene encoding the skeletal muscle α,-subunit isoform which has been provisionally 
localized to the q31-q32 region of chromosome 1 (25) More recently we have used human 
cosmid clones to localize the skeletal muscle DHPR γ-subunit (CACNLG) to band q24 of 
chromosome 17 by in situ hybndization, and identify a polymorphic, A-nch repetitive DNA 
sequence within the gene (lies et al, submitted) In this paper we report the identification and 
characterization of a new, highly polymorphic, dinucleotide repeat marker for the skeletal 
muscle β,-subunit gene (CACNLB1), and its genetic mapping to 17q11 2-q22 
A recent report presented preliminary evidence for the localization of a second MHS 
locus (MHS2) at chromosome 17q11 2-q24 (26) In order to assess whether the newly 
mapped DHPR β,- and γ-subunit genes are associated with the MHS2 locus, we tested them 
for linkage in families whose MHS trait has been shown previously not to co-segregate with 
markers for chromosome 19q12-q13 2 (12, 27) Our results appear to rule out an association 
between the β,- and y-subunit genes and MHS in the families studied Moreover linkage data 
obtained using the chromosome 17q markers HOX2B, GH1 and SCN4A (28-30) do not 
support the proposed candidacy of SCN4A as the MHS2 gene (31), nor do they support the 
localization of MHS2 to 17q11 2-q24 in our families 
RESULTS. 
Molecular cloning and partial sequence analysis of the DHPR β,-subunit gene, and 
identification of a dinucleotide repeat polymorphism at the gene locus 
Using a reverse transcnptase-PCR procedure with primers specific for the rabbit skeletal 
muscle DHPR ßrsubunit, we cloned a rabbit β,-subunit cDNA containing nt 91-1684 of the 
published sequence (32) The cDNA insert was used for screening a human genomic cosmid 
library, and the identity of cosmids which hybndized with the β,-subunit cDNA was confirmed 
by sequencing randomly subcloned Sat/ЗАІ fragments Three partial sequences within an 
approximately 1 5 kb Sau3AI subclone from cosmid DHPB-22 were found to be identical to 
the published sequence of the human DHPR β, gene (33) The first contained intron 
sequences and the exon specific for the skeletal muscle transcript The two other sequences 
(EMBL accession nos Z21725 and Z212726) were found to contain exact homology to the 5' 
region common to the β,Β1, β,Β2 and β,Β3 transcnpts of the β, gene (data not shown) We 
therefore concluded that cosmid DHPB-22 contained, at least in part, the human β, gene 
In order to develop new genetic markers for the β,-subunit, the genomic subclones 
were also screened for the presence of di- and tn-nucleotide repeat sequences Cosmid 
DHPB-22 was found to contain an (АС)2 motif adjoining an Alu repeat element, and pnmers 
were designed for its amplification A total of 40 unrelated individuals were screened for the 
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presence and degree of polymorphism As summarized in table 1, a total of 12 alleles ranging 
in size from 81-121 nt were detected by the pnmer pair, with an observed heterozygosity of 
82% (PIC = 0 8) 
Table 1. 
Dinucleotide repeat polymorphism at (he CACNLBI locus 
Allele 
1 
2 
3 
4 
5 
6 
7 
8 
9 
It) 
II 
12 
size (bp) 
121 
119 
117 
US 
113 
111 
109 
107 
105 
103 
91 
81 
frcqucnc\ 
0 0371 
0 025 
0 0375 
0 0625 
0 0875 
0 1 
0 1 
0 3Í.25 
0 1 
0 05 
0 025 
0 0125 
Note Allele frequencies were estimated from 40 unrelated individuals (Caucasians) 
Observed heterozygosity = 82%. PIC = 0 8 
Linkage analyses 
To allow an approximate estimation of the genetic distance between CACNLB1 and CACNLG 
and the placement of the loci on a framework map of chromosome 17q, we included in our 
analyses a further three large families (11, 27) in addition to the four MHS families (figure 3) 
under study, all families together represented 79 méioses across three generations The 
markers chosen for reference were HOX2B at 17q21-q22 (28), GH1 at 17q22-q24 (29) and 
SCN4A at 17q23-q25 (30) Multipoint linkage analysis suggested the order of loci as shown in 
figure 1, which is in close agreement with the recently published map of chromosome 17q 
(34) We observed no recombinations between GH1 and SCN4A, and so were unable to 
determine unequivocally the order of these two markers on the chromosome, but were 
nevertheless able to estimate tentatively the genetic distances between all the markers Since 
we have previously localized CACNLG to chromosome 17q24 by in situ hybridization, our data 
indicate that CACNLB1 and CACNLG bracket the linkage group and that CACNLB1 is located 
approximately 16 cM proximal to the HOX2B locus, previously localized to the region 17q21-
q22 (28, 34) These data are also in agreement with a recent report provisionally assigning 
CACNLB1 proximal to NGFR (34) on chromosome 17q11 2-q22 (35) 
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Figure 1. 
Genetic map of chromosome 17q The order of loci was determined using CRIMAP, and the distance 
between markers was estimated using the LINKMAP program of LINKAGE 5 2 No recombinations 
between GH1 and SCN4A were observed, so the order of these two loci shown in the figure is for 
illustrative purposes only Sex average recombination fractions were converted to centimorgans (cM) 
using the Kosambi mapping function and shown below the figure are the relative odds against inversion 
of adjacent loci 
In order to assess possible linkage of the DHPR β,- and γ-subunit markers with MHS, 
we analysed four well-characterized families whose MHS status had been determined using 
a reliable protocol (36), and whose MHS trait had previously been shown unequivocally not to 
be linked to RYR1 and other chromosome 19q12-q13 2 markers (12, 27) The results of 
multipoint linkage analysis are shown in figure 2 and haplotypes constructed from the genetic 
data are depicted in figure 3 Negative lod scores for CACNLB1, CACNLG and GH1/SCN4A 
argue against any association between these loci and MHS in all four families In family 
LMH03, a small positive lod score close to HOX2B (Zmax = 0 85 at Θ = 0 065) could be taken 
as a weak indicator of linkage near this locus, but inspection of the haplotypes in this family 
strongly suggests that the entire region between CACNLB1 and CACNLG fails to co-
segregate with MHS The proband of the family, individual IV-6, has apparently inherited a 
chromosome 17 haplotype from his MHS father that is different from that inherited by his 
MHS cousin, IV-8 Moreover, although both of the proband's two MHS aunts (111-13 and 111-15) 
carry a HOX2B allele of the same size as that inherited by the proband (allele 5), in each of 
them it can only be identical by descent to the proband's allele if two double recombinations 
have occurred between CACNLB1 and GH1/SCN4A Since our LINKMAP calculations did not 
include interference, the maximum lod score of 0 86 will be an overestimate Consequently, 
we conclude that the inhentance by the MHS individuals in this family of similarly sized 
HOX2B alleles is likely to be fortuitous 
DISCUSSION. 
MH is caused by an anaesthetic-induced breakdown in the regulation of sarcoplasmic calcium 
fluxes (2), and mutations in genes encoding skeletal muscle calcium channels are 
conceivably responsible for the MHS trait Linkage with markers flanking the sarcoplasmic 
reticulum calcium efflux channel gene locus, RYR1, at chromosome 19q13 1 has been found 
in approximately 46% of MHS families in Europe (37), but the demonstration of genetic 
heterogeneity in MHS (10-12) has clearly shown that proteins other than RYR1 must be 
involved in the MH syndrome The fact that depolarizing muscle relaxants can tngger a MH 
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Figure 2. 
Results of multipoint linkage analyses of MMS against CACNLB1, HOX2B, GH1/SCN4A and CACNLG 
in the four families Lod scores were calculated using the LINKMAP program of LINKAGE S 2 ••turning 
an autosomal dominant disorder, МНЕ and untested individuals were assigned an unknown disease 
status. Genetic distances between the markers were as shown in figure 1 and CACNLB1 is arbitrarily 
placed at 0 cM. Also shown in the figure are the lod scores at θ = 0 for each marker 
crisis and that the effective treatment for MH is the post-synaptic muscle relaxant dantrolene, 
which appears to interact with the DHPR complex (38), prompted us to investigate whether 
subunits of the DHPR calcium channel are associated with the MHS syndrome 
Tissue-specific expression of the a,- and ß-subunits of the DHPR calcium channel is 
complex Transcripts of at least three different DHPR ß-subunit genes have been detected in 
heart, aorta, brain and skeletal muscle (39, 40), while alternative splicing of gene transcripts 
has also been shown (33, 39, 40). It was therefore important to establish that cosmids 
screened for the presence of microsatellite repeats did in fact contain the skeletal muscle 
DHPR β,-subunit gene. Sequences determined for a 1 5 kb Sau3A\ subclone derived from 
cosmid DHPB-22 contained three regions of exact homology to the published human β, 
sequence (33) which showed that we had cloned, at least in part, the human skeletal muscle 
DHPR β,-subunit gene. Consequently, the dinucleotide repeat element identified in cosmid 
DHPB-22 is likely to be close to, or within the DHPR β,-subunit gene. 
θθ 
The skeletal muscle DHPR β,- and y-subunits subunits have been shown to exert 
pronounced regulatory effects on α,-subunit channel activity (20-22), and the development of 
new markers for the CACNLB1 and CACNLG loci has allowed us to investigate directly 
whether these proteins are involved in the altered calcium regulation m MHS muscle Recent 
physical mapping data and linkage data presented here place CACNLB1 and CACNLG within 
the 17q112-q24 region reported to contain the MHS2 locus (26) However, negative 
multipoint lod scores (figure 2) for MHS with CACNLB1 and CACNLG were found in all four 
families, and the combined lod scores of -5 16 at = 0 for CACNLB1 and -4 37 at = 0 for 
CACNLG would seem to rule out the involvement of these genes in MHS Moreover, the 
candidature of SCN4A for MHS2 was also ruled out in our families since the combined 
multipoint lod score at this locus was -9 83 
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Figure 3. MHS segregation data and haplotypes for CACNLB1, HOX2B, GH1/SCN4A and CACNLG in 
the families studied 
The provisional assignment of the MHS2 locus to chromosome 17q (26) was based 
on two-point linkage analyses which yielded a combined maximum lod score of 3 26 at © = 0 
with the NME1 marker (41) which is located approximately 5 cM distal to HOX2B at 
chromosome 17q21 3-q22, in a total of five MHS families However, in none of these families 
was the lod score higher than 0 87 and few details of the IVCT diagnostic data were 
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presented This assignment therefore needs strong independent confirmation before it can be 
accepted Interestingly, amongst our families a two-point Ζ„,
Μ
 of 1 2 at Θ = 0 05 was found for 
HOX2B in LMH03 However, this lod score falls to less than 0 85 at Θ = 0 065 in multipoint 
analyses (figure 2 and results), since at least two double recombination events in the interval 
between CACNLB1 and GH1/SCN4A would have to occur to maintain linkage The 
distortional effects of including incomplete data or inaccurate marker-allele frequencies in 
linkage calculations have been descnbed (42, 43) and can result in biased false-positive lod 
scores The result in LMH03 would appear to be in line with these observations since the fall 
in the lod score on multipoint analysis compared with the two point lod scores is due to the 
inclusion of data reflecting the observed haplotypes (figure 3), which apparently exclude MHS 
from the whole interval between CACNLB1 and CACNLG Taken together with the linkage 
data for the other three families, our results do not support a chromosomal localization of the 
MHS2 locus at chromosome 17q11 2-q24, nor the proposed candidature of the SCN4A gene 
for MHS2 (31) We are currently investigating whether the a,- and a2-subunits of the skeletal 
muscle DHPR channel complex are potentially invloved m MHS 
MATERIALS AND METHODS. 
Materials 
A library of human lymphocyte DNA cloned into the vector pSuperCos 1 (Stratagene) and propagated 
in E coli NM554, was kindly provided by Or M Hofker (Dept Human Genetics, University of Leiden, 
NL) The vector pGEM4 was obtained from Promega and propagated in E coli HB101 Both bacterial 
strains were cultured in Luna-Bertani medium containing amptcillm at a concentration of 50 pg/ml T7 
and SP6 sequencing primers were obtained from Promega, as was also-~T7 DNA polymerase 
Restriction enzymes, T4 polynucleotide kinase (PNK), large fragment (Klenow) DNA polymerase and 
RNase H M-MLV reverse transcriptase (Superscnpt) were obtained from BRL- Life Technologies 
AmpliTaq™ DNA polymerase was obtained from Perkin Elmer Cetus (Hoffmann-La Roche) All 
procedures using the enzymes were earned out according to the manufacturer's instructions 
Oligonucleotides were custom synthesized by Pharmacia Benelux (Woerden, NL), and a["P]dCTP and 
γ["Ρ]ΑΤΡ were purchased from Amersham International DNA fragments were purified from agarose 
gels using a GeneClean kit (Bio 101, La Jolla, USA) 
Isolation ofcosmid clones containing the human skeletal muscle DHPR β,-subunit gene 
We first cloned a rabbit cDNA encoding the DHPR β,-subunit using a reverse transcnptase/PCR 
procedure Briefly, oligonucleotide primers (forward 5'-CCACCCTCCCAGGAGATCC-3' reverse 5'-
TTCCCTGCACTCCAGTTCC-3') predicted to amplify a 1593 bp fragment, were selected on the basis 
of their specificity for the rabbit skeletal muscle DHPR β,-subunrt sequence (32, GenBank accession 
по M25817) First strand cDNA synthesized from total RNA extracted from rabbit skeletal muscle (44) 
was used as a template in a PCR reaction PCR products were treated with proteinase K, 
electrophoresed in 2% agarose, and the distinct band of approximately 1600 bp was isolated from the 
gel The PCR product was further treated with Klenow polymerase and T4 polynucleotide kinase, and 
ligated into the Smal site of pGEM4 Clones containing inserts of the expected size were partially 
sequenced by dideoxy chain termination using double-stranded plasmid template and T7 DNA 
polymerase One cDNA clone, designated pDHPß24 which contained an insert showing exact 
homology to 5'- and З'-sequences of the rabbit skeletal muscle DHPR β,-subunrt cDNA sequence, was 
used to screen a human lymphocyte DNA cosmid library using standard procedures (45) A cosmid 
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clone designated DHPB-22 was isolated which hybridized strongly with the cDNA probe In order to 
establish the identity of the cosmid, Sau3AI fragments were subcloned into pGEM4 and clones 
hybridizing with the insert from pDHP024 were sequenced All DNA sequences were analysed using 
Intelhgenerjcs Suite 5 4 software and the University of Nijmegen CAMMSA package 
Identification end charectenzation of a dinucleohde repeat at the CACNLB1 locus 
The same Seu3AI subclones used for the confirmation of cDHPB-22 identity were also screened for the 
presence of potentially polymorphic microsatellrte repeat elements by hybndizion with a 'cocktail' of 
oligonucleotide probes for repeat sequences ((TG)7, (TC)7, (CAC), and (CTG)5) Pooled 50 ng 
quantités from each oligonucleotide were end-labeled with 32P using γ[°2Ρ]ΑΤΡ and T4 PNK, and used 
directly for hybridizations Repeat-positive subclones were sequenced for the development of PCR 
primers One subclone designated pTGß was found to contain a repeat mobf adjoining the poly A* tail 
of an Alu sequence, with the structure (А)4С(А)3С(А)ДТ(АС)2, (GenBank accession no L06300) Pnmers 
(forward 5'-CTAGGCAACGTGCGAGAAC-3', reverse 5'-ATCGTAATCACCTGCAGGG-3') for the 
amplification of the repeat element were selected using OLIGO version 4 0 The expected size of the 
PCR product was 115 bp 
PCR analysis 
Amplification of the ß-subunrt cDNA was earned out in 50 μΙ 16 5 mM (NH,)2SCv 65 mM Tns-HCI pH 
8 8, 2 mM MgCI2, 0 2 mM of each dNTP, 10 mM 2-mercaptoethanol, 10% DMSO, 50 μΜ TMAC and 1 5 
mg/ml BSA, containing 100 ng of each pnmer and approximately 1 μg first strand cDNA template The 
sample was denatured at 94°C for 5 minutes, incubated at 80°C while 1 unit Taq DNA polymerase 
(Perkin Elmer Cetus) was added, and processed through 30 cycles of 94°C for 1 minute, 56°C for 1 
minute and 72°C for 3 minutes Amplifications of all microsatellrte repeats were carried out in 25 μΙ 
volumes of Cetus buffer containing 50 ng forward pnmer, 50 ng 32P-labeled reverse pnmer and 100 ng 
human genomic DNA template Samples were denatured and reactions started by the addition of 0 5 U 
AmpliTaq DNA polymerase (Perkin Elmer Cetus) as described above, and processed through 30 
cycles of 94°C for 45 seconds, 55°C for 1 minute and 72°C for 45 seconds Alleles were separated on 
4% or a% denaturing Polyacrylamide sequencing gels and visualised by autoradiography 
WHS families and in vitro contracture test 
Family MH04 was referred to the University Hospital of Antwerp for neurological examination and 
assessment of MHS status after the proband had developed severe masseter spasms and cardiac 
arrythmia following the administration of ftuothane and succinyl choline during a tonsillectomy (12) 
Family MH05 was referred to the University Hospital of Nijmegen after the proband died during 
anaesthesia with suspected fulminant MH (12) Families LMH03 (27) and LMH08 were referred to the 
Malignant Hyperthermia Investigation Unit at St James' University Hospital, Leeds In family LMH03, the 
first proband developed masseter spasm dunng the insertion of grommets, myoglobinuria and a serum 
creatane Phosphokinase (CPK) activity of 2880 U/l were later observed It was subsequently ascertained 
that a grandmother had died unexpectedly dunng hysterectomy The second cousin to the first proband 
also died with fulminant MH during an operation on a broken arm and it transpired that he had 
experienced masseter ngidrty dunng a previous general anaesthesia In family LMH08, the proband was 
undergoing an orthopaedic operation when masseter spasm developed His pulse rate increased to 
155 and his rectal temperature increased to 37 8°C Myoglobinuria and a serum CPK activity of 50,000 
U/l were subsequently recorded MHS status was determined using the standardized European in vitro 
contracture test protocol (36) MH diagnoses fall under one of three categories MH-susceptible (MHS), 
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MH-normal (ΜΗΝ) and MH-equwocal (МНЕ) 
Linkage analyses 
The most likely order of markers on chromosome 17q was calculated using the CRIMAP software 
package (46) Pairwise and multipoint lod scores were calculated using the software package of 
LINKAGE version 5 2 (47, 48) Both packages were run on a Sun 4/490 computer under SunOS 4 1 1 
at the UK Human Genome Mapping Project Resource Centre (49) For multipoint analysis, alleles were 
reduced where necessary, but in all calculations true allele frequencies were retained so as to avoid 
possible distortion of lod scores (42, 43) Recombination fractions were converted to centiMorgans (cM) 
using the Kosambi mapping function MHS penetrance was assumed to be 1 for the probands, 0 98 for 
those individuals diagnosed as MHS and 0 02 for all diagnosed as ΜΗΝ in the IVCT The frequency of 
the MHS allele was assumed to be 0 0001 without mutation, corresponding to a population incidence of 
1 in 5000 This is probably a slight overestimate, but conservative in terms of generatang false-positive 
lod scores An unknown disease status was assigned to all untested and МНЕ individuals 
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CHAPTER 7. 
Localization of the gene encoding the a2/5-subunits of the L-type 
voltage-dependent calcium channel to chromosome 7q and analysis 
of the segregation of flanking markers in malignant hyperthermia 
susceptible families. 
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ABSTRACT 
Malignant hyperthermia susceptibility (MHS) is an autosomal dominant disorder of skeletal 
muscle which manifests as a potentially fatal hypermetabolic cnsis tnggered by commonly 
used anaesthetic agents The demonstration of genetic heterogeneity m MHS prompted the 
investigation of the roles played by calcium regulatory proteins other than the ryanodine 
receptor (RYR1), which is known to be linked to MHS in fewer than half of the European MHS 
families studied to date Previously, we have excluded the genes encoding the skeletal 
muscle L-type voltage-dependent calcium channel α,-, β,- and y-subunits as candidates for 
MHS In this report, we descnbe the cloning and partial DNA sequence analysis of the gene 
encoding the σ/δ subumts, CACNL2A, and its localization on the proximal long arm of 
chromosome 7q A new dinucleotide repeat marker close to CACNL2A was identified at the 
D7S849 locus and tested for linkage in six MHS families D7S849 and flanking genetic 
markers were found to co-segregate with the MHS locus through 11 méioses in one, three 
generation family These results suggest that mutations in or near CACNL2A may be involved 
in some forms of this heterogeneous disorder 
INTRODUCTION 
Malignant hyperthermia (MH) is a clinically heterogeneous (1), autosomal dominant, 
pharmacogenetic disorder of skeletal muscle (2) A fulminant MH crisis manifests as a 
hypermetabolic state charactenzed by some combination of hyperthermia, skeletal muscle 
rigidity, tachycardia or arrythmia, respiratory and metabolic acidosis, and muscle tissue 
breakdown as reflected by elevated serum creatine kinase activities and myoglobinuna (3) In 
susceptible individuals, an MH crisis can be tnggered by volatile anaesthetics and 
depolarizing muscle relaxants (3), and unless treated promptly usually proves fatal (1) 
Presymptomatic assessment of MH nsk is earned out using the standardized European in 
vitro contracture test (IVCT) protocol (4) which allowe the following diagnoses MH-
susceptible (MHS), MH-normal (ΜΗΝ) and MH-equivocal (МНЕ) Physiological and 
biochemical studies have indicated that MH is due to a breakdown in the mechanisms 
regulating sarcoplasmic calcium ion fluxes (5), and mutations in the calcium efflux channel of 
the skeletal muscle sarcoplasmic reticulum (RYR1) on chromosome 19q13 1 (6) have 
recently been associated with MHS and a related disorder, central core disease (7-10) 
However, several families have also been desenbed where no linkage between markers for 
the RYR1 region and MHS exists, strongly suggesting genetic heterogeneity in MHS (11, 12) 
A close association is formed at the skeletal muscle tnadic junctions between the 
ryanodine receptor and the L-type voltage-dependent calcium channel (13), also referred to 
as the dihydropyndme receptor (DHPR), and the two channel complexes are believed to 
function together in excitation-contraction coupling (14) The skeletal muscle DHPR calcium 
channel complex, which is located in the T-tubule membrane, is composed of five subunits 
α,, a2, β,, γ and δ (15, 16), with the a 2 and δ subunits being encoded by a single gene (17) 
The α,-subunit forms the ion pore structure, binds calcium channel blockers, and functions 
both as a calcium channel and as a voltage sensor (18-20) The α^δ, β, and γ subunits do 
not themselves exhibit calcium channel activity but together may exert pronounced effects on 
current density, DHP pharmacology and voltage-dependence of channel activation and 
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inactivation (21, 22) Since the pathophysiology of an MH crisis involves a breakdown in the 
regulation of skeletal muscle calcium ion influx, we have investigated the potential roles 
played by the subunits of the DHPR complex in those forms of MHS not linked to RYR1 
The gene encoding the skeletal muscle isoform of the α,-subunit has been localized 
to band q32 1 of human chromosome 1 (23, 24), while the genes encoding the β, and γ 
subunits are both located on the long arm of chromosome 17 (25, 26) Genetic markers for 
CACNL1A3, CACNLB1 and CACNLG have recently been developed and tested for linkage in 
a number of European families whose MHS trait has been shown not to be linked to markers 
for chromosome 19 (25, 27) Although the skeletal muscle DHPR β, and y-subunit genes both 
map to the interval q11 2-q24 of chromosome 17, previously reported to carry the putative 
MHS2 locus (28), the results of these studies conclusively excluded all three subunits as 
candidate genes for MHS, and indeed, raised some questions as to the validity of the 
proposed MHS2 locus assignment on chromosome 17q11 2-q24 (28) 
In this paper we report on the physical and genetic mapping of the gene encoding the 
DHPRa2/6-subunits, CACNL2A, to the proximal long arm of human chromosome 7 The gene 
and a neighbouring polymorphic dinucleotide repeat marker, D7S849, were also found to be 
linked to the gene encoding the hepatocyte growth factor (HGF, 29) Using a human 
chromosome 7-specific panel of human hamster somatic cell hybnds (30), we were able to 
place D7S849 within an interval spanning the boundary of bands q11 23 and q21 1 
In order to test the potential association of mutations in the CACNL2A gene with MHS, 
we tested D7S849 and adjacent markers for linkage in a group of six MHS families (11, 12, 
25) Significantly, no recombinations were observed between MHS and D7S849 and two 
other markers through 11 méioses in one, well-charactenzed, three-generation pedigree 
These results suggest that mutations in, or near the gene encoding the DHPRa2/6-subunits 
may in some cases be associated with MHS, and raise the possibility that as many as 3 
different loci may be involved in the inhentance of this disorder 
RESULTS 
Analysis of YAC clones containing the CACNL2A locus 
A BamHI fragment containing nt 1-2814 of the published rabbit skeletal muscle DHPRa3-
subunit cDNA sequence (31), which had previously allowed the assignment of CACNL2A to 
human chromosome 7 (data not shown), was used to screen a chromosome 7-specific YAC 
library (32) Two clones, designated HSCE1129 and HSCE520 (henceforth referred to as 
E1129 and E520), were identified by hybridization with the cDNA probe The size of the 
inserts in each clone was determined by pulsed field agarose gel electrophoresis (PFGE, 33) 
and found to be approximately 660 kb for E1129 and 480 kb for E520 (figure 1a) No 
evidence was found suggesting that the clones were chimenc The identity of E1129 was 
confirmed by sequencing Sau3AI subclones which hybridized with the rabbit DHPRct2 cDNA 
probe Five different clones were isolated which contained putative exon sequences 
exhibiting 90-99% homology with nt 403-532, 1279-1368, 1369-1446, 1863-1939 and 2441-
2506 of the published rabbit DHPRot2-subunit cDNA sequence (31) In addition, a probe 
specific for the human HGF gene (29) also hybndized to E1129 and E520 The HGF gene 
was located on a 270 Sail fragment present in both YACs, thus placing it within approximately 
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Figure 1. 
Southern analysis of YACs 
E1129 and E520. YAC DNAs 
were digested with Mlul or Sail 
and subjected to PFGE as 
described in materials and A. B. 
methods. Concatemeric λ DNA 1 2 3 4 5 1 
and undigested DNAs from p» 
MW kb 
630- P-
460-
E1129 and E520 were used as 
markers. The order of samples 
in both panels is as follows:
 7 0 0 
lane 1, intact E1129 DNA; lane 
2, E1129/M/U/; lane 3, 
E1129/Sa//; lane 4, E520/Sa//; 580 
lane 5, intact E520 DNA. 
A, hybridization with a 2.8 kb 
BamHI fragment from the rabbit 
skeletal muscle DHPRa2 sub-
unit cDNA. B, hybridization with 
a 1.5 kb Pstl fragment from the 
human HGF gene. The approx­
imate migration distances of 
molecular weight markers are 290-
depicted to the left of the figure. 245- · · 
Two Sail fragments from E520 
hybridizing with the CACNL2A 1 5 4 _ 
probe (panel A, lane 4) co- 96- * ^ β Ι 
migrated under the conditions 
of PFGE, and so appear as a 
single heavy band. A restriction 
map showing the location of 
CACNL2A relative to HGF is 
depicted below the figure. ^ g S S 
1 E 1 1 2 9 
I E 5 2 0 
ю о kb C A C N L 2 A HGF/D7S849 
110-380 kb of CACNL2A (figure 1b). 
Identification and physical mapping of a dinucleotide repeat marker at D7S849. 
The same subclones as used for the confirmation of the identity of E1129 were also screened 
for the presence of microsatellite repeat sequences potentially useful as genetic markers. 
One clone was found to contain an interrupted dinucleotide repeat and primers for its 
amplification were designed. A total of 50 individuals were screened for the presence and 
extent of polymorphism at the locus, designated D7S849, and as shown in table 1, a total of 8 
alleles ranging in size from 138-166 nt were detected. The observed heterozygosity was 57%. 
Amplification of a panel of human/hamster somatic cell hybrids (30) containing defined 
fragments of human chromosome 7q (figure 2) placed D7S849 at 7q11.23-q21.1 in the same 
interval as the markers D7S524 (34) and AFM277vd5, proximal to AFM234xc7 and distal to 
AFM203vb6. In addition, D7S849 was mapped to the same 270 kb Sail fragment as the HGF 
gene (data not shown). This result also places D7S849 within 110-380 kb of CACNL2A. 
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Table 1. 
Dinucleotide repeat polymorphism at the D7S849 locus 
size (bp) 
166 
154 
152 
150 
146 
142 
140 
138 
frequency 
0 1 
0 04 
0 1 
0 04 
0 04 
0 02 
0 02 
0 64 
Note Allele frequencies were estimated from 50 unrelated individuals (Caucasians) 
Observed heterozygosity = О 57 
Physical mapping of CACNL2A by fluorescence in situ hybndization 
Total DNA from YAC E1129 was also used for fluorescence in situ hybridization (FISH) 
experiments to confirm the physical localization of the CACNL2A gene and D7S849 A total of 
30 metaphase spreads were examined, and as shown in figure 3, signals were 
unambiguously detected on the proximal long arm of chromosome 7, close to the boundaries 
of bands q11 23-q21 1 
Genetic mapping of D7S849 in MHS families 
In order to make en approximate estimation of the genetic distance between D7S849 and 
other markers in the relevant region of chromosome 7q, we tested the new marker together 
with D7S524, D7S492 (34) and COL1A2 (35) in our group of 6 MHS families All families 
together represented 63 méioses across three generations Multipoint linkage analysis of the 
combined families generated a lod score of 7 34 at Θ = 0 05 between D7S849 and D7S524 
The odds in favour of D7S849 being proximal to D7S524-D7S492-COL1A2 were 6 6 χ 103 
higher than a distal location Two-point lod scores between D7S849 and MHS were negative 
in MH04, MH05, MH09, LMH03 and LMH08 (table 2), indicating that CACNL2 is not a 
candidate gene for MHS in these families In contrast, linkage between D7S849 and MHS 
could not be excluded in family MH06 and tight linkage was detected with the fully informative 
marker AFM203vb6 (figure 4a). Haplotypes deduced from the genetic data obtained using the 
markers AFM295yg9, AFM203vb6, AFM277vd5, D7S849 and D7S524 (figure 4b) in this 
family revealed recombinations between MHS and both AFM295yg9 and D7S524, thereby 
defining the 7q11 23-q21.1 region co-segregating with MHS Multipoint linkage analysis of 
MHS against the marker set yielded a lod score of 2.91 at Θ = 0 for AFM203vb6, AFM277vd5 
and D7S849 (figure 5) 
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AFM203vb6 
AFM277vd5 
D7S849 
D7S524 
4
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AFM165yh12 
D7S492 
AFM203vb6 
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D7S849 
D7S524 
AFM234XC7 
AFM165yh12 
Figure 2. 
Physical mapping of D7S849 using human/hamster somatic cell hybrids. A schematic representation of 
the chromosome 7 content of the hybrid cell lines used in these studies is depicted in the upper panel 
and the identity of each cell line is indicated above the figure. The results of PCR analyses using 
markers from the 7q11.23-q22 region surrounding CACNL2A are shown in the lower panel. 
Amplification products were resolved on 2.5% agarose gels with the samples being loaded in the order 
indicated in the upper panel. The deduced order of markers in the four intervals across 7q11.23-q21 is 
depicted to the right of the figure. The position of AFM286xf9 relative to AFM295yg9 has not been 
determined in this study and is for illustrative purposes only. 
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Figure 3. 
Localization of CACNL2A by fluorescence in situ hybridization. (A) Positively imaged metaphase 
chromosomes counterstained with DAPI for chromosome identification and (B) chromosomes stained 
with propidium iodide showing hybridization of YAC E1129 DNA to the proximal long arm of 
chromosome 7 in the region q11 23-q21.1. 
Table 2. 
Two point lod scores MHS vs. D7S849. 
Recombination fraction 
0 
-1.69 
-0.97 
-1.62 
-1.48 
-1.71 
0.05 
-1.10 
-0.51 
-0.94 
-0.95 
-1.08 
0.1 
-0.74 
-0.32 
-0.61 
-0.71 
-0.70 
02 
-0.34 
-0.13 
-0.26 
-0.42 
-0.31 
03 
-0.13 
-0.05 
-0.09 
-0.23 
-0.12 
0.4 
-003 
-0 01 
-0.02 
-0.10 
-0.02 
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Figure 4. 
Co-segregation of markers for 7q11.23-q21.1 with MHS in family MH06. (A) Autoradiographs of alleles 
detected for AFM203vb6, 277vd5 and D7S849. The structure and MHS status of the family is illustrated 
at the top of the figure, with the order of lanes corresponding to the family structure. Allele numbers are 
indicated to the right of each panel. (B) Haplotypes deduced for MH06. Shaded bars indicate the 
grandmaternal haplotype co-segregating with MHS in this family. Recombinations between MHS and 
AFM295yg9, and between MHS and D7S524 appear to have occurred in individuals IV02 and III04 
respectively. 
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Figure 5. 
Results of multipoint linkage 
analysis for MHS on chromosome 
7q11 23-q21 1 in MH06 Lod 
scores were calculated using the 
LINKMAP package of LINKAGE 
5 2 assuming an autosomal 
dominant disorder, with untested 
individuals being assigned an 
unknown disease status The 
frequency of MHS was assumed to 
be 0 0001 penetrance was 
assumed to be 0 98 in MHS 
individuals and 1 0 for the 
proband 
DISCUSSION 
Since the demonstration of genetic heterogeneity in MHS (11, 12), we have undertaken 
studies to elucidate the potential roles played in this disorder by subunits of the skeletal 
muscle DHPR calcium channel complex We have previously isolated human genomic clones 
containing the skeletal muscle α,-, β,- and γ-subunit genes, and determined their 
chromosomal localizations (24-26) Genetic markers developed for each gene were 
subsequently used to exclude them as candidates for MHS in a number of European families 
(25, 27) In the present study, we have determined the physical and genetic localization of the 
CACNL2A gene and investigated its association with those forms of MHS not linked to 
chromosome 19q13 1 
The a^ö-subunits are both derived from the proteolytic cleavage of a single precursor 
protein and are linked together by disulphide bonds (17) It has been shown that the two 
subunits together fulfil an essential functional role in DHPR calcium channel activity, by 
perhaps being involved in the insertion of the α,-subunit into the membrane (36), the 
regulation of current density, and together with the β, subunit, in the pronounced increase in 
the voltage-sensitivity of channel activation and inactivation (21, 22) In contrast to the 
complex tissue-specific expression patterns of the a,- and ß-subunits (15, 16), only a single 
isoform of the ot2-subunit protein has been detected in skeletal muscle (15, 16), with several 
alternatively spliced isoforms of the protein found in brain being denved from the same gene 
(36, 37) 
Preliminary results (not shown) indicating that the human DHPRot?/5 gene was 
located on chromosome 7 led us to screen a human chromosome 7-specific YAC library for 
clones containing the CACNL2A locus The identity of clones hybridizing with the rabbit 
203vb6/277vd5/ 
295yg9 D7S849 D7SS24 
2 91 
05 07 08 0 9 10 11 
recombinat ion fract ion 
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DHPRa2-subunit cDNA probe was confirmed by DNA sequencing, and a search for genetic 
markers within the YACs resulted in the identification of the microsatellite marker D7S849 
Using a high resolution somatic cell hybnd mapping panel for chromosome 7 (30), we were 
able to place the new marker in a narrow interval spanning 7q11 23-q21 1 (fig 2) This 
assignment was confirmed by our FISH expenments in which specific signals were 
consistently detected on the proximal long arm of chromosome 7 (fig 3) In another recent 
study, CACNL2A was localized to the 7q21-q22 region by somatic cell hybnd analysis (38) 
The HGF locus has previously been assigned to band q21 1 of chromosome 7 (39) and since 
we have demonstrated the physical proximity of CACNL2A and HGF, we conclude that the 
most likely location of CACNL2A is in the proximal region of band 7q21 1 
Genetic mapping of D7S849 in our families generated a maximum multipoint lod score 
of 7 34 at a recombination fraction of 0 05 relative to D7S524, with odds strongly in favour of 
a proximal location for our marker relative to the linkage group D7S524-D7S492-COL1A2 
Interestingly, AFM277vd5, D7S849 and D7S524 were all placed within the same interval of 
the mapping panel (figure 2), but AFM277vd5 has also been shown to lie on the same YAC 
contig (40) as the thrombospondin gene (CD36) previously mapped to 7q11 2 (41) By 
combining genetic mapping data, the YAC contig data and our physical mapping data the 
order of markers across the region 7q11 23-q21 3 would therefore appear to be 7cen-
(AFM286xf9-AFM295yg9)-AFM203vb6-(CD36-AFM277vd5)-(CACNL2A-D7S849-HGF)-
D7S524-AFM234xc7-AFM165yh12-D7S492-7qter 
The markers D7S849, D7S524, D7S492 and COL1A2 were tested for linkage with 
MHS and multiple recombinations between the marker set and MHS were observed in five 
families, therefore excluding CACNL2A as a candidate gene for MHS in these cases 
However, only a single recombination between MHS and D7S524, D7S492 and COL1A2 was 
observed in individual III04 of family MH06 (figure 4b), while no recombinations appeared to 
have occurred between MHS and D7S849 More detailed linkage analyses m MH06 also 
revealed linkage with the markers AFM203vb6 and AFM277vd5 (figure 4a), but an apparent 
recombination between AFM295yg9/AFM286xf9 and MHS in individual IV2 (figure 4b) limits 
the region co-segregating with the trait to the 9 cM interval between D7S524 and AFM295yg9 
(J Weissenbach, personal communication) 
We have previously speculated that the high incidence of MHS in MH06 may be due 
to the presence of a second MHS allele in this family (11) However, our data clearly show 
that the same 9 cM region of 7q11 23-q21 1 has been passed on by the MHS grandmother to 
all 11 MHS individuals, and that the unusual MHS segregation pattern in this family can be 
explained by the inheritance of a single grandmatemal haplotype The lod score of 2 91 at a 
recombination fraction of 0 0 in favour of linkage with MHS is probably lower than the 
theoretical maximum for this family of 3 3 because not all méioses were fully informative and 
not all clinical and genetic data were available Although evidence in favour of linkage is not in 
itself conclusive of a causal relationship between mutations m CACNL2A and MHS, the 
presence in the immediate vicinity of the linked region of a gene so important in excitation-
contraction coupling and the regulation of sarcoplasmic calcium fluxes is interesting We are 
therefore seeking to identify mutations in the CACNL2A gene that may be associated with 
MHS in this family 
Whereas porcine MH appears to be associated with a single Arg615Cys substitution 
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in the ryanodine receptor gene (42), the situation in the human disorder is clearly more 
complex To date at least 6 different point mutations in RYR1 have been associated with 
MHS and the allelic disorder CCD (7-10), but of these, three have been detected only in 
single families, and two of the three, a Gly248Arg (7) and an lle403Met (9) substitution, seem 
to be restncted to small, two generation families Nevertheless, several different mutations in 
the same gene do appear to underly both MHS and CCD Since MHS does not seem to map 
to either chromosomes 19q or 7q in five families analysed here, our data suggesting linkage 
between markers for 7q11 23-q21 1 and MHS m MH06 imply that mutations in three or more 
genes may underly clinically similar disorders which manifest as an adverse reaction to 
commonly used anaesthetic agents This degree of genetic heterogeneity in MHS also 
implies that diagnosis of MHS by means of genetic testing rather than by the in vitro 
contracture test (4) will be difficult to validate Further studies on additional families are being 
earned out to assess the extent of involvement of a chromosome 7q locus m MHS and to 
define the proportion of MHS families for which it can account, and also to determine the 
extent of genetic heterogeneity in MHS by scanning for other chromosomal regions linked to 
MHS throughout the genome and identifying candidate genes within those regions 
MATERIALS AND METHODS 
Materials 
The plasmid vector pGEM4 was obtained from Promega and propagated in E coli DH5a Yeast cells 
were cultured in AHC medium (containing per litre 8 g yeast nitrogen base [Dlfco 091-15], 20 g glucose 
[Merk, 8337] 55 mg adenine hemisulphate [Sigma, A 9126], 55 mg l-tyrosine [Sigma, Τ 3754] and 1 4 g 
casamino acids [Difco, 0288], pH 5 8), and bacterial cells were cultured in Luna-Bertam medium 
containing ampicillin at a concentration of 50 pg/ml T7 and SP6 sequencing primers were obtained 
from Promega T7 DNA polymerase and custom synthesized oligonucleotides were purchased from 
Pharmacia Benelux (Roosendaal, NL) Restriction enzymes, T4 polynucleotide kinase (PNK) and large 
fragment (Klenow) DNA polymerase were provided by BRL-üfe Technologies GELase™ was obtained 
from Epicentre Technologies All procedures using the enzymes were earned out according to the 
manufacturer's instructions Zymolase was obtained from Kynn Breweries Japan, and AmphTaq™ DNA 
polymerase was obtained from Perkm Elmer Cetus (Hoffmann-La Roche) Low merbng temperature 
(LM) agarose was purchased from SeaPlaque (50101), and af^PJdCTP and vf"P]ATP were supplied 
by Amersham International Small DNA fragments (0 2-5 kb) were isolated from agarose gels using a 
GeneClean kit (Bio 101) Dulbecco's minimal essential medium and fetal calf serum were purchased 
from GibcoBRL-Life Technologies 
Restriction analysis of YAC clones containing the CACNL2A locus 
A BamHI fragment from the rabbit DHPRa2-subunrt cDNA containing 2 8 kb of coding sequence was 
used to screen a human chromosome 7-specific YAC library (31) using standard procedures (43) Two 
clones HSCE1129 and HSCE520, hybridized with the probe and were taken for further analysis Single 
yeast colonies were inoculated into 50 ml AHC medium, cultured for 60 hours at 30°C, and harvested 
by centrifugaron (500 χ g, 10 minutes) Procedures for the preparaten and lysis of yeast spheroplasts in 
0 5% LM agarose plugs were earned out essentially as described (33) For restriction enzyme analysis, 
the LM agarose plugs containing yeast DNA were first equilibrated in several changes of a restnebon 
enzyme buffer for 1 hour at 0°C Incubated for 2 hours on ice in 1 volume of buffer containing 20 units 
enzyme (Sail or Mlul) per pg DNA and then overnight at 37°C The buffer and enzyme were then 
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refreshed, and digesbon was allowed to continue for a further 8 hours Plugs were equilibrated in 
several volumes of 0 5 к TBE pnor to resolution of DNA fragments by PFGE (33) for 24 hours in 1% 
agarose gels, using a field strength of 200 V and a switch bme of 40 seconds Undigested yeast DNA 
and λ DNA concatemers were used as markers Visualization of DNA fragments, Southern blotting and 
hybridization were earned out as desenbed (39) 
Subcloning and partial sequence analysis of CACNL2A 
Restriction analysis of clone E1129 showed that a 580 kb МЫ fragment, which apparently overlapped 
clone E520, contained the CACNL2A locus This fragment was isolated by preparative PFGE 
Approximately 50 pg E1129 DNA in LM agarose plugs was digested to completion with /И/и/and applied 
to a preparative 1 % LM agarose gel in 0 5 χ TBE PFGE was carried out as desenbed above using 
undigested DNA and /Vf/u/-digested DNA as markers The marker lanes were removed and stained with 
ethidium bromide to localize the 580 kb МЫ band in the preparative porton of the gel, which was not 
exposed to UV light The band was removed and the DNA was recovered intact by GELase™ digestion 
followed by concentraten and dialysis against 10 mM Tns-HCI pH 7 6, 1 mM EDTA in an Amicon 10 
concentrator Random Sau3AI fragments from the isolated DNA were subcloned into pGEM4, and 
subclones hybridizing with the rabbit DHPRa2-subunrt cDNA probe were sequenced using double 
stranded plasmid DNA as template and T7 DNA polymerase as desenbed (25) All DNA sequences 
were analysed using Intelligenebcs Suite 5 4 software and the University of Nijmegen CAMMSA 
package The sequences of 5 subclones containing putative exons of CACNL2A have been deposited 
in the EMBL database (accession nos Z28599, Z28602, Z28605, Z28609 and Z28613) 
Identification and charactenzation of the D7S849 locus 
Screening the 580 kb МЫ fragment subclones for the presence of potentially polymorphic 
microsatellite repeats as desenbed previously (25) yielded the structure 
(A)5(AC)13AA(AC)eAA(AC)11AA(AC)5AA(AC)l)GA within subclone p1129Re (EMBL accession number 
Z28696), and primers (AC strand 5'-AAGGCCTGTTAAAAATCACC, TG strand 5'-
GACCCTGGGCAAGTCATTA) were synthesized for its amplification The expected size of the 
amplification product was 152 bp (GDB accession no G00-251-863) A 125 bp BamHIIAIul fragment 
from p1129Re was used as a probe on the Southern blot of the YAC clones to position D7S849 relative 
to CACNL2A 
Fluorescence in situ hybridization 
Total YAC E1129 DNA (1pg) was labeled with biobn-14-dATP (Sigma) using a Ыо-nick labeling system 
(Life Technologies), separated from unincorporated label by Sephadex G-50 column chromatography 
and ethanol precipitated in the presence of a 200-fold excess of sonicated human genomic DNA Probe 
diluted to a final concentrabon of 5 ng/μΙ was denatured, preannealed and hybridized to high resolubon 
chromosomal preparabons, with immunocytochemical detection and visualization of hybridized probe 
DNA were earned out as described (44, 45) Digital images were recorded using a Photometries high 
performance CH 250/a cooled CCD camera controlled by TCLnmage image analysis and processing 
software (TNO, Delft, The Netherlands, modified by Biological Detecbon Systems, Pittsburgh, USA) 
running on a Macintosh computer 
Somatic cell hybrids and PCR analysis 
The generabon and propagabon of human/hamster somabc hybrid cell lines containing fragments of 
human chromosome 7 have been reported in detail elsewhere (30) In the present study, the following 
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cell lines were used GM10791, enbre human chromosome 7, D1, 7pter-q11 2 q22 1-qter, 
GM05183 71, 7pter-q21 1; GM05183 17, 7q21 1-qter; D2, 7pter-q21 1 q22 1-qter, D4, 7pter-
q21 12 q22 1-qter; D3, 7pter-q21.2 q22 1-qter. Chinese hamster ovary cell line DNA was used as 
control PCR analyses of somatic hybrid cell lines were carried out in 50 μΙ volumes containing 10 mM 
Tris-HCI pH 9 0, 50 mM KCl, 1.5 mM MgCI2, 0.1% Triton X-100, 50 pmol each primer, 100ng DNA 
template and 1 U Taq DNA polymerase using a 'hot start' procedure as described (34) The reactions 
were processed through 35 cycles of denaturing at 94°C for 40 seconds, annealing at 55°C for 30 
seconds and extension at 72°C for 1 minute The reaction products were analysed by electrophoresis 
on 2.5% agarose gels 
Analysis of genomic DNA 
For the analysis of microsatellite repeats on human genomic DNA, reactions were carried out in 25 μΙ 
volumes using the same buffer as described above, but with only 50 ng DNA template, 0 5 U Taq DNA 
polymerase and 10 pmol each primer, with one primer from each pair being labelled with 32P (46) The 
conditions for amplification were as described above except that the extension time at 72°C was 
reduced to 15 seconds and the number of cycles was reduced to 30. Alleles were separated on 6% 
denaturing Polyacrylamide sequencing gels and visualized by autoradiography 
MHS families and in vitro contracture test 
Clinical details of the families MH04, MH05, MH06, MH09, LMH03 and LMH08 have been published 
previously (11, 12, 24, 47). The MHS status of all persons investigated was determined using the 
standardized European in vitro contracture (IVCT) test protocol (4), which classifies MH risk as either 
MH-susceptible (MHS), MH-normal (ΜΗΝ) or MH-equivocal (МНЕ). 
Linkage analyses 
Pairwise and multipoint lod scores were calculated using the MLINK and LINKMAP programs of the 
LINKAGE 5 2 software package run on a Sun SpardO under SunOS 4 1 3 at the University of 
Nijmegen CAOS/CAMMSA centre. For multipoint analyses, alleles were reduced where necessary, but 
correct allele frequencies were retained to avoid possible distortion of lod scores (48) The sex-average 
genetic distance between markers was based on published (35) and unpublished data (J W ) and on 
the results of this study The sex-average distances (in cM) between markers were as follows 
AFM295yg9 - 3 - AFM203vb6 - 0 1 - AFM277vd5 - 1 - D7S849 - 5 - D7S524 MHS penetrance was 
assumed to be 1 for probands, 0.98 for those individuals diagnosed as MHS and 0 02 for all those 
diagnosed as ΜΗΝ in the IVCT. The frequency of the MHS allele was assumed to be 0 0001 without 
mutation and an unknown disease status was assigned to all МНЕ and untested indviduals 
ACKNOWLEDGEMENTS 
The authors would like to thank Dr. Jean Weissenbach, Généthon, Evry, France for providing 
unpublished data on markers for chromosome 7, Dr Naomi Krtamura, Institute for Liver Research, 
Kansai Medical University, Japan for providing genomic clones for the HGF gene, Dr James Evans, 
University of Washington, Seattle, for his help in the construction and characterization of the the 
somatic cell hybrids, and Dr. Ad Geurts van Kessel for useful discussions and assistance with the FISH 
analysis. This work was supported by the Dutch PraevenNfonds (grant no. 28-1245), the Deutsche 
Forschungsgemeinschaft (DFG; grant no. DE 30721), the Canadian Genome Analysis and Technology 
Program, the Howard Hughes Medical Institute (International Scholarship to L-C T.), National Institutes 
of Health grant HL 22619-17 (A.S.), the Locally Organized Research Scheme of the Yorkshire Regional 
Health Authority (project LE186) and the British Malignant Hyperthermia Association GM s a special 
postdoctoral fellow of the Program of Excellence (NIH 41496) 
109 
REFERENCES 
1 Strazis, KP and Fox, A W (1993) Anaesth Anaig 77,297-304 
2 Bntt, BA (1987) Malignant Hyperthermia Martìnus Nijhof, Boston pp 11-42 
3 Rosenberg, H (1988) Br J Anaesth 60, 268-273 
4 European Hyperpyrexia Group (1984) Br J Anaesth 56.1267-1271 
5 Nelson, TE (1988) Cell Calcium 9,257-265 
6 MacKenzie, A E , Korneluk, R G , Zorzato, F , Fujii, J , Philips, M , Iles, D E , Wiennga, В , Leblond, 
S , Bailly, J , Willard, Η F , Duff, С , Worten, R G and MacLennan, D H (1990) Am J Hum 
Genet 46 1082-1089 
7 Gillard, E F , Otsu, К , FUJII, J , Duff, С , De Leon, S , Khanna, V К , Bntt, Β A Worten, R G and 
MacLennan, D H (1992) Genomics 13,1247-1254 
8 Zhang, Y , Chen, H S , Khanna, V К , De Leon, S , Philips, M S , Schappert, К , Bntt, В A , Brownell, 
A K W and MacLennan, D H (1993) Nature Genet 5, 46-50 
9 Quane, К A , Healy, J M S , Keating, К E , Manning, В M , Couch, F J , Palmucci, L M , Dortguzzi, С , 
Fagerlund, Τ Η , Berg, Κ, Ording, Η, Bendixen, D, Morter, W , Linz, U Müller, CR and 
McCarthy, T V (1993) Nature Genet 5,51-55 
10 Quane, К A , Keating, К E , Manning, В M , Healy, J M S , Monsieurs, К , Heffron, J J Α , Lehane, 
M , Heytens, L , Knsovic-Horber, R , Adnet, Ρ , Ellis, F R , Monmer, N , Lunardi, J and McCarthy 
T V (1994) Hum Molec Genet On press) 
11 Deufel, Τ , Golia, A , Iles, D E , Meindl, A , Mertinger, Τ Schmdelhauer, D , de Vries, A , Pongratz, 
D , MacLennan, D H , Johnson, KJ , and Lehmann-Horn, F (1992) Am J Hum Genet 50, 
1151-1161 
12 Iles, D E , Segers, В , Heytens, L, Sengers, R C A and Wiennga В (1992) Genomics 14, 749-754 
13 Franzini-Armstrong, С and Nunzi, G (1983) J Musc Res Cell Motility 4, 233-252 
14 Catterall.WA (1991) Ce//64, 871-874 
15 Hullin, R , Biel, M , Flockerzi, V and Hofmann, F (1993) Trends Cardiovasc Med 3. 48-53 
16 Miller, R J (1992) J Biol Chem 267,1403-1406 
17 De Jongh, К S , Warner, С and Catterall, W A (1990) J Biol Chem 265,14738-14741 
18 Tanabe, Τ , Takeshima, Η , Mikami, A , Flockerzi, V, Takahashi, Η , Kangawa К , Kojima, Μ , 
Matsuo, H , Hirose, Τ and Numa, S (1987) Nature 328, 313-318 
19 Perez-Reyes, E , Kim , H S , Lacersa, A E , Home, W , Wei, H S , Rampe, D , Campbell, Κ Ρ , 
Brown, Α Μ and Birnbaumer, L (1989) Nature 340, 233-236 
20 Beam, К G , Adams, В A , Niidome, Τ , Numa, S and Tanabe, Τ (1992) Nature 360,169-171 
21 Singer, D , Blei, M , Lota η, Ι , Flockerzi, V , Hofmann, F and Dascal, Ν (1991) Science 253 1553-
1557 
22 Varadi, G , Lory, Ρ , Schultz, D , Varadi, M and Schwanz, A (1992) Nature 352 159-162 
23 Drouet, В , Garcia , L , Simon-Chazottes, D , Mattel, M G , Guénet, J-L, Schwartz, A Varadi, G and 
Pinçon-Raymond, M (1993) Mammalian Genome 4, 499-503 
24 Iles, D E , Segers, В , Olde Weghuis, D , Suijkerbuijk, R , Mikala, G , Schwartz, A and Wiennga В 
(1994) Genomics 19, 561-563 
25 lies, D E , Segers, В , Sengers, R C A , Monsieurs, К , Heytens, L , Halsall, Ρ J , Hopkins Ρ M , Ellis, 
F R , Hall-Curran, J L , Stewart, A D and Wiennga, В (1993) Hum Molec Genet 2, 863-868 
26 Iles, D E , Segers, В , Olde Weghuis, D , Suijkerbuijk, R and Wiennga, В (1993) Cytogenet and 
Cell Genet 64, 227-230 
27 Sudbrak, R , Golia, A , Hogan, К , Gregg, R , Du Chesne, I, Lehmann-Horn, F and Deufel, Τ 
(1993) Hum Molec Genet 2,857-862 
28 Levitt, R С , Olckers, A , Meyers, S , Fletcher, J E , Rosenberg, H , Isaacs, H and Meyers, D A 
(1992) Genomics 14, 562-566 
29 Miyazawa, К , Krtamura, A , Naka, D and Krtamura, N (1991) Eur J Biochem 197,15-22 
30 Scherer, S W , Poorkaj, Ρ , Allen, Τ , Kim, J , Geshun, D , Nunez, M , Soder S , Pagon, R , 
Stephens, К , Patton, M , Rivera, Η , Berg, M A , Pfeiffer R A, Naritomi К , Hughes H , 
Genuardi, M , Gurnen, F , Nen, G , Lovrem, E , Magenis, E , Tsui, L-C and Evans J (1994) Am J 
Hum Genet (in press) 
31 Elhs, S В , Williams, M E , Ways, N R , Brenner, R , Sharp, Α Η , Leung, Α Τ , Campbell Κ Ρ , 
McKenna, E , Koch, W J , Hui, A , Schwartz, A and Harpold, M M (1988) Science 214, 1661-
1664 
110 
32 Scherer, S W , Tompkins, В J F and Tsui, L-C (1992) Mammalian Genome 3, 179-181 
33 Carle, G F and Olsen, M V (1987) In Wu, R (ed), Methods in Enzymology Academic Press, San 
Diego, Vol 155 part F, pp 468-482 
34 Weissenbach, J , Gyapay, G , Dib, С , Vignai, A , Monsette, J , Millasseau, Ρ , Vaysseix, G and 
Lathrop, M (1992) /Verure 359, 794-801 
35 NIH/СЕРН Collaborative Mapping Group (1992) Science 258, 63-86 
36 Brust. Ρ F , Simeson, S , McCue, A F , Deal, С R , Schoonmaker, S , Williams, Μ E , Velicelehi, G , 
Johnson, E С , Harpold, M H and Ellis, S В (1993) Neuropharmacology 32, 1089-1102 
37 Kim, H -L , Kim, Η , Lee, Ρ , King, R G and Chin, H (1992) Proc Natnl Acad Sci USA 89, 3251-
3255 
38 Powers, Ρ Α , Scherer, S W , Tsui, L-C , Gregg, R G and Hogan, К (1994) Genomics 19,192-193 
39 Saccone, S , Narsimhan, R Ρ , Gaudino, G , Dalpra, L , Comoglio, Ρ M and Della Valle, G (1992) 
Genomics 13, 912-914 
40 Kunz, J , Scherer, S W , Klawrtz, I, Soder, S , Du, Y-Z , Speich, Ν , Kalff-Suske, Μ , Heng, Η , Tsui, 
L-C and Grzeschik, K-H (1994) Genomics (in press) 
41 Fernandez-Ruiz, E , Armesilla, A L , Sanchez-Madrid, F and Vega, M A (1993) Genomics 17, 759-
761 
42 Otsu, К , Khanna, V К , Archibald, A L and MacLennan, D H (1991) Genomics 11, 744-750 
43 Sambrook, J , Fntsch, E F and Maniabs, Τ (1989) Molecular Cloning A Laboratory Manual (2nd 
edition) Cold Spring Harbour 
44 Sinke, R J , Suijkerbuijk, R F , Herbergs, J Janssen, H , Cassiman, J J and Geurts van Kessel, A 
(1992) Genomics 12, 206-213 
45 Suijkerbuijk, R F , Matthopoulos, D , Kearney, L , Monard, S , Dhut, S , Cotter, F E , Herbergs, J , 
Geurts van Kesssei, A and Young, В D (1992) Genomics 13, 355-362 
46 Weber, J L and May, Ρ E (1989) Am J Hum Genet 44, 388-396 
47 Ball, S Ρ , Dorkins, H R , Ellis. F R , Hall. J L , Halsall, Ρ J , Hopkins, Ρ M . Müller, R F and Stewart, 
A D (1993) Br J Anaesth 70, 70-75 
48 Freimer, Ν В , Sandkuijl L A and Blower, S M (1993) Am J Hum Genet 52, 1102-1110 
CHAPTER 8. 
Summary and General Discussion. 

113 
Summary and general discussion 
Malignant hyperthermia is a hereditary trait of skeletal muscle which manifests as a 
hypermetabohc crisis tnggered by commonly used anaesthetic agents At the time of its 
recognition as a clinically important syndrome in the 1960's, MH proved to be fatal in 
approximately 75% of all cases Fortunately, the application of the hydantoin muscle relaxant 
dantrolene sodium in the treatment of MH has resulted in a sharp decline in the mortality rate in 
MH dunng the last two decades, but even today MH remains one of the major causes of death 
due to anaesthesia 
As descnbed in chapter 1, a significant problem in the recognition of MH is the 
heterogeneity of its clinical presentation In its 'classic' form, MH can rapidly develop into a 
dramatic and catastrophic breakdown in the regulation of muscle metabolism leading to a loss 
of thermoregulatory control and muscle tissue integrity On the other hand, individuals 
susceptible to MH may develop no more than a transient stiffening of jaw muscles subsequent 
to administration of succinylcholine, or a slight nse in body temperature or tachycardia and 
tachypnoea dunng anaesthesia, all of which are reactions which may be encountered in non-
susceptible individuals Indeed, some patients may undergo several uneventful episodes of 
general anaesthesia before unexpectedly developing 'full blown' MH at a following operation The 
clinical picture of MH is further complicated by the propensity of patients suffenng from other 
neuromuscular disorders to develop life-threatening crises strongly resembling MH during 
anaesthesia Clearly, the question "when is an MH-like episode actually MH?" is not as easy to 
answer as it would first appear This problem has had important implications for the genetic study 
of the human MH syndrome 
A large number of diagnostic procedures for the presymptomatic assessment of MH nsk 
have been described, but only the IVCT has been found to be sufficiently reliable for the 
detection of patients at nsk Despite its general acceptance as the 'gold standard' for the 
diagnosis of MHS, the IVCT does exhibit a number of drawbacks In addition to its invasive 
nature and high cost, both in terms of patient inconvenience and medical resources, a relatively 
high percentage (10-15%) of tests fail to yield unequivocal results Moreover, the IVCT is not 
specific for MH, and patients suffenng from other neuromuscular disorders may also test as 
MHS Indeed, the tendency of muscle tissue from such patients to react abnormally in the IVCT 
may pose problems when attempting to estimate the frequency of the MH trait For example, the 
incidence of masseter muscle ngidity (MMR) among children undergoing surgery may be as high 
as 1% Since approximately half of all patients referred for contracture testing as a result of 
developing MMR are found to be MHS, the frequency of the MHS trait would be by implication 
1 in 200 of the population This figure probably represents a selectional bias since it does not 
resemble the actual occurrence of MH in the operating theatre, currently estimated at between 
1 in 15000 pediatnc and 1 in 40000 adult operations Nevertheless, the number of MH probands 
bom to parents both of whom test as MHS in the IVCT (8 out of 102 MHS families investigated 
to date by the European MH group come from MHS χ MHS mamages) would argue that 
estimates of the frequency of the MHS trait based solely on the occurrence of MH in the 
operating theatre are too low This background serves to emphasize further the need for a new, 
non-invasive, more specific and reliable test for susceptibility to MH The aim of the studies 
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presented in this thesis was to assess the feasibility of developing such a test based on the 
analysis of genomic DNA 
Susceptibility to MH in man is inhented as an autosomal dominant trait, making it 
accessible for genetic study Identification of a chromosomal region, or regions, associated with 
the occurrence of MHS would theoretically allow the accurate presymptomatic diagnosis of MHS 
in well characterized families, while the identification of causative mutations would allow the 
direct screening of all persons at risk without the need for contracture testing However, the 
localization of such regions or mutations is not straightforward Although recent technological 
advances have allowed the development of semi-automated 'genome scan' strategies for 
identifying chromosomal regions linked to disease genes, such procedures were unavailable at 
the start of our investigations Instead, as descnbed in chapters 3-7, we adopted a 'candidate 
gene' approach, wherein a gene encoding a protein suspected of playing a role in the aetiology 
of the disease under study is cloned and its chromosomal localization determined Linkage 
between the candidate gene and the disease trait segregating in families is assessed using 
genetic markers from within the gene itself or from its immediate vicinity, or from the surrounding 
chromosomal region In this way, the involvement of the candidate gene can be assessed 
directly, since failure of alleles detected by genetic markers specific for that gene to co-segregate 
with the disease will rule out an association between the gene and the disease trait 
Studies of porcine MH had shown a defect in the release of calcium from the SR to be 
a key abnormality in MH muscle These findings implicated the gene encoding the skeletal 
muscle calcium efflux channel/ryanodme receptor (RYR1) as a strong candidate for MH in swine, 
and the availability of cDNA clones encoding the human RYR1 protein allowed us to investigate 
the potential role of this gene in human MH As mentioned in chapter 1,"we first took steps to 
determine the chromosomal localization of the RYR1 gene Tight linkage between genetic 
markers for the glucose 6-phosphate isomerase (GPI) gene and the porcine MHS locus had been 
demonstrated previously, and since it was known that the human GPI locus mapped to the q12-
13 region of chromosome 19, it appeared likely that the human RYR1 locus would map here also 
Consequently, we used an existing panel of human χ hamster somatic hybnd cell lines, 
containing as sole human DNA fragments of the long arm of chromosome 19, to localize the 
RYR1 gene The results of these expenments confirmed the localization of RYR1 on 
chromosome 19, and allowed its assignment specifically to the region 19q13 1, distal to the GPI 
and MAG loa and proximal to CYP2A At the same time, tight linkage between MHS and RYR1 
was established in a separate study using restnction fragment length polymorphisms (RFLP) 
detected by RYR1 cDNA fragments The independent localization of the MHS locus to the region 
19q12-13 2 further increased the likelihood that mutations in the RYR1 gene were also 
responsible for MH in man Recently, mutations in the human RYR1 gene associated with MH 
have been identified and applied in the genetic diagnosis of MHS in a small number of families 
RFLP markers are usually of limited use as genetic markers due to their poor 
informativeness For this reason, we initiated a search for highly polymorphic microsatellite 
repeats in and around the RYR1 locus as potentially more useful markers in the study of MHS 
families, and in addition, we sought to localize more accurately existing chromosome 19 
microsatellite repeats using our somatic cell hybnd mapping panel Two markers, D19S75 and 
D19S47 were found to bracket RYR1 and were therefore ideal for the study of MHS 
Unfortunately, microsatellite repeats of sufficient size were not found within the approximately 
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205 kb region spanned by the RYR1 gene, and so the surrounding region was scanned for the 
presence of microsatelhtes Two markers, D19S190 and D19S191, resulted from this search 
and, as descnbed in chapter 3, were found to flank closely the RYR1 locus Application of the 
four markers in the study of a group of 7 European MHS families revealed linkage between the 
marker set and MHS in three families, but excluded linkage in four others These results 
conclusively demonstrated genetic heterogeneity in human MHS, and indicated for the first time 
that the clinical heterogeneity of MH presentation may result from mutations in distinct genes 
located on different chromsomal segments 
As descnbed in chapter 2, several proteins function co-ordinately to regulate the 
transduction of depolanzation signals from the sarcolemma to intracellular calcium stores and 
to effect the release of calcium into the sarcoplasm Mutations in any one of these proteins could 
conceivably lead to the abnormahtes in Ca2* regulation found in MHS muscle The DHP receptor 
embedded in the T-tubule membrane functions as an L-type voltage-dependent calcium channel 
and as the transducer of membrane depolanzation to the intenor of the muscle fibre, and 
therefore fulfils a cntical role in Ε-C coupling and in sarcoplasmic calcium regulation Moreover, 
it is the probable binding of dantrolene sodium to the DHPR complex, and not RYR1, that 
reverses an MH cnsis once underway We therefore undertook the cloning and chromosomal 
localization of the genes encoding the five subunits of the functional channel complex and sought 
to isolate microsatelhte repeat markers for each locus, in order to determine the roles, if any, 
played by the genes in those forms of MH not linked to markers for the q13 1 region of 
chromsome 19 
The skeletal muscle DHPRa,-subunit is a particularly interesting candidate for MHS 
because it functions as a voltage sensor, and because depolarizing muscle relaxants such as 
succinylchohne can tnggeran MH cnsis In addition, the DHPRot, subunit may interact with RYR1 
to trigger calcium release from the SR Mutations in the this subunit which interfere with 
DHPR/RYR1 interaction could conceivably lead to the abnormal activation kinetics of the calcium 
release channel observed in MHS muscle As descnbed in chapter 4, genomic clones containing 
the genes encoding the human cardiac (CACNL1A1) and skeletal muscle (CACNL1A3) isoforms 
of the α,-subunit were isolated and used for in situ hybndization expenments CACNL1A1 was 
found to localize to the distal short arm of chromsome 12, and CACNL1A3 localized to the distal 
long arm of chromosome 1 Microsatelhte repeats identified in the vicinity of each gene were 
found to be polymorphic, and were tested for linkage with MHS in 'non-RYRV families Despite 
the strength of the candidacy of CACNL1A3 on theoretical considerations, linkage between this 
gene and MHS was excluded, thereby ruling out any involvement of this gene in MH Linkage 
with the cardiac isoform was also excluded Surpnsingly, in a separate study CACNL1A3 was 
found to be tightly linked to another disorder of skeletal muscle, hypokalemic periodic paralysis 
(HypoPP), and studies are currently underway to identify mutations m CACNL1A3 responsible 
for HypoPP 
Genomic clones containing the genes encoding the skeletal muscle DHPR β and γ 
subunits (CACNLB1 and CACNLG) were isolated as descnbed in chapters 5 and 6, and again, 
polymorphic microsatelhte repeats were identified in the vicinity of the genes that proved to be 
useful as genetic markers Segregation analysis of our CACNLB1 marker in the MHS families 
under study located CACNLB1 to chromosome 17q proximal to the HOX2B locus, which had 
previously been assigned to the region 17q21-q22 In situ hybridization was used to localize 
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CACNLG to band q24 of chromosome 17 The localization of both of these genes to the long arm 
of chromosome 17 was particularly significant because a report appeared at the same time that 
described the localization of the MHS2 locus to the q11 2-q24 region of chromosome 17 Both 
genes were therefore located in the same region as the putative MHS2 locus, and were as a 
consequence particularly interesting as candidates for MHS2 Despite the coincidental 
assignments of CACNLB1, CACNLG and MHS2 to the same chromosomal arm, no linkage was 
detected in our'non-19' MHS families between the MHS trait and the β- and γ-subunit markers, 
and indeed several other genetic markers for chromosome 17q A second report proposed the 
gene encoding the α subunit of the skeletal muscle sodium channel (SCN4A) on 17q as a 
candidate for MHS2, but linkage between SCN4A and MHS was also excluded in our families 
Similar results were obtained by other groups, and the existence of an MHS2 locus on 
chromosome 17 therefore remains highly controversial The evidence presented in support of the 
chromosome 17 assignment was based on the summation of small positive lod scores from a 
number of small families, and not on strong linkage data obtained in larger pedigrees While the 
addition of small positive lod scores may sometimes be justifiable in the mapping of monogenic 
disease traits, this is obviously a dangerous step to take when investigating conditions in which 
genetic heterogeneity clearly exists 
As described in chapter 7, the two remaining subunits of the skeletal muscle DHPR 
channel complex, a 2 and δ, are encoded by a single gene, CACNL2A Attempts to isolate cosmid 
clones for this gene had proved unsuccessful, but somatic cell hybnd mapping allowed the 
provisional assignment of the gene to chromosome 7 The screening of a chromosome 7-specific 
yeast artificial chromosome (YAC) library subsequently yielded CACNL2A-positive clones which 
we used to localize CACNL2A to the proximal long arm of chromosome 7, specifically in the 
region 7q21 1 Again, we were able to develop a highly polymorphic microsatellite repeat marker 
for the CACNL2A gene region, which was designated D7S849 Segregation analysis of D7S849 
ailed out any association between this marker and MHS in five out of six MHS families, therefore 
excluding with all likelihood CANCL2A as a candidate gene for MHS in these families 
Interestingly, the marker was found to co-segregate with the MHS trait through 11 méioses in a 
large MHS pedigree (MH06), and other markers for the area were also tested in this family No 
recombinations were detected between MHS and the markers AFM203vb6 and AFM277vd5, 
while single recombinations between D7S524 distally and AFM295yg9 proximally delimited the 
9 cM region co-segregating with MHS in MH06. The theoretical maximum possible lod score for 
this family is 3 3, but since not all méioses were informative and since not all genetic and clinical 
data for this family were available, the resultant lod score was 2 91 at a recombination fraction 
of zero for the three markers This value, while being below the value of 3 generally accepted as 
proof of linkage, was nevertheless strongly indicative of an association between the CACNL2A 
region of chromosome 7q21 1 and MHS in this family, and provided for the first time significant 
evidence for the localization of a second MHS locus Genetic diagnosis of MHS in the remaining 
members of this family may become feasible in the near future, and this will represent the first 
instance of non-invasive, presymptomatic diagnosis of MHS in a family whose trait is not linked 
to RYR1 
Studies are currently underway to identify mutations in CACNL2A which may be 
associated with the MHS trait segregating in MH06 If mutations in CACNL2A do cause MH in 
some cases, then the question anses as to how these mutations affect intracellular Ca2 ' 
117 
regulation and result in the massive influx of Ca2* into the sarcoplasm during fulminant MH The 
DHPRa2-subunit is located in the T-tubule lumen, and the transmembrane δ-subunit anchors the 
a2-subunit to the membrane via disulphide bndges The two subunits may be involved in the 
regulation of calcium current density, and together with the ß-subunit pronouncedly increase the 
voltage-sensitivity of channel activation and inactivation Perhaps mutations which can lead to 
anaesthetic-induced conformational changes in either subunit could prevent the return of the 
voltage sensor to its 'relaxed' state, and thus lead indirectly to a prolonged opening of SR calcium 
efflux channels This could then precipitate the disturbance in calcium homeostasis within the 
muscle fibre However, if mutations in CACNL2A associated with MHS are discovered it will be 
necessary to investigate the electrophysiological and pharmacological effects of such mutations 
on DHPR channel function m vitro and in vivo before their role in MH can be established 
An Arg615Cys mutation in the porcine RYR1 gene has been detected which has been 
found to cosegregate with MHS in all swine breeds investigated to date, thus providing strong 
evidence of a causal association between the mutation and porcine MH In contrast, MH in 
humans is more complex While mutations in RYR1 have been associated with MHS in some 
families, our results have demonstrated the involvement of other genes in the human syndrome 
Since the trait in many families is linked neither to RYR1 nor to CACNL2A, this implies that three 
or more genes may be involved in MHS The identity of the other gene or genes remains 
unknown Having excluded the DHPRa,-, p- and γ-subunits as candidate genes for MHS, other 
proteins involved in Ε-C coupling and skeletal muscle calcium regulation must be investigated 
for their potential roles m MHS One such candidate for investigation is triadin, a protein which 
co-localizes with the calcium eflfux channel in the terminal SR, and which is thought to play an 
important role in Ε-C coupling If this protein functions in a way similar to that proposed in 
chapter 2, by transducing depolanzation-mduced conformational changes in the T-tubule voltage 
sensor or RYR1 to calsequestnn which in turn lead to a lowering of the affinity of calsequestnn 
for calcium, then mutations in tnadin could result in pathological alterations in the ability of 
calsequestnn to retain calcium under conditions capable of provoking MH Alternatively 
mutations in the FKBP12 protein responsible for the stabilization of RYR1 channel opening may 
under certain conditions influence the gating characteristics of the channel, again leading to 
mappropnate release of calcium Other calcium regulatory proteins of skeletal muscle, such as 
calsequestnn and the SR Ca2*ATPases, may also be important in MH, although it is not clear 
how known tnggers of MH such as succmylcholine and halothane, could influence their activity 
in such a way that an MH cnsis results 
It is attractive to speculate that the observed heterogeneity in the clinical manifestation 
of MH may to some extent be due to the genetic heterogeneity of the disorder Is MH then a 
syndrome of clinically similar disorders which manifest as an adverse reaction to anaesthetics? 
While mutations in different genes may be a convenient means to explain the occurrence or 
absence of a particular symptom of MH, such as skeletal muscle rigidity, the clinical progression 
of an MH cnsis in probands from families whose trait is linked to chromosome 19q12-13 2 can 
be very similar to those from families not linked to this region Therefore, mutations in different 
genes can give nse to MH episodes which are almost indistinguishable clinically This conundrum 
is compounded further by the fact that mutations in RYR1 have also been identified which are 
associated with the non-progressive neuromuscular disorder, central core disease In an attempt 
to resolve the complexity of the genetic background of MH and to identify the other protein(s) 
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involved in the disorder, the European MH group elected to carry out a genome scan using more 
than 250 microsatellite repeat markers distnbuted evenly across the entire genome, as descnbed 
earlier For this purpose a number of well characterized MHS families in which linkage with 
chromosome 19 had been excluded were selected, and only family members whose MHS status 
was unequivocal were included in the study A total of 167 individuals from 10, three generation 
families met these entena and were selected The results of the genome scan are awaited with 
interest 
Samenvatting. 

121 
Samenvatting. 
Maligne Hyperthermie (ΜΗ) is een erfelijke aandoening van de skeletspieren die zich in gevoelige 
personen kan manifesteren als een hypermetabohsche cnsis, die kan worden uitgelokt door 
depolanserende spierrelaxantia, zoals succinylcholme, en vluchtige anaesthetica, zoals 
halothaan In dejaren 60, rond de tijd van haar herkenning als een klinisch belangrijk syndroom, 
bleek MH een fatale afloop te hebben in minstens 75% van alle gevallen Gedurende de laatste 
twee decennia is dit sterftepercentage gelukkig sterk teruggedrongen, grotendeels dankzij de 
behandeling van MH met het hydantome spierrelaxans dantroleen sodium Desondanks, is MH 
tot op heden één van de belangrijkste doodsoorzaken in de anaesthesie gebleven 
In hoofdstuk 1 wordt de heterogeniteit van de klinische presentatie van MH beschreven 
In haar 'klassieke' vorm, kan MH zich snel ontwikkelen tot een dramatische en levens-
bedreigende storing in de regulatie van metabolische processen in skeletspieren, veroorzaakt 
door een ontregeling van de calcium ion homeostase In tegenstelling hiermee, kan een MH 
episode zich ook uiten in een transiente verstijving van de kaakspieren, in een kleine verhoging 
van de lichaamstemperatuur, of in een versnelling van hartslag en ademhahngs-frequentie, 
allemaal aspecifieke verschijnselen die ook bij MH-ongevoelige personen kunnen optreden 
Bovendien kunnen sommige MH patiënten verscheidene operaties ondergaan zonder 
complicaties, voordat er onverwachts een 'explosieve MH crisis' optreedt tijdens een volgende 
operatieve ingreep Het klinische beeld van MH wordt nog gecompliceerder gemaakt door het 
optreden van MH-achtige crises bij sommige patiënten die lijden aan andere neuromuscular 
ziekten Inmiddels is het duidelijk geworden, dat de vraag "wanneer is een MH crisis echt MH?" 
niet zo eenvoudig te beantwoorden is 
Het erfelijke karakter van MH-susceptibiliteit (MHS) maakt het ziektebeeld toegankelijk 
voor genetisch onderzoek Biochemische en fysiologische studies, grotendeels uitgevoerd aan 
het varkensmodel van MH, hadden aangetoond dat MH naar alle waarschijnlijkheid een gevolg 
was van het ongereguleerd vnjkomen van calcium ionen vanuit de intracellulaire opslag plaatsen 
in het sarcoplasmatisch reticulum (SR) De weg die leidde tot de identificatie van het SR calcium 
efflux kanaal, de ryanodine receptor (RYR), als een goed kandidaat gen voor MHS, zowel in het 
varken als in de mens, wordt ook in hoofdstuk 1 beschreven De beschikbaarheid van cDNA 
klonen die coderen voor het RYR eiwit, maakte het ons mogelijk de chromosomale localisatie van 
het humane RYR1 gen te bepalen op de lange arm van chromosoom 19 Tegelijkertijd werd 
koppeling tussen de overerving van MHS en genetische merkers vanuit het RYR1 gengebied op 
19q12-13 2 aangetoond in andere studies Inmiddels is het mogelijk door middel van genetisch 
analyse in een klem aantal klinisch goed gekaraktenseerde families betrouwbare voorspellingen 
te doen aangaande het MH nsico Bovendien zijn er mutaties in het RYR1 gen gevonden die 
mogelijk als oorzakelijk kunnen worden beschouwd voor MHS 
Een speurtocht naar hoogpolymorfe, 'microsatelhte repeat' merkers rondom het RYR1 
gen op chromosoom 19q13 1 leidde tot de ontdekking van twee nieuwe loci, D19S190 en 
D19S191 Gebruik makend van deze twee merkers, in combinatie met twee andere 
hoogpolymorfe merkers, D19S47 en D19S75, hebben WIJ het overervingspatroon van MH in een 
zevental Europese families onderzocht Zoals beschreven in hoofdstuk 3, is er in een drietal 
families genetische koppeling tussen MHS en de merkergroep gevonden, maar in vier andere 
families werd een associatie tussen de merkers en MHS uitgesloten Dit betekende dat in deze 
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families RYR1 onmogelijk als een oorzakelijk gen beschouwd kan worden Onze resultaten 
toonden voor het eerst aan, dat de heterogeniteit in de klinische presentatie van MH mogelijk te 
wijten was aan mutaties in verschillende genen gelegen op meerdere chromosomen 
In hoofdstuk 2 wordt beschreven hoe door structurele en electrofysiologische 
samenwerking van een aantal eiwitten, de overdracht van depolansatie-signalen van het 
sarcolemma naar het SR wordt geëffectueerd, en het vrijkomen van calcium ionen vanuit het SR 
wordt gereguleerd De dihydropyndine receptor (DHPR), die gelegen is in de membraan van de 
T-tubuli, functioneert als een L-type voltage-afhankelijk calcium kanaal, en tevens ook als een 
transductor van membraan depolansatie naar de binnenkant van de spiervezel De DHPR vervult 
daarmee een cruciale rol in de excitatie-contractie koppeling en de regulatie van calcium fluxen 
Het vermogen van depolanserende spierrelaxantia om een MH cnsis uit te lokken, en het feit dat 
de M H-blokkerende werking van dantroleen sodium waarschijnlijk berust op een binding aan de 
DHPR, vormen aanwijzigmgen voor de stelling dat de vijf verschillende onderdelen van het DHPR 
complex ook als kandidaten voor MHS beschouwd kunnen worden Om hun mogelijke 
betrokkenheid bij MH te onderzoeken, hebben WIJ daarom de klonenng en chromosomale 
localisenng van deze onderdelen (subunits) ondernomen 
De DHPR σ,-subunit is een belangnjke kandidaat voor MHS omdat ZIJ functioneert als de 
voltage-sensor van het complex, door calcium kanaal blokkers wordt gebonden, en mogelijk een 
interactie met RYR1 aangaat om het vnjkomen van calcium te reguleren Het is daarom denkbaar 
dat mutaties in dit eiwit kunnen resulteren in de ontregeling van calcium ion homeostase die 
optreedt tijdens een MH crisis In hoofdstuk 4 worden de isolatie van genomische klonen voor 
de hartspier- (CACNL1A1) en skeletspier (CACNL1A3)-isovormen van de α,-subunit, en de 
daarmee uitgevoerde genkartenngsexpenmenten beschreven De resultaten-hebben aangetoond 
dat CACNL1A1 is gelegen op de korte arm van chromosoom 12, en dat CACNL1A3 ligt op de 
distale lange arm van chromosoom 1 Genetische merkers, ontwikkeld voor elk van de twee 
subunits, zijn vervolgens getest voor koppeling met MHS in de families waarin geen koppeling 
met het RYR1 gen kon worden aangetoond, de zogenaamde 'niet-19' families Ondanks de 
sterke aanwijzigmgen op theoretische gronden, konden beide genen worden uitgesloten als 
kandidaten voor MHS Onverwacht echter, was de bevinding van een andere studie, dat 
CACNL1A3 en de erfelijke aandoening hypokalemic penodic paralysis (HypoPP) nauw waren 
gekoppeld Momenteel wordt er gezocht naar mutaties in CACNL1A3 die oorzakelijk kunnen zijn 
voor HypoPP 
De mogelijke betrokkenheid van de DHPR β- en γ-subunits (CACNLB1 en CACNLG) bij 
MH werd door ons onderzocht middels genomische klonenng, chromosomale genkartenng, 
genetische merker ontwikkeling en koppehngsstudies De resultaten zijn beschreven in 
hoofdstukken 5 en 6 Beide genen werden gelocahseerd op de lange arm van chromosoom 17, 
CACNLB1 in de regio 17q11 2-q22 en CACNLG in de regio 17q24 De localisata van de twee 
genen op chromosoom 17q kreeg extra betekenis toen een mogelijke MHS2 locus werd 
geïdentificeerd in het gebied 17q11 2-q24 Ondanks de localisatie van de twee genen en het 
voorgestelde MHS2 locus in hetzelfde chromosoomgebied, werden er in onze 'niet-19' families 
geen aanwijzigmgen gevonden voor koppeling tussen CACNLB1, CACNLG en MHS Opmerkelijk 
was de bevinding dat in deze families vrijwel uitgesloten kon worden dat een MHS locus op de 
lange arm van chromosoom 17 ligt Recente studies in andere Europese MH centra hebben 
evenmin aanwijzigmgen gevonden voor een MHS2 locus op 17q De localisatie van een MHS2 
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locus op chromosoom 17 blijft daarom onbevestigd en controversieel 
In hoofdstuk 7 worden de resultaten van de klonenng en genkartenng van de laatste twee 
subunits van de DHPR, a 2 en δ, beschreven Beide eiwitten worden geproduceerd door de 
posttranslationele splitsing van een enkel genprodukt, dat gecodeerd wordt door het CACNL2A 
gen Dit gen werd gelocaliseerd op de lange arm van chromosoom 7, en een genetische merker, 
D7S849, werd geïdentificeerd in de nabijheid van CACNL2A Hoewel geen koppeling tussen 
D7S849 en MHS kon worden aangetoond in vijf 'niet-19' MHS families, bleek in één familie wel 
sprake te zijn van mogelijke koppeling Meer gedetailleerde studies met andere genetische 
merkers van dezelfde regio van chromosoom 7 bevestigden deze koppeling, en toonden aan dat 
er waarschijnlijk in 11 méioses over dne generaties geen recombinaties hadden plaatsgevonden 
tussen D7S849 en MHS Hoewel deze resultaten onvoldoende zijn als bewijs dat mutaties in 
CACNL2A oorzakelijk zijn voor MH in deze familie, leveren ZIJ toch de eerste harde 
aanwijzigmgen voor het bestaan van een tweede MHS locus en haar locatie op chromosoom 7 
Binnen deze familie zal in de toekomst wellicht de presymptomatische diagnose van MHS door 
middel van een DNA test tot de mogelijkheden gaan behoren Dit zou het eerste voorbeeld zijn 
van de niet-invasieve vaststelling van MH-nsico in een familie waann de MH status niet 
gekoppeld is met RYR1 
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